olddirtbag的个人主页 - 老虎社区

olddirtbag

暂无个人介绍

IP属地：未知

259关注

5粉丝

0主题

0勋章

2021-12-29

Comment

These 3 Indicators May Predict How the Stock Market Performs in 2022: Analyst

2021-12-28

Like

U.S. regulators step up probe into Hyundai, Kia engine fires

2021-12-27

Like

Toplines Before US Market Open on Monday

2021-12-23

Comment

Tencent ADR rose more than 4% in early trading

2021-12-22

Comment

Amgen's Otezla Wins FDA Approval For Psoriasis, Regardless Of Severity Level

2021-12-19

Test

抱歉，原内容已删除

2021-12-17

Buy

3 Reasons to Buy Home Depot Stock and 1 Reason to Sell

2021-12-16

Like

Stocks Set to Extend Gains Ahead of More Central Bank Decisions

2021-12-15

Like and comment

Pfizer says COVID-19 pill near 90% protective against hospitalization, death

2021-12-13

Comment

Taper pace and path to liftoff set the themes for Fed meeting this week

2021-12-12

Zzz

Want $1 Million in Retirement? Invest $100,000 in These 2 Stocks and Hold Until 2035

2021-12-12

Sure anot??

Want $1 Million in Retirement? Invest $100,000 in These 2 Stocks and Hold Until 2035

2021-12-11

Comment and like

Wall St Week Ahead-Investors await faster taper, inflation view at Fed meeting

2021-12-09

Comm

抱歉，原内容已删除

2021-12-09

Comment

抱歉，原内容已删除

2021-12-08

Like

Not-So-Great Expectations for the Year Ahead?

2021-12-07

Like and comment

Stocks linked to the reopening of the economy gained on Monday

2021-12-05

Should I buy?

抱歉，原内容已删除

2021-12-04

comment and like

Adobe worth $26 billion less as DocuSign fears spark 'knee-jerk reaction' for stock

2021-09-30

comment and like

Micron Stock: Buy the Dip or Bail After Post-Earnings Decline?

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":3578003727844992,"uuid":"3578003727844992","gmtCreate":1616147516307,"gmtModify":1616147516307,"name":"olddirtbag","pinyin":"olddirtbag","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":5,"headSize":259,"tweetSize":90,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.23","exceedPercentage":"93.46%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.08.01","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.22","exceedPercentage":"80.59%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":4,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":696573176,"gmtCreate":1640741411722,"gmtModify":1640741411807,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Comment","listText":"Comment","text":"Comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/696573176","repostId":"1157924593","repostType":4,"repost":{"id":"1157924593","pubTimestamp":1640738343,"share":"https://www.laohu8.com/m/news/1157924593?lang=&edition=full","pubTime":"2021-12-29 08:39","market":"us","language":"en","title":"These 3 Indicators May Predict How the Stock Market Performs in 2022: Analyst","url":"https://stock-news.laohu8.com/highlight/detail?id=1157924593","media":"finance.yahoo","summary":"Christmas may be over, but for investors, the gifts may have only just begun.\nThe \"Santa Claus Rally","content":"<p>Christmas may be over, but for investors, the gifts may have only just begun.</p>\n<p>The \"Santa Claus Rally\" looks to send 2021 off on a high note for the stock market. The S&amp;P 500 (^GSPC) set a record high for the second consecutive day on Tuesday,subsequently falling&nbsp;a bit in light of a small midday tech stock sell-off.</p>\n<p><b>‘Ho, ho ho’, stocks on the rise?</b></p>\n<p>The last five trading days of the year and the first two trading days of the next year together are often the biggest week of the year for the market. The 1.2% average growth in the S&amp;P 500 over the period since 1945 is the largest of any seven-day period.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1c54ea712b8fce648fa682efa965a15a\" tg-width=\"705\" tg-height=\"470\" width=\"100%\" height=\"auto\"><span>A trader wears a Santa hat as he works on the floor of the New York Stock Exchange the day before Christmas in New York December 24, 2015. REUTERS/Lucas Jackson</span></p>\n<p>Why do these days perform so well historically?Animal spirits, as the 20th century economist John Maynard Keynes might put it, have a lot to do with the Santa Clause Rally.</p>\n<p>“It's [the result of] sentiment,” said Sam Stovall, chief investment strategist at CFRA Research, on the causes of the rally. “Because [investors know that] if the market does well in the month of January, then it usually does well for the full year. But if we find that a lot of money has flowed into the markets, right off the bat, then the indication is that it's likely to be a very good year.”</p>\n<p>Investors anticipate that the period is coming, and that equity prices are about to rise, so they are more likely to invest money to earn higher returns, Stovall explained.</p>\n<p>Though the sentiments behind the Santa Clause Rally may appear to be begging-the-question, there is nothing mythical about its results.</p>\n<p>According to a recent research note published by Stovall, years following a Santa Claus Rally period with a price increase, experienced an S&amp;P 500 growth rate of 10.3%, higher than the average rate of 9.2% (since 1945).</p>\n<p><b>January Barometers</b></p>\n<p>Two other barometers exist for investors eager to predict the outlook for 2022’s market, both of them involving market performance during the month of January, Stovall wrote. The first five days of January are a great indicator for the rest of the month’s performance.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/99e3e7627b845414da42f555bc4db069\" tg-width=\"705\" tg-height=\"470\" width=\"100%\" height=\"auto\"><span>A screen displays a stock update on the trading floor at the New York Stock Exchange (NYSE) in Manhattan, New York City, U.S., December 28, 2021. REUTERS/Andrew Kelly</span></p>\n<p>“The first five days offer an early warning signal as to how the market will likely perform during the entire month,” Stovall wrote in the CFRA report. “And it has done so with impressive accuracy, being correct two out of every three years for both up and down signals. What’s more, a positive showing for the equity market during the first five days of January improved the likelihood of an annual price increase by 12.8%, as well as an improvement in the FoA to 82%.”</p>\n<p>And as the old Wall Street adage goes, ‘So goes January, so goes the year.’ The third indicator, which Stovall dubbed “the January Barometer,” draws a correlation between the performance of the market in January and the succeeding 11 months.</p>\n<p>“Should the S&amp;P 500 go on to record a positive performance in the entire month of January, it has historically enhanced the possibility of a positive full-year performance, as the average annual price gain rose to 15.9% and the FoA (Frequency of Advance) increased to 87%,” the report noted.</p>\n<p>The biggest conclusion investors should draw from the barometers is that there is significant enough data to presume a causal relationship between the late December/January market performance and the larger year’s performance, Stovall said.</p>\n<p>“Not all of the year’s price gains were concentrated in the first month of the year, as a rise for the S&amp;P 500 in January was followed by an average 11.3% climb for the remaining 11 months of the year, with the market posting an 11-month FoA 83% of the time,” he wrote in the report.</p>\n<p>Though January’s gains appear to set the standard for the rest of the year by setting investor attitudes and expectations, Stovall stressed that these indicators are not guarantees.</p>\n<p>“Investors should always view history as a great guide, but never gospel,” he said. Past performance “gives a pretty strong hint of what might happen, but certainly no guarantee.”</p>\n<p>In 2022, the market will likely encounter challenges from the ongoing COVID pandemic as well as high inflation and the Federal Reserve’s attempts to control it.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a8c6b1ff968cfd5507f8c17566398310\" tg-width=\"705\" tg-height=\"470\" width=\"100%\" height=\"auto\"><span>NEW YORK, USA - DECEMBER 28: A man is getting a Covid-19 test at a Covid-19 testing center next to the Queens Hospital Center as hundreds of residents line up to get Covid-19 test in Queens of New York, United States on December 28, 2021 as Omicron rises around the country. (Photo by Tayfun Coskun/Anadolu Agency via Getty Images)More</span></p>\n<p>“When you think about some of the headwinds that could upset the track record of these different barometers, should they all be triggered,” Stovall said, adding the next COVID variant should be a top concern.</p>\n<p>The Omicron variant has been the latest strain of the coronavirus to spread throughout&nbsp;all 50 U.S. states. Though recent research suggests that Omicron cases are&nbsp;less severe&nbsp;than previous strains of the virus, it is highly transmissible and has already had an effect on consumer demand insome industries&nbsp;while some remain relatively&nbsp;unaffected.</p>\n<p>Secondly, the Federal Reserve has made it clear that it intends to raise interest rates in response to high inflation. Many economists expect these rate hikes to begin sometime next year.</p>\n<p>“That's a concern because if the Fed is too aggressive raising rates, that could throw the market into a tailspin,” Stovall said. “Also, historically, we have seen PE multiple contraction in a rising interest rate environment.”</p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These 3 Indicators May Predict How the Stock Market Performs in 2022: Analyst</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese 3 Indicators May Predict How the Stock Market Performs in 2022: Analyst\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-29 08:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/these-three-indicators-may-predict-how-the-stock-market-performs-in-2022-analyst-201508279.html><strong>finance.yahoo</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Christmas may be over, but for investors, the gifts may have only just begun.\nThe \"Santa Claus Rally\" looks to send 2021 off on a high note for the stock market. The S&P 500 (^GSPC) set a record high ...</p>\n\n<a href=\"https://finance.yahoo.com/news/these-three-indicators-may-predict-how-the-stock-market-performs-in-2022-analyst-201508279.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite",".DJI":"道琼斯"},"source_url":"https://finance.yahoo.com/news/these-three-indicators-may-predict-how-the-stock-market-performs-in-2022-analyst-201508279.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1157924593","content_text":"Christmas may be over, but for investors, the gifts may have only just begun.\nThe \"Santa Claus Rally\" looks to send 2021 off on a high note for the stock market. The S&P 500 (^GSPC) set a record high for the second consecutive day on Tuesday,subsequently falling a bit in light of a small midday tech stock sell-off.\n‘Ho, ho ho’, stocks on the rise?\nThe last five trading days of the year and the first two trading days of the next year together are often the biggest week of the year for the market. The 1.2% average growth in the S&P 500 over the period since 1945 is the largest of any seven-day period.\nA trader wears a Santa hat as he works on the floor of the New York Stock Exchange the day before Christmas in New York December 24, 2015. REUTERS/Lucas Jackson\nWhy do these days perform so well historically?Animal spirits, as the 20th century economist John Maynard Keynes might put it, have a lot to do with the Santa Clause Rally.\n“It's [the result of] sentiment,” said Sam Stovall, chief investment strategist at CFRA Research, on the causes of the rally. “Because [investors know that] if the market does well in the month of January, then it usually does well for the full year. But if we find that a lot of money has flowed into the markets, right off the bat, then the indication is that it's likely to be a very good year.”\nInvestors anticipate that the period is coming, and that equity prices are about to rise, so they are more likely to invest money to earn higher returns, Stovall explained.\nThough the sentiments behind the Santa Clause Rally may appear to be begging-the-question, there is nothing mythical about its results.\nAccording to a recent research note published by Stovall, years following a Santa Claus Rally period with a price increase, experienced an S&P 500 growth rate of 10.3%, higher than the average rate of 9.2% (since 1945).\nJanuary Barometers\nTwo other barometers exist for investors eager to predict the outlook for 2022’s market, both of them involving market performance during the month of January, Stovall wrote. The first five days of January are a great indicator for the rest of the month’s performance.\nA screen displays a stock update on the trading floor at the New York Stock Exchange (NYSE) in Manhattan, New York City, U.S., December 28, 2021. REUTERS/Andrew Kelly\n“The first five days offer an early warning signal as to how the market will likely perform during the entire month,” Stovall wrote in the CFRA report. “And it has done so with impressive accuracy, being correct two out of every three years for both up and down signals. What’s more, a positive showing for the equity market during the first five days of January improved the likelihood of an annual price increase by 12.8%, as well as an improvement in the FoA to 82%.”\nAnd as the old Wall Street adage goes, ‘So goes January, so goes the year.’ The third indicator, which Stovall dubbed “the January Barometer,” draws a correlation between the performance of the market in January and the succeeding 11 months.\n“Should the S&P 500 go on to record a positive performance in the entire month of January, it has historically enhanced the possibility of a positive full-year performance, as the average annual price gain rose to 15.9% and the FoA (Frequency of Advance) increased to 87%,” the report noted.\nThe biggest conclusion investors should draw from the barometers is that there is significant enough data to presume a causal relationship between the late December/January market performance and the larger year’s performance, Stovall said.\n“Not all of the year’s price gains were concentrated in the first month of the year, as a rise for the S&P 500 in January was followed by an average 11.3% climb for the remaining 11 months of the year, with the market posting an 11-month FoA 83% of the time,” he wrote in the report.\nThough January’s gains appear to set the standard for the rest of the year by setting investor attitudes and expectations, Stovall stressed that these indicators are not guarantees.\n“Investors should always view history as a great guide, but never gospel,” he said. Past performance “gives a pretty strong hint of what might happen, but certainly no guarantee.”\nIn 2022, the market will likely encounter challenges from the ongoing COVID pandemic as well as high inflation and the Federal Reserve’s attempts to control it.\nNEW YORK, USA - DECEMBER 28: A man is getting a Covid-19 test at a Covid-19 testing center next to the Queens Hospital Center as hundreds of residents line up to get Covid-19 test in Queens of New York, United States on December 28, 2021 as Omicron rises around the country. (Photo by Tayfun Coskun/Anadolu Agency via Getty Images)More\n“When you think about some of the headwinds that could upset the track record of these different barometers, should they all be triggered,” Stovall said, adding the next COVID variant should be a top concern.\nThe Omicron variant has been the latest strain of the coronavirus to spread throughout all 50 U.S. states. Though recent research suggests that Omicron cases are less severe than previous strains of the virus, it is highly transmissible and has already had an effect on consumer demand insome industries while some remain relatively unaffected.\nSecondly, the Federal Reserve has made it clear that it intends to raise interest rates in response to high inflation. Many economists expect these rate hikes to begin sometime next year.\n“That's a concern because if the Fed is too aggressive raising rates, that could throw the market into a tailspin,” Stovall said. “Also, historically, we have seen PE multiple contraction in a rising interest rate environment.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":446,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696656798,"gmtCreate":1640689318434,"gmtModify":1640689363451,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696656798","repostId":"2194610717","repostType":4,"repost":{"id":"2194610717","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640689014,"share":"https://www.laohu8.com/m/news/2194610717?lang=&edition=full","pubTime":"2021-12-28 18:56","market":"uk","language":"en","title":"U.S. regulators step up probe into Hyundai, Kia engine fires","url":"https://stock-news.laohu8.com/highlight/detail?id=2194610717","media":"Reuters","summary":"Dec 27 (Reuters) -The U.S. auto safety agency has stepped up its probe into engine fires that have p","content":"<p>Dec 27 (Reuters) -The U.S. auto safety agency has stepped up its probe into engine fires that have plagued some Hyundai Motor Co and Kia Motors Corp vehicles for over six years.</p>\n<p>The National Highway Traffic Safety Administration (NHTSA) said it had opened an \"engineering analysis\" covering about 3 million vehicles to evaluate, among other things, the efficacy of recalls initiated by the two automakers. The agency added that it was aware of 161 fires occurring potentially due to engine failures.</p>\n<p>An engineering analysis is the next step in a process that could lead to a recall, although sometimes NHTSA closes such probes without requiring any action.</p>\n<p>The agency had opened an investigation in 2019 covering the 2011-2014 Kia Optima and Sorento and the 2010-2015 Kia Soul, along with the 2011-2014 Hyundai Sonata and Santa Fe to investigate instances of non-crash fires.</p>\n<p>Hyundai said on Monday it continues to fully cooperate with NHTSA in regards to non-collision engine fires. Kia did not respond to a request for comment.</p>\n<p>The two South Korean companies had agreed to a record $210 million civil penalty last year after regulators said they failed to recall 1.6 million vehicles for engine issues in a timely fashion.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. regulators step up probe into Hyundai, Kia engine fires</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. regulators step up probe into Hyundai, Kia engine fires\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-28 18:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dec 27 (Reuters) -The U.S. auto safety agency has stepped up its probe into engine fires that have plagued some Hyundai Motor Co and Kia Motors Corp vehicles for over six years.</p>\n<p>The National Highway Traffic Safety Administration (NHTSA) said it had opened an \"engineering analysis\" covering about 3 million vehicles to evaluate, among other things, the efficacy of recalls initiated by the two automakers. The agency added that it was aware of 161 fires occurring potentially due to engine failures.</p>\n<p>An engineering analysis is the next step in a process that could lead to a recall, although sometimes NHTSA closes such probes without requiring any action.</p>\n<p>The agency had opened an investigation in 2019 covering the 2011-2014 Kia Optima and Sorento and the 2010-2015 Kia Soul, along with the 2011-2014 Hyundai Sonata and Santa Fe to investigate instances of non-crash fires.</p>\n<p>Hyundai said on Monday it continues to fully cooperate with NHTSA in regards to non-collision engine fires. Kia did not respond to a request for comment.</p>\n<p>The two South Korean companies had agreed to a record $210 million civil penalty last year after regulators said they failed to recall 1.6 million vehicles for engine issues in a timely fashion.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HYUD.UK":"现代汽车","HYEVF":"Hyundai Elevator Co Ltd.","KIMTF":"Kia Motors Corp."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2194610717","content_text":"Dec 27 (Reuters) -The U.S. auto safety agency has stepped up its probe into engine fires that have plagued some Hyundai Motor Co and Kia Motors Corp vehicles for over six years.\nThe National Highway Traffic Safety Administration (NHTSA) said it had opened an \"engineering analysis\" covering about 3 million vehicles to evaluate, among other things, the efficacy of recalls initiated by the two automakers. The agency added that it was aware of 161 fires occurring potentially due to engine failures.\nAn engineering analysis is the next step in a process that could lead to a recall, although sometimes NHTSA closes such probes without requiring any action.\nThe agency had opened an investigation in 2019 covering the 2011-2014 Kia Optima and Sorento and the 2010-2015 Kia Soul, along with the 2011-2014 Hyundai Sonata and Santa Fe to investigate instances of non-crash fires.\nHyundai said on Monday it continues to fully cooperate with NHTSA in regards to non-collision engine fires. Kia did not respond to a request for comment.\nThe two South Korean companies had agreed to a record $210 million civil penalty last year after regulators said they failed to recall 1.6 million vehicles for engine issues in a timely fashion.","news_type":1},"isVote":1,"tweetType":1,"viewCount":754,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696942268,"gmtCreate":1640610355358,"gmtModify":1640610355458,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/696942268","repostId":"1185167492","repostType":4,"repost":{"id":"1185167492","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640609888,"share":"https://www.laohu8.com/m/news/1185167492?lang=&edition=full","pubTime":"2021-12-27 20:58","market":"us","language":"en","title":"Toplines Before US Market Open on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1185167492","media":"Tiger Newspress","summary":"U.S. stock index futures inched higher on Monday, boosted by megacap companies, while hundreds of Om","content":"<p>U.S. stock index futures inched higher on Monday, boosted by megacap companies, while hundreds of Omicron-driven flight cancellations kept investors on edge at the start of this year's final trading week.</p>\n<p>Travel-related stocks, typically sensitive to news around the coronavirus, slid after U.S. airlines called off many flights for a third day on Sunday as surging COVID-19 cases forced Christmas weekend travelers to change plans.</p>\n<p>The S&amp;P 500 closed at a record high on Thursday, as upbeat news related to the Omicron coronavirus variant calmed investor nerves over the highly infection strain's economic impact after it upended markets earlier this month.</p>\n<p>Wall Street's three main indexes are eyeing a third straight yearly gain, with the benchmark S&amp;P 500 (.SPX) on track to close out the year 25.8% higher. The Dow is set to rise 17.5%, while the Nasdaq is looking at a 21.4% climb.</p>\n<p>At 8:00 a.m. ET, Dow e-minis were up 72 points, or 0.20% and S&amp;P 500 e-minis were up 15.50 points, or 0.33%.</p>\n<p>Nasdaq 100 e-minis were up 70.00 points, or 0.43% as megacap companies Tesla Inc (TSLA.O) and Microsoft Corp (MSFT.O) and Meta Platform (FB.O) firmed between 0.5% and 1%.Airline stocks – The major carriers saw their shares fall in the premarket after a surge in weekend cancellations due to staffing issues. United Airlines (UAL) slid 1.8%, American Airlines (AAL) fell 1.4%, Delta Air Lines (DAL) was down 1% and Southwest (LUV) declined 1.5%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/09541de8c4bcd965c62dbe3f6b7f6bc5\" tg-width=\"649\" tg-height=\"205\" width=\"100%\" height=\"auto\"><span>*Source From Tiger Trade, EST 08:00</span></p>\n<p><b>Stocks making the biggest moves premarket</b></p>\n<p>Cruise line stocks – Stocks of major cruise lines declined in premarket trading following three Covid-19 outbreaks in the past week on ships operated by Carnival (CCL) and Royal Caribbean (RCL). Carnival slid 2.2% in the premarket, while Royal Caribbean lost 1.9% and Norwegian Cruise Line Holdings (NCLH) slid 1.6%.</p>\n<p>Grab（GRAB）–&nbsp;Grab stock climbed more than 7% in premarket trading&nbsp;as&nbsp;Wall Street saw massive upside for Asian tech giant Grab, after disappointing debut.</p>\n<p>GoDaddy (GDDY) – GoDaddy jumped 3.9% in premarket action after the Wall Street Journal reported that activist investor Starboard Value had taken a 6.5% stake in the internet domain name registration company.</p>\n<p></p>\n<p>Apple (AAPL) – Apple was cited by the top competition regulator in the Netherlands, which said the company broke competition laws, and ordered changes to Apple’s App Store payment policies. Apple said it would appeal the ruling.</p>\n<p></p>\n<p>Cigna (CI) – The insurer will reaffirm its 2021 and 2022 earnings guidance at its upcoming investor meetings, according to an SEC filing. Cigna expected 2021 adjusted earnings of at least $20.35 per share and sees projected growth of at least 10% for 2022.</p>\n<p></p>\n<p>Moderna (MRNA) – The drugmaker is fighting a shareholder proposal that the company open up its vaccine technology to poorer countries, according to a report in the Financial Times. The proposal calls on Moderna to explain why its prices are so high in light of the amount of government financial support it has received. Moderna fell 2% in the premarket.</p>\n<p></p>\n<p>Avis Budget (CAR) – The car rental firm’s shares jumped 2.6% in premarket trading, following a 3.2% gain Thursday. Average daily rental rates are at $81 per day, according to travel firm Kayak. That’s up 31% from a year ago.</p>\n<p></p>\n<p>Didi Global (DIDI) – Didi fell 1.3% in the premarket after the Financial Times reported that the China-based ride-hailing company is blocking employees from selling the shares for an indefinite period. That follows the company’s move to delist in the United States.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-27 20:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. stock index futures inched higher on Monday, boosted by megacap companies, while hundreds of Omicron-driven flight cancellations kept investors on edge at the start of this year's final trading week.</p>\n<p>Travel-related stocks, typically sensitive to news around the coronavirus, slid after U.S. airlines called off many flights for a third day on Sunday as surging COVID-19 cases forced Christmas weekend travelers to change plans.</p>\n<p>The S&amp;P 500 closed at a record high on Thursday, as upbeat news related to the Omicron coronavirus variant calmed investor nerves over the highly infection strain's economic impact after it upended markets earlier this month.</p>\n<p>Wall Street's three main indexes are eyeing a third straight yearly gain, with the benchmark S&amp;P 500 (.SPX) on track to close out the year 25.8% higher. The Dow is set to rise 17.5%, while the Nasdaq is looking at a 21.4% climb.</p>\n<p>At 8:00 a.m. ET, Dow e-minis were up 72 points, or 0.20% and S&amp;P 500 e-minis were up 15.50 points, or 0.33%.</p>\n<p>Nasdaq 100 e-minis were up 70.00 points, or 0.43% as megacap companies Tesla Inc (TSLA.O) and Microsoft Corp (MSFT.O) and Meta Platform (FB.O) firmed between 0.5% and 1%.Airline stocks – The major carriers saw their shares fall in the premarket after a surge in weekend cancellations due to staffing issues. United Airlines (UAL) slid 1.8%, American Airlines (AAL) fell 1.4%, Delta Air Lines (DAL) was down 1% and Southwest (LUV) declined 1.5%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/09541de8c4bcd965c62dbe3f6b7f6bc5\" tg-width=\"649\" tg-height=\"205\" width=\"100%\" height=\"auto\"><span>*Source From Tiger Trade, EST 08:00</span></p>\n<p><b>Stocks making the biggest moves premarket</b></p>\n<p>Cruise line stocks – Stocks of major cruise lines declined in premarket trading following three Covid-19 outbreaks in the past week on ships operated by Carnival (CCL) and Royal Caribbean (RCL). Carnival slid 2.2% in the premarket, while Royal Caribbean lost 1.9% and Norwegian Cruise Line Holdings (NCLH) slid 1.6%.</p>\n<p>Grab（GRAB）–&nbsp;Grab stock climbed more than 7% in premarket trading&nbsp;as&nbsp;Wall Street saw massive upside for Asian tech giant Grab, after disappointing debut.</p>\n<p>GoDaddy (GDDY) – GoDaddy jumped 3.9% in premarket action after the Wall Street Journal reported that activist investor Starboard Value had taken a 6.5% stake in the internet domain name registration company.</p>\n<p></p>\n<p>Apple (AAPL) – Apple was cited by the top competition regulator in the Netherlands, which said the company broke competition laws, and ordered changes to Apple’s App Store payment policies. Apple said it would appeal the ruling.</p>\n<p></p>\n<p>Cigna (CI) – The insurer will reaffirm its 2021 and 2022 earnings guidance at its upcoming investor meetings, according to an SEC filing. Cigna expected 2021 adjusted earnings of at least $20.35 per share and sees projected growth of at least 10% for 2022.</p>\n<p></p>\n<p>Moderna (MRNA) – The drugmaker is fighting a shareholder proposal that the company open up its vaccine technology to poorer countries, according to a report in the Financial Times. The proposal calls on Moderna to explain why its prices are so high in light of the amount of government financial support it has received. Moderna fell 2% in the premarket.</p>\n<p></p>\n<p>Avis Budget (CAR) – The car rental firm’s shares jumped 2.6% in premarket trading, following a 3.2% gain Thursday. Average daily rental rates are at $81 per day, according to travel firm Kayak. That’s up 31% from a year ago.</p>\n<p></p>\n<p>Didi Global (DIDI) – Didi fell 1.3% in the premarket after the Financial Times reported that the China-based ride-hailing company is blocking employees from selling the shares for an indefinite period. That follows the company’s move to delist in the United States.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1185167492","content_text":"U.S. stock index futures inched higher on Monday, boosted by megacap companies, while hundreds of Omicron-driven flight cancellations kept investors on edge at the start of this year's final trading week.\nTravel-related stocks, typically sensitive to news around the coronavirus, slid after U.S. airlines called off many flights for a third day on Sunday as surging COVID-19 cases forced Christmas weekend travelers to change plans.\nThe S&P 500 closed at a record high on Thursday, as upbeat news related to the Omicron coronavirus variant calmed investor nerves over the highly infection strain's economic impact after it upended markets earlier this month.\nWall Street's three main indexes are eyeing a third straight yearly gain, with the benchmark S&P 500 (.SPX) on track to close out the year 25.8% higher. The Dow is set to rise 17.5%, while the Nasdaq is looking at a 21.4% climb.\nAt 8:00 a.m. ET, Dow e-minis were up 72 points, or 0.20% and S&P 500 e-minis were up 15.50 points, or 0.33%.\nNasdaq 100 e-minis were up 70.00 points, or 0.43% as megacap companies Tesla Inc (TSLA.O) and Microsoft Corp (MSFT.O) and Meta Platform (FB.O) firmed between 0.5% and 1%.Airline stocks – The major carriers saw their shares fall in the premarket after a surge in weekend cancellations due to staffing issues. United Airlines (UAL) slid 1.8%, American Airlines (AAL) fell 1.4%, Delta Air Lines (DAL) was down 1% and Southwest (LUV) declined 1.5%.\n*Source From Tiger Trade, EST 08:00\nStocks making the biggest moves premarket\nCruise line stocks – Stocks of major cruise lines declined in premarket trading following three Covid-19 outbreaks in the past week on ships operated by Carnival (CCL) and Royal Caribbean (RCL). Carnival slid 2.2% in the premarket, while Royal Caribbean lost 1.9% and Norwegian Cruise Line Holdings (NCLH) slid 1.6%.\nGrab（GRAB）– Grab stock climbed more than 7% in premarket trading as Wall Street saw massive upside for Asian tech giant Grab, after disappointing debut.\nGoDaddy (GDDY) – GoDaddy jumped 3.9% in premarket action after the Wall Street Journal reported that activist investor Starboard Value had taken a 6.5% stake in the internet domain name registration company.\n\nApple (AAPL) – Apple was cited by the top competition regulator in the Netherlands, which said the company broke competition laws, and ordered changes to Apple’s App Store payment policies. Apple said it would appeal the ruling.\n\nCigna (CI) – The insurer will reaffirm its 2021 and 2022 earnings guidance at its upcoming investor meetings, according to an SEC filing. Cigna expected 2021 adjusted earnings of at least $20.35 per share and sees projected growth of at least 10% for 2022.\n\nModerna (MRNA) – The drugmaker is fighting a shareholder proposal that the company open up its vaccine technology to poorer countries, according to a report in the Financial Times. The proposal calls on Moderna to explain why its prices are so high in light of the amount of government financial support it has received. Moderna fell 2% in the premarket.\n\nAvis Budget (CAR) – The car rental firm’s shares jumped 2.6% in premarket trading, following a 3.2% gain Thursday. Average daily rental rates are at $81 per day, according to travel firm Kayak. That’s up 31% from a year ago.\n\nDidi Global (DIDI) – Didi fell 1.3% in the premarket after the Financial Times reported that the China-based ride-hailing company is blocking employees from selling the shares for an indefinite period. That follows the company’s move to delist in the United States.","news_type":1},"isVote":1,"tweetType":1,"viewCount":725,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698906072,"gmtCreate":1640271237633,"gmtModify":1640271237710,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Comment","listText":"Comment","text":"Comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/698906072","repostId":"1177863167","repostType":4,"repost":{"id":"1177863167","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640270946,"share":"https://www.laohu8.com/m/news/1177863167?lang=&edition=full","pubTime":"2021-12-23 22:49","market":"us","language":"en","title":"Tencent ADR rose more than 4% in early trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1177863167","media":"Tiger Newspress","summary":"Tencent ADR rose more than 4% in early trading.Tencent said on Thursday it will transfer HK$127.69 b","content":"<p>Tencent&nbsp;ADR&nbsp;rose&nbsp;more&nbsp;than&nbsp;4%&nbsp;in&nbsp;early&nbsp;trading.<img src=\"https://static.tigerbbs.com/5c64eef1168fcdac16b6cdfe487310c5\" tg-width=\"707\" tg-height=\"595\" width=\"100%\" height=\"auto\">Tencent said on Thursday it will transfer HK$127.69 billion ($16.37 billion) worth of its JD.com stake to shareholders, slashing its holding in China's second-biggest e-commerce company to 2.3% from around 17% now and losing its spot as JD.com's biggest shareholder to Walmart(WMT.N).</p>\n<p>The owner of WeChat, which first invested in JD.com in 2014, said it was the right time for the divestment, given the e-commerce firm had reached a stage where it can self-finance its growth.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tencent ADR rose more than 4% in early trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTencent ADR rose more than 4% in early trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-23 22:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Tencent&nbsp;ADR&nbsp;rose&nbsp;more&nbsp;than&nbsp;4%&nbsp;in&nbsp;early&nbsp;trading.<img src=\"https://static.tigerbbs.com/5c64eef1168fcdac16b6cdfe487310c5\" tg-width=\"707\" tg-height=\"595\" width=\"100%\" height=\"auto\">Tencent said on Thursday it will transfer HK$127.69 billion ($16.37 billion) worth of its JD.com stake to shareholders, slashing its holding in China's second-biggest e-commerce company to 2.3% from around 17% now and losing its spot as JD.com's biggest shareholder to Walmart(WMT.N).</p>\n<p>The owner of WeChat, which first invested in JD.com in 2014, said it was the right time for the divestment, given the e-commerce firm had reached a stage where it can self-finance its growth.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"00700":"腾讯控股","TCEHY":"腾讯控股ADR"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1177863167","content_text":"Tencent ADR rose more than 4% in early trading.Tencent said on Thursday it will transfer HK$127.69 billion ($16.37 billion) worth of its JD.com stake to shareholders, slashing its holding in China's second-biggest e-commerce company to 2.3% from around 17% now and losing its spot as JD.com's biggest shareholder to Walmart(WMT.N).\nThe owner of WeChat, which first invested in JD.com in 2014, said it was the right time for the divestment, given the e-commerce firm had reached a stage where it can self-finance its growth.","news_type":1},"isVote":1,"tweetType":1,"viewCount":452,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691985311,"gmtCreate":1640125986981,"gmtModify":1640126022488,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Comment","listText":"Comment","text":"Comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691985311","repostId":"1198919837","repostType":4,"repost":{"id":"1198919837","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1640098127,"share":"https://www.laohu8.com/m/news/1198919837?lang=&edition=full","pubTime":"2021-12-21 22:48","market":"us","language":"en","title":"Amgen's Otezla Wins FDA Approval For Psoriasis, Regardless Of Severity Level","url":"https://stock-news.laohu8.com/highlight/detail?id=1198919837","media":"Benzinga","summary":"The FDA has approved Amgen Inc's Otezla (apremilast) to treat adult patients with plaque psoriasis w","content":"<p>The&nbsp;FDA has approved&nbsp;<b>Amgen Inc's</b>&nbsp;Otezla (apremilast) to treat adult patients with plaque psoriasis who are candidates for phototherapy or systemic therapy.</p>\n<ul>\n <li>With this expanded indication, Otezla is now the first and only oral treatment approved in adult patients with plaque psoriasis across all severities, including mild, moderate, and severe.</li>\n <li>The FDA approval is based on Phase 3 ADVANCE trial data. Five times as many adults receiving oral Otezla 30 achieved the primary endpoint of Static Physician's Global Assessment response at week 16 compared to placebo (21.6% versus 4.1%).</li>\n <li>Otezla is approved for three indications in the U.S.</li>\n <li><b>Price Action:</b>&nbsp;AMGN shares closed at $219.99 on Monday.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Amgen's Otezla Wins FDA Approval For Psoriasis, Regardless Of Severity Level</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmgen's Otezla Wins FDA Approval For Psoriasis, Regardless Of Severity Level\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-12-21 22:48</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>The&nbsp;FDA has approved&nbsp;<b>Amgen Inc's</b>&nbsp;Otezla (apremilast) to treat adult patients with plaque psoriasis who are candidates for phototherapy or systemic therapy.</p>\n<ul>\n <li>With this expanded indication, Otezla is now the first and only oral treatment approved in adult patients with plaque psoriasis across all severities, including mild, moderate, and severe.</li>\n <li>The FDA approval is based on Phase 3 ADVANCE trial data. Five times as many adults receiving oral Otezla 30 achieved the primary endpoint of Static Physician's Global Assessment response at week 16 compared to placebo (21.6% versus 4.1%).</li>\n <li>Otezla is approved for three indications in the U.S.</li>\n <li><b>Price Action:</b>&nbsp;AMGN shares closed at $219.99 on Monday.</li>\n</ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMGN":"安进"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1198919837","content_text":"The FDA has approved Amgen Inc's Otezla (apremilast) to treat adult patients with plaque psoriasis who are candidates for phototherapy or systemic therapy.\n\nWith this expanded indication, Otezla is now the first and only oral treatment approved in adult patients with plaque psoriasis across all severities, including mild, moderate, and severe.\nThe FDA approval is based on Phase 3 ADVANCE trial data. Five times as many adults receiving oral Otezla 30 achieved the primary endpoint of Static Physician's Global Assessment response at week 16 compared to placebo (21.6% versus 4.1%).\nOtezla is approved for three indications in the U.S.\nPrice Action: AMGN shares closed at $219.99 on Monday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":425,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699741032,"gmtCreate":1639911447414,"gmtModify":1639911447498,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Test","listText":"Test","text":"Test","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/699741032","repostId":"2192035909","repostType":4,"isVote":1,"tweetType":1,"viewCount":884,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699341695,"gmtCreate":1639752339922,"gmtModify":1639752629684,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Buy","listText":"Buy","text":"Buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699341695","repostId":"2192997802","repostType":4,"repost":{"id":"2192997802","pubTimestamp":1639749092,"share":"https://www.laohu8.com/m/news/2192997802?lang=&edition=full","pubTime":"2021-12-17 21:51","market":"us","language":"en","title":"3 Reasons to Buy Home Depot Stock and 1 Reason to Sell","url":"https://stock-news.laohu8.com/highlight/detail?id=2192997802","media":"Motley Fool","summary":"The home improvement retailer is firing on all cylinders from a fundamental standpoint.","content":"<p>Year to date, <b>Home Depot</b>'s (NYSE:HD) stock has soared roughly 51% as a result of its marvelous business performance. This has absolutely trounced the <b>S&amp;P 500</b>'s 24.4% appreciation year to date, which raises the following question: Is Home Depot's stock still a buy?</p>\n<p>To answer this question, let's go over three reasons to buy the stock and one reason you might want to consider selling it.</p>\n<h2>1. Home Depot torched third-quarter analyst estimates</h2>\n<p>Home Depot managed to easily beat analysts' expectations of revenue and diluted earnings per share (EPS) in the third quarter ended Oct. 31.</p>\n<p>The retailer reported $36.82 billion in sales during the quarter, representing a 9.8% increase compared to the year-ago period. This exceeded the average analyst forecast of $34.87 billion by 5.6%.&nbsp;How was Home Depot able to surpass the consensus revenue projection?</p>\n<p>First, Home Depot increased its overall comparable-store sales by 6.1% year over year.&nbsp;This was the result of the fact that 12 out of Home Depot's 14 merchandising departments posted positive comps during the quarter, according to COO Ted Decker's opening remarks during the company's Q3 2021 earnings call. Decker noted that the only two departments that didn't grow comps were indoor garden (comps were basically flat) and lumber (comps were down by high single-digit percentages year over year for the department).</p>\n<p>Second, Home Depot's store count edged higher to 2,317 stores across U.S. states and territories, Canada, and Mexico.</p>\n<p>Home Depot produced $3.92 in diluted EPS during the quarter, which works out to a robust 23.3% growth rate against the year-ago period. This helped the company to top analysts' prediction of $3.41 in diluted EPS by 15%.</p>\n<p>A year-over-year 100-basis-point increase in Home Depot's net margins during the third quarter to 11.2%, paired with a 2.3% decline in the stock's outstanding diluted share count, enabled the company to put together another highly profitable quarter.</p>\n<p>The most encouraging figure from Home Depot's third quarter was that its big-ticket transactions (defined as purchases $1,000 and up) were up 18% year over year.&nbsp;This is important because the vast majority of big-ticket transactions tend to come from professional contractors, which are the most lucrative customer base for home improvement retailers. This healthy growth suggests that Home Depot will remain the preferred destination of pros for the foreseeable future.</p>\n<h2>2. The balance sheet is a fortress</h2>\n<p>Home Depot's operating results were once again spectacular in the third quarter. But an equally impressive reason to buy the stock is its strong financial positioning.</p>\n<p>As of Q3, Home Depot's net debt was $34.08 billion ($39.15 billion in long-term debt less $5.07 billion in cash). Over the last 12 months, Home Depot has generated $24.64 billion in earnings before interest, taxes, depreciation, and amortization (EBITDA). This equates to a net debt-to-EBITDA ratio of 1.4.</p>\n<p>This means that Home Depot could completely repay its long-term debt in about 17 months if it didn't pay a dividend and income taxes. Of course, it will take longer because the company will continue to pay a dividend and income taxes. But the gist of it is that Home Depot maintains a conservative balance sheet. This should translate into a very low risk of bankruptcy in the long term.</p>\n<h2>3. A safe and market-beating dividend</h2>\n<p>The third reason to consider buying Home Depot is that the stock offers income investors a sustainable 1.6% dividend yield, which is moderately higher than the S&amp;P 500's 1.3% yield.</p>\n<p>Because Home Depot's payout ratio will be 42.7% for this year based on the average analyst estimate of $15.46 in diluted EPS, the stock has plenty of room to keep growing its dividend going forward.</p>\n<p>Since analysts anticipate that Home Depot will grow its diluted EPS by 15% annually over the next five years, this should allow for double-digit percentage dividend increases in the medium term.</p>\n<h2>Home Depot's stock has run up too far, too fast</h2>\n<p>Home Depot's operating momentum and impeccable balance sheet haven't gone unnoticed by Mr. Market, however. That explains why the stock has outperformed the broader market by such a wide margin.</p>\n<p>As a result, I believe that the stock has appreciated too much in too short of a period of time. For instance, Home Depot's forward P/E ratio of 25.2 is considerably higher than the S&amp;P 500's forward P/E ratio of 21.3.&nbsp;The stock undoubtedly deserves to be trading at a premium to the S&amp;P 500, but I would argue the current 18% premium is a bit too much. That's why I believe investors should put Home Depot on their watch list as one of the very first stocks to buy the next time the market experiences a pullback.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Reasons to Buy Home Depot Stock and 1 Reason to Sell</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Reasons to Buy Home Depot Stock and 1 Reason to Sell\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-17 21:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/17/3-reasons-buy-home-depot-stock-1-reason-to-sell/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Year to date, Home Depot's (NYSE:HD) stock has soared roughly 51% as a result of its marvelous business performance. This has absolutely trounced the S&P 500's 24.4% appreciation year to date, which ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/17/3-reasons-buy-home-depot-stock-1-reason-to-sell/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4567":"ESG概念","BK4083":"家庭装潢零售","BK4534":"瑞士信贷持仓","BK4550":"红杉资本持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4504":"桥水持仓","BK4566":"资本集团","HD":"家得宝"},"source_url":"https://www.fool.com/investing/2021/12/17/3-reasons-buy-home-depot-stock-1-reason-to-sell/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192997802","content_text":"Year to date, Home Depot's (NYSE:HD) stock has soared roughly 51% as a result of its marvelous business performance. This has absolutely trounced the S&P 500's 24.4% appreciation year to date, which raises the following question: Is Home Depot's stock still a buy?\nTo answer this question, let's go over three reasons to buy the stock and one reason you might want to consider selling it.\n1. Home Depot torched third-quarter analyst estimates\nHome Depot managed to easily beat analysts' expectations of revenue and diluted earnings per share (EPS) in the third quarter ended Oct. 31.\nThe retailer reported $36.82 billion in sales during the quarter, representing a 9.8% increase compared to the year-ago period. This exceeded the average analyst forecast of $34.87 billion by 5.6%. How was Home Depot able to surpass the consensus revenue projection?\nFirst, Home Depot increased its overall comparable-store sales by 6.1% year over year. This was the result of the fact that 12 out of Home Depot's 14 merchandising departments posted positive comps during the quarter, according to COO Ted Decker's opening remarks during the company's Q3 2021 earnings call. Decker noted that the only two departments that didn't grow comps were indoor garden (comps were basically flat) and lumber (comps were down by high single-digit percentages year over year for the department).\nSecond, Home Depot's store count edged higher to 2,317 stores across U.S. states and territories, Canada, and Mexico.\nHome Depot produced $3.92 in diluted EPS during the quarter, which works out to a robust 23.3% growth rate against the year-ago period. This helped the company to top analysts' prediction of $3.41 in diluted EPS by 15%.\nA year-over-year 100-basis-point increase in Home Depot's net margins during the third quarter to 11.2%, paired with a 2.3% decline in the stock's outstanding diluted share count, enabled the company to put together another highly profitable quarter.\nThe most encouraging figure from Home Depot's third quarter was that its big-ticket transactions (defined as purchases $1,000 and up) were up 18% year over year. This is important because the vast majority of big-ticket transactions tend to come from professional contractors, which are the most lucrative customer base for home improvement retailers. This healthy growth suggests that Home Depot will remain the preferred destination of pros for the foreseeable future.\n2. The balance sheet is a fortress\nHome Depot's operating results were once again spectacular in the third quarter. But an equally impressive reason to buy the stock is its strong financial positioning.\nAs of Q3, Home Depot's net debt was $34.08 billion ($39.15 billion in long-term debt less $5.07 billion in cash). Over the last 12 months, Home Depot has generated $24.64 billion in earnings before interest, taxes, depreciation, and amortization (EBITDA). This equates to a net debt-to-EBITDA ratio of 1.4.\nThis means that Home Depot could completely repay its long-term debt in about 17 months if it didn't pay a dividend and income taxes. Of course, it will take longer because the company will continue to pay a dividend and income taxes. But the gist of it is that Home Depot maintains a conservative balance sheet. This should translate into a very low risk of bankruptcy in the long term.\n3. A safe and market-beating dividend\nThe third reason to consider buying Home Depot is that the stock offers income investors a sustainable 1.6% dividend yield, which is moderately higher than the S&P 500's 1.3% yield.\nBecause Home Depot's payout ratio will be 42.7% for this year based on the average analyst estimate of $15.46 in diluted EPS, the stock has plenty of room to keep growing its dividend going forward.\nSince analysts anticipate that Home Depot will grow its diluted EPS by 15% annually over the next five years, this should allow for double-digit percentage dividend increases in the medium term.\nHome Depot's stock has run up too far, too fast\nHome Depot's operating momentum and impeccable balance sheet haven't gone unnoticed by Mr. Market, however. That explains why the stock has outperformed the broader market by such a wide margin.\nAs a result, I believe that the stock has appreciated too much in too short of a period of time. For instance, Home Depot's forward P/E ratio of 25.2 is considerably higher than the S&P 500's forward P/E ratio of 21.3. The stock undoubtedly deserves to be trading at a premium to the S&P 500, but I would argue the current 18% premium is a bit too much. That's why I believe investors should put Home Depot on their watch list as one of the very first stocks to buy the next time the market experiences a pullback.","news_type":1},"isVote":1,"tweetType":1,"viewCount":691,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690177008,"gmtCreate":1639650842823,"gmtModify":1639650842951,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/690177008","repostId":"1184616731","repostType":4,"repost":{"id":"1184616731","pubTimestamp":1639650290,"share":"https://www.laohu8.com/m/news/1184616731?lang=&edition=full","pubTime":"2021-12-16 18:24","market":"us","language":"en","title":"Stocks Set to Extend Gains Ahead of More Central Bank Decisions","url":"https://stock-news.laohu8.com/highlight/detail?id=1184616731","media":"WSJ","summary":"Stocks were poised to extend gains ahead of policy decisions by the European Central Bank and Bank o","content":"<p>Stocks were poised to extend gains ahead of policy decisions by the European Central Bank and Bank of England, which follow the Federal Reserve’s pivot toward higher interest rates.</p>\n<p>Futures for the S&amp;P 500 rose 0.5% Thursday, a day after the broad stocks gauge closed at its second-highest level on record. Contracts for the Dow Jones Industrial Average added 0.4% and Nasdaq-100 futures climbed 0.6%, pointing to a strong start to the session for technology stocks.</p>\n<p>Brent-crude futures, the benchmark in international oil markets, rose 0.9% to $74.51 a barrel. Yields on 10-year Treasury notes ticked down to 1.451% Thursday from 1.460% Wednesday. Yields move in the opposite direction to bond prices and barely moved in response to the Fed’s shift to tighten monetary policy.</p>\n<p>Stocks rallied when the central bank completed that pivot Wednesday, approving plans to end a program of asset purchases by March and penciling in three rate rises in 2022. Investors said the change of stance—ending months in which the Fed said higher inflation would fade—removed the risk of runaway growth in consumer prices.</p>\n<p>“There’s a goldilocks interpretation,” said Edward Park, chief investment officer at Brooks Macdonald, referring to a situation in which the Fed tames inflation but doesn’t push rates high enough to kill the economic recovery.</p>\n<p>Mr. Park said stocks are likely to keep rising through to year end. “You have people saying, you know, it’s painful being in fixed income or cash.”</p>\n<p>European stock markets followed Wall Street higher Thursday. The pan-continental Stoxx Europe 600 rose 1.4%, led by tech, energy, travel and leisure stocks.</p>\n<p>Turkey’s currency crisis deepened ahead of a potential interest-rate cut by the central bank, which has come under pressure from President Recep Tayyip Erdogan to lower borrowing costs. The lira weakened 2.5% to trade at 15.18 per dollar.</p>\n<p>Like the U.S., the eurozone and the U.K. are experiencing their highest inflation in years. Central banks there are also contending with waves of coronavirus infections that complicate the outlook for consumer prices and economic growth.</p>\n<p>The Bank of England, which will publish its decision at 7 a.m. ET, was until recently expected to raise interest rates Thursday. However, a jump in Covid-19 cases driven by the Omicron variant might encourage the central bank to keep policy on hold, Mr. Park said. The pound rose 0.2% to $1.3293 before the decision.</p>\n<p>The European Central Bank, meanwhile, is expected to signal that it will continue buying bonds for some time, and that it won’t increase interest rates next year. The central bank is due to publish its decision at 7:45 a.m. The euro traded 0.2% higher at $1.1316.</p>\n<p>Investors will parse surveys of purchasing managers in the U.S. and Europe for evidence of the extent to which rising coronavirus cases have knocked economic growth. The reports—due at 9:45 a.m. for the U.S.—are expected to show factory output is growing, though at a slower pace than in November.</p>\n<p>In individual European stock moves, Novartis rose 4.3% after the Swiss pharmaceutical firm said it would use the proceeds from the recent sale of its stake in Roche to buy back up to $15 billion of its shares. Food-delivery firms Just Eat Takeaway.com and Delivery Hero both rose more than 5%. Électricité de France dropped 11% after the French utility cut earnings forecasts to reflect the safety-related outages at nuclear-power plants.</p>\n<p>In Asia, Japan’s Nikkei 225 gained 2.1%, the Shanghai Composite Index rose 0.8% and Hong Kong’s Hang Seng added 0.2%.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks Set to Extend Gains Ahead of More Central Bank Decisions</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks Set to Extend Gains Ahead of More Central Bank Decisions\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 18:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/articles/global-stock-markets-dow-update-12-16-2021-11639643633?mod=hp_lead_pos1><strong>WSJ</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Stocks were poised to extend gains ahead of policy decisions by the European Central Bank and Bank of England, which follow the Federal Reserve’s pivot toward higher interest rates.\nFutures for the S&...</p>\n\n<a href=\"https://www.wsj.com/articles/global-stock-markets-dow-update-12-16-2021-11639643633?mod=hp_lead_pos1\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"source_url":"https://www.wsj.com/articles/global-stock-markets-dow-update-12-16-2021-11639643633?mod=hp_lead_pos1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1184616731","content_text":"Stocks were poised to extend gains ahead of policy decisions by the European Central Bank and Bank of England, which follow the Federal Reserve’s pivot toward higher interest rates.\nFutures for the S&P 500 rose 0.5% Thursday, a day after the broad stocks gauge closed at its second-highest level on record. Contracts for the Dow Jones Industrial Average added 0.4% and Nasdaq-100 futures climbed 0.6%, pointing to a strong start to the session for technology stocks.\nBrent-crude futures, the benchmark in international oil markets, rose 0.9% to $74.51 a barrel. Yields on 10-year Treasury notes ticked down to 1.451% Thursday from 1.460% Wednesday. Yields move in the opposite direction to bond prices and barely moved in response to the Fed’s shift to tighten monetary policy.\nStocks rallied when the central bank completed that pivot Wednesday, approving plans to end a program of asset purchases by March and penciling in three rate rises in 2022. Investors said the change of stance—ending months in which the Fed said higher inflation would fade—removed the risk of runaway growth in consumer prices.\n“There’s a goldilocks interpretation,” said Edward Park, chief investment officer at Brooks Macdonald, referring to a situation in which the Fed tames inflation but doesn’t push rates high enough to kill the economic recovery.\nMr. Park said stocks are likely to keep rising through to year end. “You have people saying, you know, it’s painful being in fixed income or cash.”\nEuropean stock markets followed Wall Street higher Thursday. The pan-continental Stoxx Europe 600 rose 1.4%, led by tech, energy, travel and leisure stocks.\nTurkey’s currency crisis deepened ahead of a potential interest-rate cut by the central bank, which has come under pressure from President Recep Tayyip Erdogan to lower borrowing costs. The lira weakened 2.5% to trade at 15.18 per dollar.\nLike the U.S., the eurozone and the U.K. are experiencing their highest inflation in years. Central banks there are also contending with waves of coronavirus infections that complicate the outlook for consumer prices and economic growth.\nThe Bank of England, which will publish its decision at 7 a.m. ET, was until recently expected to raise interest rates Thursday. However, a jump in Covid-19 cases driven by the Omicron variant might encourage the central bank to keep policy on hold, Mr. Park said. The pound rose 0.2% to $1.3293 before the decision.\nThe European Central Bank, meanwhile, is expected to signal that it will continue buying bonds for some time, and that it won’t increase interest rates next year. The central bank is due to publish its decision at 7:45 a.m. The euro traded 0.2% higher at $1.1316.\nInvestors will parse surveys of purchasing managers in the U.S. and Europe for evidence of the extent to which rising coronavirus cases have knocked economic growth. The reports—due at 9:45 a.m. for the U.S.—are expected to show factory output is growing, though at a slower pace than in November.\nIn individual European stock moves, Novartis rose 4.3% after the Swiss pharmaceutical firm said it would use the proceeds from the recent sale of its stake in Roche to buy back up to $15 billion of its shares. Food-delivery firms Just Eat Takeaway.com and Delivery Hero both rose more than 5%. Électricité de France dropped 11% after the French utility cut earnings forecasts to reflect the safety-related outages at nuclear-power plants.\nIn Asia, Japan’s Nikkei 225 gained 2.1%, the Shanghai Composite Index rose 0.8% and Hong Kong’s Hang Seng added 0.2%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":589,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607805191,"gmtCreate":1639521531337,"gmtModify":1639521531424,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/607805191","repostId":"2191937155","repostType":4,"repost":{"id":"2191937155","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639521474,"share":"https://www.laohu8.com/m/news/2191937155?lang=&edition=full","pubTime":"2021-12-15 06:37","market":"us","language":"en","title":"Pfizer says COVID-19 pill near 90% protective against hospitalization, death","url":"https://stock-news.laohu8.com/highlight/detail?id=2191937155","media":"Reuters","summary":"NEW YORK, Dec 14 (Reuters) - Pfizer Inc on Tuesday said its antiviral COVID-19 pill showed near 90% ","content":"<p>NEW YORK, Dec 14 (Reuters) - Pfizer Inc&nbsp;on Tuesday said its antiviral COVID-19 pill showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent lab data suggests the drug retains its effectiveness against the fast spreading Omicron variant of the coronavirus.</p>\n<p>The U.S. drugmaker last month said the oral medicine was around 89% effective in preventing hospitalizations or deaths when compared to placebo, based on interim results in around 1,200 people. Data from its final analysis of the trial disclosed on Tuesday includes an additional 1,000 people.</p>\n<p>Nobody in the trial who received the Pfizer treatment died, compared with 12 deaths among placebo recipients.</p>\n<p>The Pfizer pills are taken with the older antiviral ritonavir every 12 hours for five days beginning shortly after onset of symptoms. If authorized, the treatment will be sold as Paxlovid.</p>\n<p>\"It's a stunning outcome,\" Pfizer Chief Scientific Officer Mikael Dolsten said in an interview.</p>\n<p>\"We're talking about a staggering number of lives saved and hospitalizations prevented. And of course, if you deploy this quickly after infection, we are likely to reduce transmission dramatically,\" Dolsten said.</p>\n<p>Pfizer also released early data from a second study suggesting that the treatment reduced hospitalizations by around 70% in a smaller trial of standard-risk adults, including some higher-risk vaccinated people.</p>\n<p>Pfizer said those results showed a positive trend, but were not statistically significant. They are following the results and plan to release data from the final 20% of participants in the 1,100-patient trial. The trial did not show that the drug alleviated symptoms of COVID-19 in that population.</p>\n<p>Dolsten said he expects authorization for use in high-risk individuals from the U.S. Food and Drug Administration and other regulatory agencies soon. He does not believe an FDA advisory panel meeting will be needed.</p>\n<p>\"We're in very advanced regulatory dialogues with both Europe and the UK, and we have dialogues with most of the major regulatory agencies globally,\" Dolsten said.</p>\n<p><b>'VERY EXCITING RESULTS'</b></p>\n<p>Pfizer submitted data to the FDA last month, asking for emergency use authorization (EUA) of the drug.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/04e1175e6a0c8ba936538fabc8038071\" tg-width=\"960\" tg-height=\"640\" width=\"100%\" height=\"auto\"><span>Paxlovid, a Pfizer's coronavirus disease (COVID-19) pill, is seen manufactured in Ascoli, Italy, in this undated handout photo obtained by Reuters on November 16, 2021. Pfizer/Handout via REUTERS</span></p>\n<p>\"These are very exciting results,\" said Dr. Paul Sax, a professor at Harvard Medical School.</p>\n<p>Sax said the FDA should try to accelerate the authorization process as much as possible, noting there are very limited treatment options for high-risk people outside of the hospital.</p>\n<p>There are currently no oral antiviral treatments for COVID-9 authorized in the United States.</p>\n<p>Analysts on average forecast 2022 revenue of more than $24 billion from the pill, which would more than make up for any decline in vaccine sales after 2021.</p>\n<p>Rival Merck &amp; Co&nbsp;has asked for an EUA for its antiviral pill molnupiravir. But that drug only reduced hospitalizations and deaths in its clinical trial of high-risk patients by around 30%.</p>\n<p>Some scientists have also raised safety concerns about the potential for birth defects from the Merck drug, as well as worries that it could cause the virus to mutate.</p>\n<p>Pfizer's treatment works differently. It is part of a class of drugs called protease inhibitors currently used to treat HIV, hepatitis C and other viruses.</p>\n<p>Recent laboratory testing showed that activity against the protease of the Omicron variant is as \"good as basically any SARS-COV-2 variant of concern,\" Dolsten said.</p>\n<p>The company has said it can have 180,000 treatment courses ready to ship this year and plans to produce at least 80 million more in 2022.</p>\n<p>Dolsten said Pfizer is looking to expand that output further as new variants, like the newly-discovered Omicron, could push the need for antivirals substantially higher. Current vaccines appear to be less effective at preventing infection with Omicron.</p>\n<p>Pfizer, which makes one of the leading COVID-19 vaccines with German partner BioNTech , has agreed to allow generic manufacturers to supply versions of the drug to 95 low- and middle-income countries through a licensing agreement with international public health group Medicines Patent Pool (MPP). However, Dolsten said that for next year he expects the drug will be mainly produced by Pfizer.</p>\n<p>The MPP told Reuters in a statement, that it will be \"well into next year\" before pills produced by generic manufacturers under its licenses will be ready for use.</p>\n<p>The U.S. government has already secured 10 million courses of the Pfizer treatment for $5.29 billion.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer says COVID-19 pill near 90% protective against hospitalization, death</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer says COVID-19 pill near 90% protective against hospitalization, death\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-15 06:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>NEW YORK, Dec 14 (Reuters) - Pfizer Inc&nbsp;on Tuesday said its antiviral COVID-19 pill showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent lab data suggests the drug retains its effectiveness against the fast spreading Omicron variant of the coronavirus.</p>\n<p>The U.S. drugmaker last month said the oral medicine was around 89% effective in preventing hospitalizations or deaths when compared to placebo, based on interim results in around 1,200 people. Data from its final analysis of the trial disclosed on Tuesday includes an additional 1,000 people.</p>\n<p>Nobody in the trial who received the Pfizer treatment died, compared with 12 deaths among placebo recipients.</p>\n<p>The Pfizer pills are taken with the older antiviral ritonavir every 12 hours for five days beginning shortly after onset of symptoms. If authorized, the treatment will be sold as Paxlovid.</p>\n<p>\"It's a stunning outcome,\" Pfizer Chief Scientific Officer Mikael Dolsten said in an interview.</p>\n<p>\"We're talking about a staggering number of lives saved and hospitalizations prevented. And of course, if you deploy this quickly after infection, we are likely to reduce transmission dramatically,\" Dolsten said.</p>\n<p>Pfizer also released early data from a second study suggesting that the treatment reduced hospitalizations by around 70% in a smaller trial of standard-risk adults, including some higher-risk vaccinated people.</p>\n<p>Pfizer said those results showed a positive trend, but were not statistically significant. They are following the results and plan to release data from the final 20% of participants in the 1,100-patient trial. The trial did not show that the drug alleviated symptoms of COVID-19 in that population.</p>\n<p>Dolsten said he expects authorization for use in high-risk individuals from the U.S. Food and Drug Administration and other regulatory agencies soon. He does not believe an FDA advisory panel meeting will be needed.</p>\n<p>\"We're in very advanced regulatory dialogues with both Europe and the UK, and we have dialogues with most of the major regulatory agencies globally,\" Dolsten said.</p>\n<p><b>'VERY EXCITING RESULTS'</b></p>\n<p>Pfizer submitted data to the FDA last month, asking for emergency use authorization (EUA) of the drug.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/04e1175e6a0c8ba936538fabc8038071\" tg-width=\"960\" tg-height=\"640\" width=\"100%\" height=\"auto\"><span>Paxlovid, a Pfizer's coronavirus disease (COVID-19) pill, is seen manufactured in Ascoli, Italy, in this undated handout photo obtained by Reuters on November 16, 2021. Pfizer/Handout via REUTERS</span></p>\n<p>\"These are very exciting results,\" said Dr. Paul Sax, a professor at Harvard Medical School.</p>\n<p>Sax said the FDA should try to accelerate the authorization process as much as possible, noting there are very limited treatment options for high-risk people outside of the hospital.</p>\n<p>There are currently no oral antiviral treatments for COVID-9 authorized in the United States.</p>\n<p>Analysts on average forecast 2022 revenue of more than $24 billion from the pill, which would more than make up for any decline in vaccine sales after 2021.</p>\n<p>Rival Merck &amp; Co&nbsp;has asked for an EUA for its antiviral pill molnupiravir. But that drug only reduced hospitalizations and deaths in its clinical trial of high-risk patients by around 30%.</p>\n<p>Some scientists have also raised safety concerns about the potential for birth defects from the Merck drug, as well as worries that it could cause the virus to mutate.</p>\n<p>Pfizer's treatment works differently. It is part of a class of drugs called protease inhibitors currently used to treat HIV, hepatitis C and other viruses.</p>\n<p>Recent laboratory testing showed that activity against the protease of the Omicron variant is as \"good as basically any SARS-COV-2 variant of concern,\" Dolsten said.</p>\n<p>The company has said it can have 180,000 treatment courses ready to ship this year and plans to produce at least 80 million more in 2022.</p>\n<p>Dolsten said Pfizer is looking to expand that output further as new variants, like the newly-discovered Omicron, could push the need for antivirals substantially higher. Current vaccines appear to be less effective at preventing infection with Omicron.</p>\n<p>Pfizer, which makes one of the leading COVID-19 vaccines with German partner BioNTech , has agreed to allow generic manufacturers to supply versions of the drug to 95 low- and middle-income countries through a licensing agreement with international public health group Medicines Patent Pool (MPP). However, Dolsten said that for next year he expects the drug will be mainly produced by Pfizer.</p>\n<p>The MPP told Reuters in a statement, that it will be \"well into next year\" before pills produced by generic manufacturers under its licenses will be ready for use.</p>\n<p>The U.S. government has already secured 10 million courses of the Pfizer treatment for $5.29 billion.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4007":"制药","BK4550":"红杉资本持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4534":"瑞士信贷持仓","BK4568":"美国抗疫概念","PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191937155","content_text":"NEW YORK, Dec 14 (Reuters) - Pfizer Inc on Tuesday said its antiviral COVID-19 pill showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent lab data suggests the drug retains its effectiveness against the fast spreading Omicron variant of the coronavirus.\nThe U.S. drugmaker last month said the oral medicine was around 89% effective in preventing hospitalizations or deaths when compared to placebo, based on interim results in around 1,200 people. Data from its final analysis of the trial disclosed on Tuesday includes an additional 1,000 people.\nNobody in the trial who received the Pfizer treatment died, compared with 12 deaths among placebo recipients.\nThe Pfizer pills are taken with the older antiviral ritonavir every 12 hours for five days beginning shortly after onset of symptoms. If authorized, the treatment will be sold as Paxlovid.\n\"It's a stunning outcome,\" Pfizer Chief Scientific Officer Mikael Dolsten said in an interview.\n\"We're talking about a staggering number of lives saved and hospitalizations prevented. And of course, if you deploy this quickly after infection, we are likely to reduce transmission dramatically,\" Dolsten said.\nPfizer also released early data from a second study suggesting that the treatment reduced hospitalizations by around 70% in a smaller trial of standard-risk adults, including some higher-risk vaccinated people.\nPfizer said those results showed a positive trend, but were not statistically significant. They are following the results and plan to release data from the final 20% of participants in the 1,100-patient trial. The trial did not show that the drug alleviated symptoms of COVID-19 in that population.\nDolsten said he expects authorization for use in high-risk individuals from the U.S. Food and Drug Administration and other regulatory agencies soon. He does not believe an FDA advisory panel meeting will be needed.\n\"We're in very advanced regulatory dialogues with both Europe and the UK, and we have dialogues with most of the major regulatory agencies globally,\" Dolsten said.\n'VERY EXCITING RESULTS'\nPfizer submitted data to the FDA last month, asking for emergency use authorization (EUA) of the drug.\nPaxlovid, a Pfizer's coronavirus disease (COVID-19) pill, is seen manufactured in Ascoli, Italy, in this undated handout photo obtained by Reuters on November 16, 2021. Pfizer/Handout via REUTERS\n\"These are very exciting results,\" said Dr. Paul Sax, a professor at Harvard Medical School.\nSax said the FDA should try to accelerate the authorization process as much as possible, noting there are very limited treatment options for high-risk people outside of the hospital.\nThere are currently no oral antiviral treatments for COVID-9 authorized in the United States.\nAnalysts on average forecast 2022 revenue of more than $24 billion from the pill, which would more than make up for any decline in vaccine sales after 2021.\nRival Merck & Co has asked for an EUA for its antiviral pill molnupiravir. But that drug only reduced hospitalizations and deaths in its clinical trial of high-risk patients by around 30%.\nSome scientists have also raised safety concerns about the potential for birth defects from the Merck drug, as well as worries that it could cause the virus to mutate.\nPfizer's treatment works differently. It is part of a class of drugs called protease inhibitors currently used to treat HIV, hepatitis C and other viruses.\nRecent laboratory testing showed that activity against the protease of the Omicron variant is as \"good as basically any SARS-COV-2 variant of concern,\" Dolsten said.\nThe company has said it can have 180,000 treatment courses ready to ship this year and plans to produce at least 80 million more in 2022.\nDolsten said Pfizer is looking to expand that output further as new variants, like the newly-discovered Omicron, could push the need for antivirals substantially higher. Current vaccines appear to be less effective at preventing infection with Omicron.\nPfizer, which makes one of the leading COVID-19 vaccines with German partner BioNTech , has agreed to allow generic manufacturers to supply versions of the drug to 95 low- and middle-income countries through a licensing agreement with international public health group Medicines Patent Pool (MPP). However, Dolsten said that for next year he expects the drug will be mainly produced by Pfizer.\nThe MPP told Reuters in a statement, that it will be \"well into next year\" before pills produced by generic manufacturers under its licenses will be ready for use.\nThe U.S. government has already secured 10 million courses of the Pfizer treatment for $5.29 billion.","news_type":1},"isVote":1,"tweetType":1,"viewCount":512,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604341968,"gmtCreate":1639354721573,"gmtModify":1639354721699,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Comment","listText":"Comment","text":"Comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/604341968","repostId":"1155743884","repostType":4,"repost":{"id":"1155743884","pubTimestamp":1639353588,"share":"https://www.laohu8.com/m/news/1155743884?lang=&edition=full","pubTime":"2021-12-13 07:59","market":"us","language":"en","title":"Taper pace and path to liftoff set the themes for Fed meeting this week","url":"https://stock-news.laohu8.com/highlight/detail?id=1155743884","media":"seekingalpha","summary":"Last week's consumer inflation reading reinforces the narrative that the Federal Reserve will quicke","content":"<p></p>\n<p>Last week's consumer inflation reading reinforces the narrative that the Federal Reserve will quicken its pace to taper asset purchases, setting the stage for an earlier rate increase when the central banks' policymakers meet on Tuesday and Wednesday.</p>\n<p>Investors will also gain insight on the central bankers' expectations for when rates will rise with the release of the \"Summary of Economic Projections,\" especially the closely watched \"dot-plot.\"</p>\n<p>Expect to see a change in timing for winding down its purchases of Treasurys and mortgage-backed securities. At their November meeting, the Fed said it planned to reduce purchases by $15B per month, setting a pace to end the purchases in mid-2022.</p>\n<p>Fed Chair Jerome Powell has already said it's time to talk about speeding up the taper by a few months. \"At this point, the economy is very strong\" and inflation is elevated, he said at his testimony in Congress on Nov. 30.</p>\n<p>Since those comments, the November jobs and inflation numbers have come out. The jobs report presented mixed signals, with the number of jobs created last month far below the consensus, but the unemployment rate better than expected (at 4.2%, approaching its prepandemic rate of 3.5%) and an improved labor force participation rate.</p>\n<p>The consumer price index, which gauges inflation, jumped the most in 39 years in November, but came in about as expected. Especially with the jobs number, keep in mind that month-to-month numbers can be volatile. For example, the number of jobs created in November could be revised up when the December numbers come out in early January.</p>\n<p>The inflation report \"confirms that the Fed is on track to begin hiking rates at some point next year,\" Sarah House, senior economist at Wells Fargo told Bloomberg News. \"I think this keeps them on track to see the dots move up pretty notably when we get the forecast next week.\"</p>\n<p>The strong November CPI data \"only solidify the case for a faster tapering of asset purchases,\" Rubeela Farooqi, Highway Frequency Economics' chief U.S. economist, told Reuters. \"More important will be Chair Powell's message on tightening of policy going forward.\"</p>\n<p>\"I think that their plan right now probably is three rate hikes next year, four rate hikes in 2023,\" David Kelly, J.P. Morgan Asset Management chief global strategist, said in an interview on Bloomberg Television.</p>\n<p>In the September meeting dot-plot, most Fed officials expected the first rate increase in 2023, with a few pulling the first rate hike to 2022.</p>\n<p>The federal funds rate target range currently stands at 0.0%-0.25%. The central bankers said it expected to increase its Treasury holdings by at least $60B per month and increase it agency MBS holdings by at least $30B month, down from its prior pace of $80B of Treasurys and $40B of MBS in October.</p>\n<p>The CME FedWatch tool shows that more traders are pulling up their expectation for a rate hike. The probability of a 25-50 basis-point rate hike for the March meeting rises to 34.2%, up from a 25.9% probability a week ago.</p>\n<p>The probability of a 25-50 bps hike in May increased to 43.2% from 38.4% a week ago, and there's a 13.1% probability of a 50-75 bps increase.</p>\n<p>SGH Macro Advisors Chief U.S. Economist Tim Duy sees a \"high probability that the Fed hikes rates in March,\" although he doesn't expect the policymakers will pencil in that timeline on the dot-plot. \"Where the Fed is now and where the Fed is in three months are two different things,\" he wrote in a note dated Dec. 7.</p>\n<p>SA contributor John M. Mason sees complications in the Fed's taper due to the massive amounts of reverse repurchase agreements it has used to keep the effective federal funds rate positive.</p>","source":"lsy1638401102509","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Taper pace and path to liftoff set the themes for Fed meeting this week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTaper pace and path to liftoff set the themes for Fed meeting this week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-13 07:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3779240-taper-pace-and-path-to-liftoff-set-to-the-themes-for-fed-meeting-this-week><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Last week's consumer inflation reading reinforces the narrative that the Federal Reserve will quicken its pace to taper asset purchases, setting the stage for an earlier rate increase when the central...</p>\n\n<a href=\"https://seekingalpha.com/news/3779240-taper-pace-and-path-to-liftoff-set-to-the-themes-for-fed-meeting-this-week\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"source_url":"https://seekingalpha.com/news/3779240-taper-pace-and-path-to-liftoff-set-to-the-themes-for-fed-meeting-this-week","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1155743884","content_text":"Last week's consumer inflation reading reinforces the narrative that the Federal Reserve will quicken its pace to taper asset purchases, setting the stage for an earlier rate increase when the central banks' policymakers meet on Tuesday and Wednesday.\nInvestors will also gain insight on the central bankers' expectations for when rates will rise with the release of the \"Summary of Economic Projections,\" especially the closely watched \"dot-plot.\"\nExpect to see a change in timing for winding down its purchases of Treasurys and mortgage-backed securities. At their November meeting, the Fed said it planned to reduce purchases by $15B per month, setting a pace to end the purchases in mid-2022.\nFed Chair Jerome Powell has already said it's time to talk about speeding up the taper by a few months. \"At this point, the economy is very strong\" and inflation is elevated, he said at his testimony in Congress on Nov. 30.\nSince those comments, the November jobs and inflation numbers have come out. The jobs report presented mixed signals, with the number of jobs created last month far below the consensus, but the unemployment rate better than expected (at 4.2%, approaching its prepandemic rate of 3.5%) and an improved labor force participation rate.\nThe consumer price index, which gauges inflation, jumped the most in 39 years in November, but came in about as expected. Especially with the jobs number, keep in mind that month-to-month numbers can be volatile. For example, the number of jobs created in November could be revised up when the December numbers come out in early January.\nThe inflation report \"confirms that the Fed is on track to begin hiking rates at some point next year,\" Sarah House, senior economist at Wells Fargo told Bloomberg News. \"I think this keeps them on track to see the dots move up pretty notably when we get the forecast next week.\"\nThe strong November CPI data \"only solidify the case for a faster tapering of asset purchases,\" Rubeela Farooqi, Highway Frequency Economics' chief U.S. economist, told Reuters. \"More important will be Chair Powell's message on tightening of policy going forward.\"\n\"I think that their plan right now probably is three rate hikes next year, four rate hikes in 2023,\" David Kelly, J.P. Morgan Asset Management chief global strategist, said in an interview on Bloomberg Television.\nIn the September meeting dot-plot, most Fed officials expected the first rate increase in 2023, with a few pulling the first rate hike to 2022.\nThe federal funds rate target range currently stands at 0.0%-0.25%. The central bankers said it expected to increase its Treasury holdings by at least $60B per month and increase it agency MBS holdings by at least $30B month, down from its prior pace of $80B of Treasurys and $40B of MBS in October.\nThe CME FedWatch tool shows that more traders are pulling up their expectation for a rate hike. The probability of a 25-50 basis-point rate hike for the March meeting rises to 34.2%, up from a 25.9% probability a week ago.\nThe probability of a 25-50 bps hike in May increased to 43.2% from 38.4% a week ago, and there's a 13.1% probability of a 50-75 bps increase.\nSGH Macro Advisors Chief U.S. Economist Tim Duy sees a \"high probability that the Fed hikes rates in March,\" although he doesn't expect the policymakers will pencil in that timeline on the dot-plot. \"Where the Fed is now and where the Fed is in three months are two different things,\" he wrote in a note dated Dec. 7.\nSA contributor John M. Mason sees complications in the Fed's taper due to the massive amounts of reverse repurchase agreements it has used to keep the effective federal funds rate positive.","news_type":1},"isVote":1,"tweetType":1,"viewCount":452,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604928940,"gmtCreate":1639314954285,"gmtModify":1639318695866,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Zzz","listText":"Zzz","text":"Zzz","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604928940","repostId":"2190679207","repostType":4,"repost":{"id":"2190679207","pubTimestamp":1639281804,"share":"https://www.laohu8.com/m/news/2190679207?lang=&edition=full","pubTime":"2021-12-12 12:03","market":"us","language":"en","title":"Want $1 Million in Retirement? Invest $100,000 in These 2 Stocks and Hold Until 2035","url":"https://stock-news.laohu8.com/highlight/detail?id=2190679207","media":"Motley Fool","summary":"These two stocks could change your retirement.","content":"<p>Over the past 15 years, the <b>S&amp;P 500</b> has risen in price 232%, which results in a 9.8% compound annual growth rate without inflation. If this continued for the next 15 years, you would have over $300,000 in savings to retire on if you invested $100,000, which is bigger than the average 60-year-old American's 401(k) balance.</p>\n<p>While this strategy could produce solid returns, there are two stocks that could crush that average by 2035. Here's why I think <b>Latch</b> (NASDAQ:LTCH) and <b>Lemonade</b> (NYSE:LMND) have the potential to provide high-quality returns so that you can retire right.</p>\n<h2>1. Latch: Smart security</h2>\n<p>This smart lock manufacturer is taking the industry by storm with its software. With LatchOS, apartment managers can get a birds-eye view of all their apartments on <a href=\"https://laohu8.com/S/AONE.U\">one</a> platform, making sure all of their tenants are safe and secure. Moreover, managers can let in workers or delivery people from that platform. Latch is the only company that can offer a combination of smart, keyless locks and innovative software, so it's no wonder it is rapidly being adopted by apartment buildings across America.</p>\n<p>Nearly a third of new apartment buildings are being built today with Latch installed in them, and once Latch's locks are in, it can be incredibly hard to replace them with a competitor. Additionally, when customers agree to use Latch, they sign six- to 10-year contracts to use LatchOS. These two factors provide amazingly high switching costs, so once Latch is installed, it's likely that its users will stay Latch users for a long time. Latch has experienced zero turnovers since it started operations in 2017, and that will probably continue to be the case.</p>\n<p>Latch's market is massive, and the high switching costs and first-mover advantage will likely allow the company to capitalize on it. Latch sees a market opportunity of $54 billion in the U.S. alone, and if the company is able to expand internationally in a few years, that adds another $90 billion.</p>\n<p>Latch's partnerships will be another integral part of the company's success. Since Latch customers sign agreements with Latch to use its products before the apartments are even built, it is crucial that Latch is in talks with apartment managers before the construction team breaks ground. That is why Latch has partnered with some of the largest apartment builders in the U.S., like <b>Brookfield</b> (NYSE:BAM) and <b>Avalon Bay</b> (NYSE:AVB).</p>\n<p>This company has only been operational since 2017, so there are plenty of risks with this business. The primary risk is that it is losing lots of cash.</p>\n<table border=\"1\">\n <tbody>\n  <tr>\n   <th>Metric</th>\n   <th>Q3 2020</th>\n   <th>Q3 2021</th>\n   <th>Change</th>\n  </tr>\n  <tr>\n   <td>Net loss</td>\n   <td>$15.9 million</td>\n   <td>$34.2 million</td>\n   <td>115%</td>\n  </tr>\n  <tr>\n   <td>Net loss as a percentage of revenue</td>\n   <td>311.5%</td>\n   <td>305.7%</td>\n   <td>N/A</td>\n  </tr>\n </tbody>\n</table>\n<p>The company is making most of its money today on its locks, which it sells at a loss. These losses are bad today, but Latch's profitability can improve. Latch has noted that the timeframe it takes from construction to a builder beginning their subscription services is 24 months. The contracts the company has seen could finally turn into reportable revenue within the next couple of years. Analysts see the potential as well with growth forecasts of nearly 50% for the next five years.</p>\n<p>Also, as its customers stay with the company longer and pay more in its subscription fees for the software -- which has gross margins of 90% -- the company's losses will likely improve to provide a pathway to profitability. This could be a multi-year effort, but if it can use its differentiated product and strong partnerships to attract customers and its high switching costs to retain them, Latch could give investors immense returns by 2035.</p>\n<h2>2. Lemonade: An insurance provider anyone can love</h2>\n<p>Lemonade is making insurance enjoyable. Whether applying for insurance or getting a claim, Lemonade's process is easy and hassle-free with its artificial intelligence (AI)-based bots that can approve applicants and claims in seconds. The company is also aligning its interest with its consumers: Lemonade charges a flat fee, and any money from leftover claims that went unpaid goes to charities that Lemonade customers choose. So far in 2021, Lemonade has donated over $2.2 million in unpaid claims on behalf of its customers.</p>\n<p>Lemonade's incentive alignment structure can hurt its bottom line, but it has resulted in amazing customer attraction. Lemonade has over 1.3 million customers, and it has been one of the fastest-growing insurance stocks ever.</p>\n<p>The company started in renters insurance, targeting young renters. However, just as its customers have moved on in life, Lemonade has expanded. Now it offers homeowners, pet, life, and even car insurance. Lemonade hopes to attract young customers with small offerings like renters and car insurance, then integrate them deeper into the ecosystem with its fast and delightful service.</p>\n<table border=\"1\">\n <tbody>\n  <tr>\n   <th>Metric</th>\n   <th>First Nine Months of 2020</th>\n   <th>First Nine Months of 2021</th>\n   <th>Change</th>\n  </tr>\n  <tr>\n   <td>Net loss</td>\n   <td>$88.4 million</td>\n   <td>$171.0 million</td>\n   <td>93.4%</td>\n  </tr>\n  <tr>\n   <td>Net loss as a percentage of revenue</td>\n   <td>119.6%</td>\n   <td>195.6%</td>\n   <td><p>N/A</p></td>\n  </tr>\n </tbody>\n</table>\n<p>This major uptick in net losses has primarily been because of the company's loss ratio. Lemonade's net loss ratio -- which represents the amount of premium paid out on claims -- was 77% in the third quarter. A ratio of 75% or below is the long-term goal that management is targeting, but it has been consistently higher in 2021 because of the new products that Lemonade has launched this year and in 2020.</p>\n<p>Lemonade's AI can often take time to learn and collect data about its new markets, resulting in poor short-term performance but long-term opportunities. As its AI obtains more data, it should become more accurate, lowering its loss ratio and its net loss. With the lowered loss ratio, investors could expect the company to generate a profit, which would provide optimism beyond its environmental, social, and governance (ESG) efforts.</p>\n<p>Both of these companies are incredibly young and are quite risky today, which is clearly noted in the stock decreases of more than 25% for each year-to-date. But in a balanced portfolio, these stocks could define someone's future investing success. If both companies can use their competitive edges to rapidly grow their business over the next 15 years and become profitable, they could reward investors by 2035.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want $1 Million in Retirement? Invest $100,000 in These 2 Stocks and Hold Until 2035</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant $1 Million in Retirement? Invest $100,000 in These 2 Stocks and Hold Until 2035\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-12 12:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/11/want-1-million-in-retirement-invest-100000-in-thes/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Over the past 15 years, the S&P 500 has risen in price 232%, which results in a 9.8% compound annual growth rate without inflation. If this continued for the next 15 years, you would have over $300,...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/11/want-1-million-in-retirement-invest-100000-in-thes/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AVB":"阿湾物产","BK4528":"SaaS概念","BK4023":"应用软件","BK4107":"财产与意外伤害保险","BK4551":"寇图资本持仓","LTCH":"Latch, Inc.","ESG":"FlexShares STOXX US ESG Select Index Fund","BK4535":"淡马锡持仓","BK4543":"AI","BK4549":"软银资本持仓","BK4135":"资产管理与托管银行","AI":"C3.ai, Inc.","BK4548":"巴美列捷福持仓","BAM":"布鲁克菲尔德资产管理","BK4215":"住宅房地产投资信托","LMND":"Lemonade, Inc."},"source_url":"https://www.fool.com/investing/2021/12/11/want-1-million-in-retirement-invest-100000-in-thes/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190679207","content_text":"Over the past 15 years, the S&P 500 has risen in price 232%, which results in a 9.8% compound annual growth rate without inflation. If this continued for the next 15 years, you would have over $300,000 in savings to retire on if you invested $100,000, which is bigger than the average 60-year-old American's 401(k) balance.\nWhile this strategy could produce solid returns, there are two stocks that could crush that average by 2035. Here's why I think Latch (NASDAQ:LTCH) and Lemonade (NYSE:LMND) have the potential to provide high-quality returns so that you can retire right.\n1. Latch: Smart security\nThis smart lock manufacturer is taking the industry by storm with its software. With LatchOS, apartment managers can get a birds-eye view of all their apartments on one platform, making sure all of their tenants are safe and secure. Moreover, managers can let in workers or delivery people from that platform. Latch is the only company that can offer a combination of smart, keyless locks and innovative software, so it's no wonder it is rapidly being adopted by apartment buildings across America.\nNearly a third of new apartment buildings are being built today with Latch installed in them, and once Latch's locks are in, it can be incredibly hard to replace them with a competitor. Additionally, when customers agree to use Latch, they sign six- to 10-year contracts to use LatchOS. These two factors provide amazingly high switching costs, so once Latch is installed, it's likely that its users will stay Latch users for a long time. Latch has experienced zero turnovers since it started operations in 2017, and that will probably continue to be the case.\nLatch's market is massive, and the high switching costs and first-mover advantage will likely allow the company to capitalize on it. Latch sees a market opportunity of $54 billion in the U.S. alone, and if the company is able to expand internationally in a few years, that adds another $90 billion.\nLatch's partnerships will be another integral part of the company's success. Since Latch customers sign agreements with Latch to use its products before the apartments are even built, it is crucial that Latch is in talks with apartment managers before the construction team breaks ground. That is why Latch has partnered with some of the largest apartment builders in the U.S., like Brookfield (NYSE:BAM) and Avalon Bay (NYSE:AVB).\nThis company has only been operational since 2017, so there are plenty of risks with this business. The primary risk is that it is losing lots of cash.\n\n\n\nMetric\nQ3 2020\nQ3 2021\nChange\n\n\nNet loss\n$15.9 million\n$34.2 million\n115%\n\n\nNet loss as a percentage of revenue\n311.5%\n305.7%\nN/A\n\n\n\nThe company is making most of its money today on its locks, which it sells at a loss. These losses are bad today, but Latch's profitability can improve. Latch has noted that the timeframe it takes from construction to a builder beginning their subscription services is 24 months. The contracts the company has seen could finally turn into reportable revenue within the next couple of years. Analysts see the potential as well with growth forecasts of nearly 50% for the next five years.\nAlso, as its customers stay with the company longer and pay more in its subscription fees for the software -- which has gross margins of 90% -- the company's losses will likely improve to provide a pathway to profitability. This could be a multi-year effort, but if it can use its differentiated product and strong partnerships to attract customers and its high switching costs to retain them, Latch could give investors immense returns by 2035.\n2. Lemonade: An insurance provider anyone can love\nLemonade is making insurance enjoyable. Whether applying for insurance or getting a claim, Lemonade's process is easy and hassle-free with its artificial intelligence (AI)-based bots that can approve applicants and claims in seconds. The company is also aligning its interest with its consumers: Lemonade charges a flat fee, and any money from leftover claims that went unpaid goes to charities that Lemonade customers choose. So far in 2021, Lemonade has donated over $2.2 million in unpaid claims on behalf of its customers.\nLemonade's incentive alignment structure can hurt its bottom line, but it has resulted in amazing customer attraction. Lemonade has over 1.3 million customers, and it has been one of the fastest-growing insurance stocks ever.\nThe company started in renters insurance, targeting young renters. However, just as its customers have moved on in life, Lemonade has expanded. Now it offers homeowners, pet, life, and even car insurance. Lemonade hopes to attract young customers with small offerings like renters and car insurance, then integrate them deeper into the ecosystem with its fast and delightful service.\n\n\n\nMetric\nFirst Nine Months of 2020\nFirst Nine Months of 2021\nChange\n\n\nNet loss\n$88.4 million\n$171.0 million\n93.4%\n\n\nNet loss as a percentage of revenue\n119.6%\n195.6%\nN/A\n\n\n\nThis major uptick in net losses has primarily been because of the company's loss ratio. Lemonade's net loss ratio -- which represents the amount of premium paid out on claims -- was 77% in the third quarter. A ratio of 75% or below is the long-term goal that management is targeting, but it has been consistently higher in 2021 because of the new products that Lemonade has launched this year and in 2020.\nLemonade's AI can often take time to learn and collect data about its new markets, resulting in poor short-term performance but long-term opportunities. As its AI obtains more data, it should become more accurate, lowering its loss ratio and its net loss. With the lowered loss ratio, investors could expect the company to generate a profit, which would provide optimism beyond its environmental, social, and governance (ESG) efforts.\nBoth of these companies are incredibly young and are quite risky today, which is clearly noted in the stock decreases of more than 25% for each year-to-date. But in a balanced portfolio, these stocks could define someone's future investing success. If both companies can use their competitive edges to rapidly grow their business over the next 15 years and become profitable, they could reward investors by 2035.","news_type":1},"isVote":1,"tweetType":1,"viewCount":131,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604928017,"gmtCreate":1639314938678,"gmtModify":1639314938787,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Sure anot??","listText":"Sure anot??","text":"Sure anot??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/604928017","repostId":"2190679207","repostType":4,"repost":{"id":"2190679207","pubTimestamp":1639281804,"share":"https://www.laohu8.com/m/news/2190679207?lang=&edition=full","pubTime":"2021-12-12 12:03","market":"us","language":"en","title":"Want $1 Million in Retirement? Invest $100,000 in These 2 Stocks and Hold Until 2035","url":"https://stock-news.laohu8.com/highlight/detail?id=2190679207","media":"Motley Fool","summary":"These two stocks could change your retirement.","content":"<p>Over the past 15 years, the <b>S&amp;P 500</b> has risen in price 232%, which results in a 9.8% compound annual growth rate without inflation. If this continued for the next 15 years, you would have over $300,000 in savings to retire on if you invested $100,000, which is bigger than the average 60-year-old American's 401(k) balance.</p>\n<p>While this strategy could produce solid returns, there are two stocks that could crush that average by 2035. Here's why I think <b>Latch</b> (NASDAQ:LTCH) and <b>Lemonade</b> (NYSE:LMND) have the potential to provide high-quality returns so that you can retire right.</p>\n<h2>1. Latch: Smart security</h2>\n<p>This smart lock manufacturer is taking the industry by storm with its software. With LatchOS, apartment managers can get a birds-eye view of all their apartments on <a href=\"https://laohu8.com/S/AONE.U\">one</a> platform, making sure all of their tenants are safe and secure. Moreover, managers can let in workers or delivery people from that platform. Latch is the only company that can offer a combination of smart, keyless locks and innovative software, so it's no wonder it is rapidly being adopted by apartment buildings across America.</p>\n<p>Nearly a third of new apartment buildings are being built today with Latch installed in them, and once Latch's locks are in, it can be incredibly hard to replace them with a competitor. Additionally, when customers agree to use Latch, they sign six- to 10-year contracts to use LatchOS. These two factors provide amazingly high switching costs, so once Latch is installed, it's likely that its users will stay Latch users for a long time. Latch has experienced zero turnovers since it started operations in 2017, and that will probably continue to be the case.</p>\n<p>Latch's market is massive, and the high switching costs and first-mover advantage will likely allow the company to capitalize on it. Latch sees a market opportunity of $54 billion in the U.S. alone, and if the company is able to expand internationally in a few years, that adds another $90 billion.</p>\n<p>Latch's partnerships will be another integral part of the company's success. Since Latch customers sign agreements with Latch to use its products before the apartments are even built, it is crucial that Latch is in talks with apartment managers before the construction team breaks ground. That is why Latch has partnered with some of the largest apartment builders in the U.S., like <b>Brookfield</b> (NYSE:BAM) and <b>Avalon Bay</b> (NYSE:AVB).</p>\n<p>This company has only been operational since 2017, so there are plenty of risks with this business. The primary risk is that it is losing lots of cash.</p>\n<table border=\"1\">\n <tbody>\n  <tr>\n   <th>Metric</th>\n   <th>Q3 2020</th>\n   <th>Q3 2021</th>\n   <th>Change</th>\n  </tr>\n  <tr>\n   <td>Net loss</td>\n   <td>$15.9 million</td>\n   <td>$34.2 million</td>\n   <td>115%</td>\n  </tr>\n  <tr>\n   <td>Net loss as a percentage of revenue</td>\n   <td>311.5%</td>\n   <td>305.7%</td>\n   <td>N/A</td>\n  </tr>\n </tbody>\n</table>\n<p>The company is making most of its money today on its locks, which it sells at a loss. These losses are bad today, but Latch's profitability can improve. Latch has noted that the timeframe it takes from construction to a builder beginning their subscription services is 24 months. The contracts the company has seen could finally turn into reportable revenue within the next couple of years. Analysts see the potential as well with growth forecasts of nearly 50% for the next five years.</p>\n<p>Also, as its customers stay with the company longer and pay more in its subscription fees for the software -- which has gross margins of 90% -- the company's losses will likely improve to provide a pathway to profitability. This could be a multi-year effort, but if it can use its differentiated product and strong partnerships to attract customers and its high switching costs to retain them, Latch could give investors immense returns by 2035.</p>\n<h2>2. Lemonade: An insurance provider anyone can love</h2>\n<p>Lemonade is making insurance enjoyable. Whether applying for insurance or getting a claim, Lemonade's process is easy and hassle-free with its artificial intelligence (AI)-based bots that can approve applicants and claims in seconds. The company is also aligning its interest with its consumers: Lemonade charges a flat fee, and any money from leftover claims that went unpaid goes to charities that Lemonade customers choose. So far in 2021, Lemonade has donated over $2.2 million in unpaid claims on behalf of its customers.</p>\n<p>Lemonade's incentive alignment structure can hurt its bottom line, but it has resulted in amazing customer attraction. Lemonade has over 1.3 million customers, and it has been one of the fastest-growing insurance stocks ever.</p>\n<p>The company started in renters insurance, targeting young renters. However, just as its customers have moved on in life, Lemonade has expanded. Now it offers homeowners, pet, life, and even car insurance. Lemonade hopes to attract young customers with small offerings like renters and car insurance, then integrate them deeper into the ecosystem with its fast and delightful service.</p>\n<table border=\"1\">\n <tbody>\n  <tr>\n   <th>Metric</th>\n   <th>First Nine Months of 2020</th>\n   <th>First Nine Months of 2021</th>\n   <th>Change</th>\n  </tr>\n  <tr>\n   <td>Net loss</td>\n   <td>$88.4 million</td>\n   <td>$171.0 million</td>\n   <td>93.4%</td>\n  </tr>\n  <tr>\n   <td>Net loss as a percentage of revenue</td>\n   <td>119.6%</td>\n   <td>195.6%</td>\n   <td><p>N/A</p></td>\n  </tr>\n </tbody>\n</table>\n<p>This major uptick in net losses has primarily been because of the company's loss ratio. Lemonade's net loss ratio -- which represents the amount of premium paid out on claims -- was 77% in the third quarter. A ratio of 75% or below is the long-term goal that management is targeting, but it has been consistently higher in 2021 because of the new products that Lemonade has launched this year and in 2020.</p>\n<p>Lemonade's AI can often take time to learn and collect data about its new markets, resulting in poor short-term performance but long-term opportunities. As its AI obtains more data, it should become more accurate, lowering its loss ratio and its net loss. With the lowered loss ratio, investors could expect the company to generate a profit, which would provide optimism beyond its environmental, social, and governance (ESG) efforts.</p>\n<p>Both of these companies are incredibly young and are quite risky today, which is clearly noted in the stock decreases of more than 25% for each year-to-date. But in a balanced portfolio, these stocks could define someone's future investing success. If both companies can use their competitive edges to rapidly grow their business over the next 15 years and become profitable, they could reward investors by 2035.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want $1 Million in Retirement? Invest $100,000 in These 2 Stocks and Hold Until 2035</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant $1 Million in Retirement? Invest $100,000 in These 2 Stocks and Hold Until 2035\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-12 12:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/11/want-1-million-in-retirement-invest-100000-in-thes/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Over the past 15 years, the S&P 500 has risen in price 232%, which results in a 9.8% compound annual growth rate without inflation. If this continued for the next 15 years, you would have over $300,...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/11/want-1-million-in-retirement-invest-100000-in-thes/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AVB":"阿湾物产","BK4528":"SaaS概念","BK4023":"应用软件","BK4107":"财产与意外伤害保险","BK4551":"寇图资本持仓","LTCH":"Latch, Inc.","ESG":"FlexShares STOXX US ESG Select Index Fund","BK4535":"淡马锡持仓","BK4543":"AI","BK4549":"软银资本持仓","BK4135":"资产管理与托管银行","AI":"C3.ai, Inc.","BK4548":"巴美列捷福持仓","BAM":"布鲁克菲尔德资产管理","BK4215":"住宅房地产投资信托","LMND":"Lemonade, Inc."},"source_url":"https://www.fool.com/investing/2021/12/11/want-1-million-in-retirement-invest-100000-in-thes/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190679207","content_text":"Over the past 15 years, the S&P 500 has risen in price 232%, which results in a 9.8% compound annual growth rate without inflation. If this continued for the next 15 years, you would have over $300,000 in savings to retire on if you invested $100,000, which is bigger than the average 60-year-old American's 401(k) balance.\nWhile this strategy could produce solid returns, there are two stocks that could crush that average by 2035. Here's why I think Latch (NASDAQ:LTCH) and Lemonade (NYSE:LMND) have the potential to provide high-quality returns so that you can retire right.\n1. Latch: Smart security\nThis smart lock manufacturer is taking the industry by storm with its software. With LatchOS, apartment managers can get a birds-eye view of all their apartments on one platform, making sure all of their tenants are safe and secure. Moreover, managers can let in workers or delivery people from that platform. Latch is the only company that can offer a combination of smart, keyless locks and innovative software, so it's no wonder it is rapidly being adopted by apartment buildings across America.\nNearly a third of new apartment buildings are being built today with Latch installed in them, and once Latch's locks are in, it can be incredibly hard to replace them with a competitor. Additionally, when customers agree to use Latch, they sign six- to 10-year contracts to use LatchOS. These two factors provide amazingly high switching costs, so once Latch is installed, it's likely that its users will stay Latch users for a long time. Latch has experienced zero turnovers since it started operations in 2017, and that will probably continue to be the case.\nLatch's market is massive, and the high switching costs and first-mover advantage will likely allow the company to capitalize on it. Latch sees a market opportunity of $54 billion in the U.S. alone, and if the company is able to expand internationally in a few years, that adds another $90 billion.\nLatch's partnerships will be another integral part of the company's success. Since Latch customers sign agreements with Latch to use its products before the apartments are even built, it is crucial that Latch is in talks with apartment managers before the construction team breaks ground. That is why Latch has partnered with some of the largest apartment builders in the U.S., like Brookfield (NYSE:BAM) and Avalon Bay (NYSE:AVB).\nThis company has only been operational since 2017, so there are plenty of risks with this business. The primary risk is that it is losing lots of cash.\n\n\n\nMetric\nQ3 2020\nQ3 2021\nChange\n\n\nNet loss\n$15.9 million\n$34.2 million\n115%\n\n\nNet loss as a percentage of revenue\n311.5%\n305.7%\nN/A\n\n\n\nThe company is making most of its money today on its locks, which it sells at a loss. These losses are bad today, but Latch's profitability can improve. Latch has noted that the timeframe it takes from construction to a builder beginning their subscription services is 24 months. The contracts the company has seen could finally turn into reportable revenue within the next couple of years. Analysts see the potential as well with growth forecasts of nearly 50% for the next five years.\nAlso, as its customers stay with the company longer and pay more in its subscription fees for the software -- which has gross margins of 90% -- the company's losses will likely improve to provide a pathway to profitability. This could be a multi-year effort, but if it can use its differentiated product and strong partnerships to attract customers and its high switching costs to retain them, Latch could give investors immense returns by 2035.\n2. Lemonade: An insurance provider anyone can love\nLemonade is making insurance enjoyable. Whether applying for insurance or getting a claim, Lemonade's process is easy and hassle-free with its artificial intelligence (AI)-based bots that can approve applicants and claims in seconds. The company is also aligning its interest with its consumers: Lemonade charges a flat fee, and any money from leftover claims that went unpaid goes to charities that Lemonade customers choose. So far in 2021, Lemonade has donated over $2.2 million in unpaid claims on behalf of its customers.\nLemonade's incentive alignment structure can hurt its bottom line, but it has resulted in amazing customer attraction. Lemonade has over 1.3 million customers, and it has been one of the fastest-growing insurance stocks ever.\nThe company started in renters insurance, targeting young renters. However, just as its customers have moved on in life, Lemonade has expanded. Now it offers homeowners, pet, life, and even car insurance. Lemonade hopes to attract young customers with small offerings like renters and car insurance, then integrate them deeper into the ecosystem with its fast and delightful service.\n\n\n\nMetric\nFirst Nine Months of 2020\nFirst Nine Months of 2021\nChange\n\n\nNet loss\n$88.4 million\n$171.0 million\n93.4%\n\n\nNet loss as a percentage of revenue\n119.6%\n195.6%\nN/A\n\n\n\nThis major uptick in net losses has primarily been because of the company's loss ratio. Lemonade's net loss ratio -- which represents the amount of premium paid out on claims -- was 77% in the third quarter. A ratio of 75% or below is the long-term goal that management is targeting, but it has been consistently higher in 2021 because of the new products that Lemonade has launched this year and in 2020.\nLemonade's AI can often take time to learn and collect data about its new markets, resulting in poor short-term performance but long-term opportunities. As its AI obtains more data, it should become more accurate, lowering its loss ratio and its net loss. With the lowered loss ratio, investors could expect the company to generate a profit, which would provide optimism beyond its environmental, social, and governance (ESG) efforts.\nBoth of these companies are incredibly young and are quite risky today, which is clearly noted in the stock decreases of more than 25% for each year-to-date. But in a balanced portfolio, these stocks could define someone's future investing success. If both companies can use their competitive edges to rapidly grow their business over the next 15 years and become profitable, they could reward investors by 2035.","news_type":1},"isVote":1,"tweetType":1,"viewCount":283,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605532748,"gmtCreate":1639188876484,"gmtModify":1639188876558,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Comment and like","listText":"Comment and like","text":"Comment and like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/605532748","repostId":"2190673267","repostType":4,"repost":{"id":"2190673267","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639176815,"share":"https://www.laohu8.com/m/news/2190673267?lang=&edition=full","pubTime":"2021-12-11 06:53","market":"us","language":"en","title":"Wall St Week Ahead-Investors await faster taper, inflation view at Fed meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2190673267","media":"Reuters","summary":"NEW YORK, Dec 10 (Reuters) - Investors are bracing for the last Federal Reserve meeting of the year,","content":"<p>NEW YORK, Dec 10 (Reuters) - Investors are bracing for the last Federal Reserve meeting of the year, with market participants hungry to learn how quickly the central bank plans to finish unwinding its bond-buying program and pick up signs of when it may start to raise rates in 2022.</p>\n<p>Stocks are back at record highs following last week’s selloff – a market spasm brought on by worries over the Omicron variant of the coronavirus&nbsp;and comments from Fed Chairman Jerome Powell, who said the central bank may discuss speeding up the reduction of its $120 billion per month bond buying program at next week's meeting.</p>\n<p>There is potential for renewed volatility, however, if the Fed takes a more hawkish than expected view on rolling back the easy money policies that have helped stocks more than double from their March 2020 lows, including a rapid reduction in bond buying that clears the way for the central bank to raise rates sooner.</p>\n<p>Markets could also be roiled if the Fed signals greater worry about inflation, which Powell said can no longer be described as \"transitory.\" Data on Friday showed consumer prices last month notched their largest annual gain in nearly four decades, bolstering the case for higher rates.</p>\n<p>“The biggest factor in the equity market remains and will remain to be interest rates,\" said Jack Ablin, chief investment officer at Cresset Capital Management.</p>\n<p>Higher yields - which can rise on expectations of tighter monetary policy - can dim the allure of stocks by creating a greater discount for companies' future cash flows, potentially pressuring valuations that are already elevated by historical standards.</p>\n<p>The S&amp;P 500 , which has climbed 25% this year, is trading at 20.5 times forward 12-month earnings estimates, compared with its historic valuation average of 15.5 times, according to Refinitiv Datastream.</p>\n<p>The yield on the benchmark 10-year Treasury note has climbed about 15 basis points from the start of the month to 1.49%, but is below the 1.776% it reached in March.</p>\n<p>Some stocks have already been hit by higher rate worries this year, including technology and growth companies that thrived during 2020's lockdowns.</p>\n<p>The broader market, however, has generally tolerated tightening monetary policy, analysts at BofA Global Research said in a recent report, noting that stocks mostly climbed as the Fed normalized policy in the last decade.</p>\n<p>The Fed last month began \"tapering\" its purchases of Treasuries and mortgage-backed securities at a pace that would have put it on track to complete the wind-down by mid-2022. Following Powell's comments, investors now believe the Fed could quicken the pace of reductions that will end the bond-buying by March, which could allow the central bank to potentially start raising rates sooner.</p>\n<p>Bets on earlier rate increases have also grown. Traders late on Friday saw a more than 50% chance of a rate hike by May 2022, up from a roughly 30% chance a month ago, according to the CME Group's FedWatch program.</p>\n<p>Investors are also keen to learn the central bank's view on the Omicron variant's potential impact on economic growth or inflation.</p>\n<p>One possible scenario outlined by UBS Global Wealth Management in a report sees the virus complicating supply-chain issues that have helped stoke inflation in recent months, bringing concerns the Fed may need to tighten monetary policy faster. The bank’s base case scenario, however, assumes the Omicron variant will not derail the recovery.</p>\n<p>Mona Mahajan, senior investment strategist at Edward Jones, said the Fed meeting could bring more clarity to investors after an upsurge of volatility in recent weeks.</p>\n<p>“It feels like the market has climbed two walls of worry already: Omicron and the path of the Fed,\" she said. \"I do think over the next couple of weeks we will get a little bit more certainty on both fronts.”</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St Week Ahead-Investors await faster taper, inflation view at Fed meeting</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St Week Ahead-Investors await faster taper, inflation view at Fed meeting\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-11 06:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>NEW YORK, Dec 10 (Reuters) - Investors are bracing for the last Federal Reserve meeting of the year, with market participants hungry to learn how quickly the central bank plans to finish unwinding its bond-buying program and pick up signs of when it may start to raise rates in 2022.</p>\n<p>Stocks are back at record highs following last week’s selloff – a market spasm brought on by worries over the Omicron variant of the coronavirus&nbsp;and comments from Fed Chairman Jerome Powell, who said the central bank may discuss speeding up the reduction of its $120 billion per month bond buying program at next week's meeting.</p>\n<p>There is potential for renewed volatility, however, if the Fed takes a more hawkish than expected view on rolling back the easy money policies that have helped stocks more than double from their March 2020 lows, including a rapid reduction in bond buying that clears the way for the central bank to raise rates sooner.</p>\n<p>Markets could also be roiled if the Fed signals greater worry about inflation, which Powell said can no longer be described as \"transitory.\" Data on Friday showed consumer prices last month notched their largest annual gain in nearly four decades, bolstering the case for higher rates.</p>\n<p>“The biggest factor in the equity market remains and will remain to be interest rates,\" said Jack Ablin, chief investment officer at Cresset Capital Management.</p>\n<p>Higher yields - which can rise on expectations of tighter monetary policy - can dim the allure of stocks by creating a greater discount for companies' future cash flows, potentially pressuring valuations that are already elevated by historical standards.</p>\n<p>The S&amp;P 500 , which has climbed 25% this year, is trading at 20.5 times forward 12-month earnings estimates, compared with its historic valuation average of 15.5 times, according to Refinitiv Datastream.</p>\n<p>The yield on the benchmark 10-year Treasury note has climbed about 15 basis points from the start of the month to 1.49%, but is below the 1.776% it reached in March.</p>\n<p>Some stocks have already been hit by higher rate worries this year, including technology and growth companies that thrived during 2020's lockdowns.</p>\n<p>The broader market, however, has generally tolerated tightening monetary policy, analysts at BofA Global Research said in a recent report, noting that stocks mostly climbed as the Fed normalized policy in the last decade.</p>\n<p>The Fed last month began \"tapering\" its purchases of Treasuries and mortgage-backed securities at a pace that would have put it on track to complete the wind-down by mid-2022. Following Powell's comments, investors now believe the Fed could quicken the pace of reductions that will end the bond-buying by March, which could allow the central bank to potentially start raising rates sooner.</p>\n<p>Bets on earlier rate increases have also grown. Traders late on Friday saw a more than 50% chance of a rate hike by May 2022, up from a roughly 30% chance a month ago, according to the CME Group's FedWatch program.</p>\n<p>Investors are also keen to learn the central bank's view on the Omicron variant's potential impact on economic growth or inflation.</p>\n<p>One possible scenario outlined by UBS Global Wealth Management in a report sees the virus complicating supply-chain issues that have helped stoke inflation in recent months, bringing concerns the Fed may need to tighten monetary policy faster. The bank’s base case scenario, however, assumes the Omicron variant will not derail the recovery.</p>\n<p>Mona Mahajan, senior investment strategist at Edward Jones, said the Fed meeting could bring more clarity to investors after an upsurge of volatility in recent weeks.</p>\n<p>“It feels like the market has climbed two walls of worry already: Omicron and the path of the Fed,\" she said. \"I do think over the next couple of weeks we will get a little bit more certainty on both fronts.”</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190673267","content_text":"NEW YORK, Dec 10 (Reuters) - Investors are bracing for the last Federal Reserve meeting of the year, with market participants hungry to learn how quickly the central bank plans to finish unwinding its bond-buying program and pick up signs of when it may start to raise rates in 2022.\nStocks are back at record highs following last week’s selloff – a market spasm brought on by worries over the Omicron variant of the coronavirus and comments from Fed Chairman Jerome Powell, who said the central bank may discuss speeding up the reduction of its $120 billion per month bond buying program at next week's meeting.\nThere is potential for renewed volatility, however, if the Fed takes a more hawkish than expected view on rolling back the easy money policies that have helped stocks more than double from their March 2020 lows, including a rapid reduction in bond buying that clears the way for the central bank to raise rates sooner.\nMarkets could also be roiled if the Fed signals greater worry about inflation, which Powell said can no longer be described as \"transitory.\" Data on Friday showed consumer prices last month notched their largest annual gain in nearly four decades, bolstering the case for higher rates.\n“The biggest factor in the equity market remains and will remain to be interest rates,\" said Jack Ablin, chief investment officer at Cresset Capital Management.\nHigher yields - which can rise on expectations of tighter monetary policy - can dim the allure of stocks by creating a greater discount for companies' future cash flows, potentially pressuring valuations that are already elevated by historical standards.\nThe S&P 500 , which has climbed 25% this year, is trading at 20.5 times forward 12-month earnings estimates, compared with its historic valuation average of 15.5 times, according to Refinitiv Datastream.\nThe yield on the benchmark 10-year Treasury note has climbed about 15 basis points from the start of the month to 1.49%, but is below the 1.776% it reached in March.\nSome stocks have already been hit by higher rate worries this year, including technology and growth companies that thrived during 2020's lockdowns.\nThe broader market, however, has generally tolerated tightening monetary policy, analysts at BofA Global Research said in a recent report, noting that stocks mostly climbed as the Fed normalized policy in the last decade.\nThe Fed last month began \"tapering\" its purchases of Treasuries and mortgage-backed securities at a pace that would have put it on track to complete the wind-down by mid-2022. Following Powell's comments, investors now believe the Fed could quicken the pace of reductions that will end the bond-buying by March, which could allow the central bank to potentially start raising rates sooner.\nBets on earlier rate increases have also grown. Traders late on Friday saw a more than 50% chance of a rate hike by May 2022, up from a roughly 30% chance a month ago, according to the CME Group's FedWatch program.\nInvestors are also keen to learn the central bank's view on the Omicron variant's potential impact on economic growth or inflation.\nOne possible scenario outlined by UBS Global Wealth Management in a report sees the virus complicating supply-chain issues that have helped stoke inflation in recent months, bringing concerns the Fed may need to tighten monetary policy faster. The bank’s base case scenario, however, assumes the Omicron variant will not derail the recovery.\nMona Mahajan, senior investment strategist at Edward Jones, said the Fed meeting could bring more clarity to investors after an upsurge of volatility in recent weeks.\n“It feels like the market has climbed two walls of worry already: Omicron and the path of the Fed,\" she said. \"I do think over the next couple of weeks we will get a little bit more certainty on both fronts.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":131,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602543556,"gmtCreate":1639047177157,"gmtModify":1639047177229,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Comm","listText":"Comm","text":"Comm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602543556","repostId":"1128116582","repostType":4,"isVote":1,"tweetType":1,"viewCount":269,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602543287,"gmtCreate":1639047168951,"gmtModify":1639047169020,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Comment","listText":"Comment","text":"Comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602543287","repostId":"1128116582","repostType":4,"isVote":1,"tweetType":1,"viewCount":164,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602987487,"gmtCreate":1638957914980,"gmtModify":1638957915210,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/602987487","repostId":"1149172224","repostType":4,"repost":{"id":"1149172224","pubTimestamp":1638956614,"share":"https://www.laohu8.com/m/news/1149172224?lang=&edition=full","pubTime":"2021-12-08 17:43","market":"us","language":"en","title":"Not-So-Great Expectations for the Year Ahead?","url":"https://stock-news.laohu8.com/highlight/detail?id=1149172224","media":"Bloomberg","summary":"Statistical probabilities and the calendar distort market predictions in any case, but while omicron","content":"<p>Statistical probabilities and the calendar distort market predictions in any case, but while omicron looks less deadly than feared,&nbsp;inflation is clouding the picture for 2022.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ac5ecf1c9731a06567566d0b3e8be705\" tg-width=\"1400\" tg-height=\"933\" width=\"100%\" height=\"auto\"><span>It’s already hard to see through the inflation confetti how 2022 will turn out. Photographer: Roy Rochlin/Getty Images</span></p>\n<p><b>Pretending to See the Future</b></p>\n<p>It’s the season for predicting 2022. I’m currently burdened&nbsp; by huge piles of paper as every analyst out there comes up with their own estimates for where we will&nbsp;be by the end of next year. They’re very useful. A&nbsp;lot of bright people work&nbsp;in the investment industry, and the exercise of trying to arrive at their most likely scenario for 2022&nbsp;helps them<s>to</s>organize their thoughts and ask and answer important questions. I’m very grateful for their efforts, which I’m finding&nbsp;useful for my own job.</p>\n<p>However, the endeavor has to contend with two problems. The first is the infuriating statistical concept of the “expected value.”&nbsp;One of the first notions introduced in business school statistics classes, it’s simple enough. If you have two probable outcomes, you multiply each by&nbsp;their probability and add together to get an expected value. If there’s a 50% chance that you will win $1, and a 50% chance that you will win $2, then the expected value of your winnings is $1.50. This is true even though there is zero chance of&nbsp;your winning that amount.</p>\n<p>That’s&nbsp;the problem with scenario analysis. Any sensible analyst accepts that there is uncertainty and produces a range of risks, with the outcomes if they come to pass, and a probability for each. Once you move from this thoroughly sensible exercise to derive&nbsp;a single forecast or expected value, however, you find yourself predicting something that&nbsp;you don’t think can possibly happen.</p>\n<p>A second problem is that the break-off of a calendar year is arbitrary. Some aspects of markets follow an annual cycle, but others don’t. A big rise or selloff in December can transform the following year’s returns. And of course markets tend to overshoot in both directions. In the long run they get it right, with stock market growth tracking economic growth closely. In the shorter term, returns look far more like a random walk. Stocks tend to stage lengthy rallies with occasional brutal selloffs to correct themselves. An “average” year, in which stocks trundle upward&nbsp;by about 8%, is actually quite unusual.</p>\n<p>The following chart was produced by Aneet Chachra of Janus Henderson Group PLC, and covers all the the S&amp;P 500’s annual price returns since 1928:</p>\n<p><img src=\"https://static.tigerbbs.com/70b57f5d42510c0c57d8a754e8c0c124\" tg-width=\"720\" tg-height=\"465\" width=\"100%\" height=\"auto\"></p>\n<p>This is nothing at all like a bell curve&nbsp;or a normal distribution. The most common outcomes are returns between 10% and 30%, while a loss of up to 20% is considerably more likely than a positive return in that central range of 0 to 10%. The average outcome that it might make sense for us to expect is about 8%, but that outcome in itself is very unlikely, given markets’ tendency toward&nbsp;over-excitability.</p>\n<p>This leads us to the forecasts for 2022. There is a long-established Wall Street tradition that equity strategists should pretend to see the future, as OMD put it, and come up with a number for the index at the end of the next year. Chachra compiled the following list from reports available on Bloomberg, and I thank him&nbsp;for doing the work:</p>\n<p><img src=\"https://static.tigerbbs.com/ada68eff07275c5e18be09f42ea63bcd\" tg-width=\"386\" tg-height=\"525\" width=\"100%\" height=\"auto\"></p>\n<p>On Dec. 3, when he carried out the exercise, the S&amp;P stood at 4,538. Assuming it stayed at that&nbsp;level until the end of the month, the average end-year forecast of 4,909 implied a 2022 return of 8.2%. That is almost exactly the long-term average. It’s the classic “expected value” which nobody in fact expects.</p>\n<p>Two hectic days of bullish trading later, the S&amp;P stands just under 4,700 at the time of typing. That makes our forecasters far less bullish for 2022, with an average return prediction down to only 4.5%. The number of houses in Chachra’s list predicting an outright fall next year has risen from one (Morgan Stanley) to three (including Bank of America Corp. and Cornerstone Macro LLC.)</p>\n<p>That in itself demonstrates the folly of looking at the market in calendar-year increments. It also explains why balanced portfolio investing continues, despite the well-established tendency for equities to outperform in the long run.</p>\n<p>Beyond that, it’s interesting that Wall Street is perceptibly less bullish than usual. It’s rare for institutions as big and influential as Morgan Stanley and BofA to be predicting an outright negative return, both because sell-side research departments have an interest in the market continuing to go up, and because the market does indeed usually go up. This year’s increase in inflation is a big deal, and it might require higher rates to cope&nbsp;with it. There will be much more to write about this between now and New Year’s Eve, but the clearest message from all the predictions is that inflation has clouded the picture. That might help a bigger return, or it might presage a major regime change. For now,&nbsp;the main point is that uncertainty is higher than usual.</p>\n<p><b>Scattergraph of Hope</b></p>\n<p>If one chart sums up the reason for resurgent animal spirits, it’s this one (produced by Deutsche Bank AG):</p>\n<p><img src=\"https://static.tigerbbs.com/451b1640d5a3c676c2b46601bd030a24\" tg-width=\"1052\" tg-height=\"692\" width=\"100%\" height=\"auto\"></p>\n<p>We all know the caveats by now. We’ve learned a lot about epidemiology in the last two years, and how little we or anyone else knows about epidemiology. But the basic point, at this early stage, is clear. In South Africa, there is a well-established relationship between the number of new Covid-19 cases that are reported, and the number of deaths that will occur from the disease 12 days later. Omicron has been identified for long enough that we can now look at how its lethality compares to pre-omicron lethality. And the two pale blue dots far below the cluster of dark blue dots above them suggest that something has changed, and that omicron is significantly less deadly&nbsp;than its predecessor variants.</p>\n<p>Not only is this good news in the sense that we needn’t worry too&nbsp;much about catching it. There’s even a chance, as omicron does indeed appear to be more transmissible than other variants, that it will crowd them out to become the dominant form of the virus. That would entail more people getting mildly ill and having some degree of natural immunity, leading to&nbsp;Covid-19 as a whole becoming a less dangerous disease. For a really optimistic parallel, consider the Spanish Flu of 1918, which died down because it had steadily morphed into a less dangerous but still highly contagious virus. As&nbsp;this Washington Post piece shows, the descendants of that dreadful pandemic are still around today.</p>\n<p>Does this mean we can be&nbsp;sure the pandemic is about to end? Of course not. We&nbsp;all now understand&nbsp;the fallibility of medical science&nbsp;(making&nbsp;those of us who earn&nbsp;a living from economics, which everybody already knows is fallible, feel a bit better). For a reminder that even cancer research can be very ambiguous, and that researchers can lead themselves badly astray, I recommend&nbsp;this reportby the&nbsp;Reproducibility Project, a massive effort to replicate key experiments from more than 50 influential breakthrough papers. The bottom line to their findings, published this week, is that 46% of the effects that had previously been identified in the literature could be replicated successfully on more criteria than they failed. Or in other words, the results of more than half the experiments didn’t stand up when people tried to repeat them. So we shouldn’t assume that omicron is our savior just yet. But when it comes to daily&nbsp;trading in the stock market, the South African scattergraph is a good reason for prices to go up. And that’s why they did.</p>\n<p><b>Labor, Productivity and Inflation</b></p>\n<p>A key issue for 2021 involves the very heart of capitalism. Who is going to get the better in the battle between labor and capital? And if labor succeeds in extracting a better return, will capitalists respond by accepting lower profits, or by raising prices? The issue is important&nbsp;to the question of whether 2021’s resurgence of inflation turns into a secular increase in inflationary pressure.</p>\n<p>The effect of the Global Financial Crisis was to crush workers’ negotiating power, particularly for the poorest paid. In the chart below (which I adapted from a chart in Pimco’s asset allocation outlook for next year), the proportion of small businesses finding it hard to fill jobs and the average wage increases&nbsp;for the lowest-paid 25% of workers are mapped on separate scales. The low-paid had a terrible time of it in the years after the GFC, but their power had been steadily recovering even ahead of the pandemic:</p>\n<p><img src=\"https://static.tigerbbs.com/1e1ba72f58c821651c02787cb7018551\" tg-width=\"1200\" tg-height=\"675\" width=\"100%\" height=\"auto\"></p>\n<p>This is an&nbsp;unambiguous&nbsp;upward trend, and is in line with the experience of past pandemics, in which the power of labor tended to increase in the aftermath. Meanwhile, Tuesday also saw publication of new productivity data for the U.S. Unit labor costs rose much faster than had been expected in the third quarter.</p>\n<p>Looking to the longer term, unit labor costs have risen roughly in line with growth in gross domestic product&nbsp;for much of history, but this has contained big swings in the trend. In the following chart, unit labor costs for all non-financial corporates is shown as a share of constant-currency GDP, rebased to 1950:</p>\n<p><img src=\"https://static.tigerbbs.com/7c577875709712624b3c584992bc80db\" tg-width=\"1200\" tg-height=\"675\" width=\"100%\" height=\"auto\"></p>\n<p>Companies got a great deal in the 1950s and early 1960s as productivity steadily improved. Labor&nbsp;enjoyed the upper hand until the early 1980s, when a combination of Reaganomics and the determined anti-inflationary&nbsp;monetary policy of Paul Volcker at the Federal Reserve saw unit labor costs diminish sharply. Since the GFC, the relationship has been constant, with GDP and unit labor costs moving in line with each other (barring a very brief upward blip in productivity during the mass layoffs in spring last year).</p>\n<p>This relationship has been flatlining at a level that is a great deal for companies and capital, and lousy for workers and labor. It’s also a level that has helped keep prices low. Are we seeing the first signs of a belated reversal?</p>\n<p><b>Survival Tips</b></p>\n<p>On the subject of vaccine hesitancy, vaccine inequality, vaccine nationalism and deep-seated distrust of science, I recently re-watched a movie that plays to the themes of today with startling relevance.The Constant Gardener, the film&nbsp;version of the John le Carre novel with Ralph Fiennes and Rachel Weisz in the leading roles, is&nbsp;a great thriller, shot through with all the classic le Carre themes of doubt, distrust and betrayal. Fiennes is brilliant, as are many of the others. Set mostly in Kenya, it’s also a sumptuously beautiful film to watch.</p>\n<p>The particular reason to see&nbsp;it now is that the central plot concerns the attempt by Weisz’s character to get to the bottom of a dastardly plot by a big pharmaceutical company, aided and abetted by the British government, to test new drugs on poor Kenyans forced to be guinea pigs, and cover up evidence of the harmful side effects that result. There’s more to it than that, but like all great fiction it was written for one moment, and captures another perfectly —&nbsp;which is to say that its themes are eternal. I strongly recommend catching up with it.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Not-So-Great Expectations for the Year Ahead?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNot-So-Great Expectations for the Year Ahead?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-08 17:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/opinion/articles/2021-12-08/inflation-not-omicron-is-clouding-year-end-market-predictions-for-2022><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Statistical probabilities and the calendar distort market predictions in any case, but while omicron looks less deadly than feared, inflation is clouding the picture for 2022.\nIt’s already hard to see...</p>\n\n<a href=\"https://www.bloomberg.com/opinion/articles/2021-12-08/inflation-not-omicron-is-clouding-year-end-market-predictions-for-2022\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"source_url":"https://www.bloomberg.com/opinion/articles/2021-12-08/inflation-not-omicron-is-clouding-year-end-market-predictions-for-2022","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1149172224","content_text":"Statistical probabilities and the calendar distort market predictions in any case, but while omicron looks less deadly than feared, inflation is clouding the picture for 2022.\nIt’s already hard to see through the inflation confetti how 2022 will turn out. Photographer: Roy Rochlin/Getty Images\nPretending to See the Future\nIt’s the season for predicting 2022. I’m currently burdened  by huge piles of paper as every analyst out there comes up with their own estimates for where we will be by the end of next year. They’re very useful. A lot of bright people work in the investment industry, and the exercise of trying to arrive at their most likely scenario for 2022 helps themtoorganize their thoughts and ask and answer important questions. I’m very grateful for their efforts, which I’m finding useful for my own job.\nHowever, the endeavor has to contend with two problems. The first is the infuriating statistical concept of the “expected value.” One of the first notions introduced in business school statistics classes, it’s simple enough. If you have two probable outcomes, you multiply each by their probability and add together to get an expected value. If there’s a 50% chance that you will win $1, and a 50% chance that you will win $2, then the expected value of your winnings is $1.50. This is true even though there is zero chance of your winning that amount.\nThat’s the problem with scenario analysis. Any sensible analyst accepts that there is uncertainty and produces a range of risks, with the outcomes if they come to pass, and a probability for each. Once you move from this thoroughly sensible exercise to derive a single forecast or expected value, however, you find yourself predicting something that you don’t think can possibly happen.\nA second problem is that the break-off of a calendar year is arbitrary. Some aspects of markets follow an annual cycle, but others don’t. A big rise or selloff in December can transform the following year’s returns. And of course markets tend to overshoot in both directions. In the long run they get it right, with stock market growth tracking economic growth closely. In the shorter term, returns look far more like a random walk. Stocks tend to stage lengthy rallies with occasional brutal selloffs to correct themselves. An “average” year, in which stocks trundle upward by about 8%, is actually quite unusual.\nThe following chart was produced by Aneet Chachra of Janus Henderson Group PLC, and covers all the the S&P 500’s annual price returns since 1928:\n\nThis is nothing at all like a bell curve or a normal distribution. The most common outcomes are returns between 10% and 30%, while a loss of up to 20% is considerably more likely than a positive return in that central range of 0 to 10%. The average outcome that it might make sense for us to expect is about 8%, but that outcome in itself is very unlikely, given markets’ tendency toward over-excitability.\nThis leads us to the forecasts for 2022. There is a long-established Wall Street tradition that equity strategists should pretend to see the future, as OMD put it, and come up with a number for the index at the end of the next year. Chachra compiled the following list from reports available on Bloomberg, and I thank him for doing the work:\n\nOn Dec. 3, when he carried out the exercise, the S&P stood at 4,538. Assuming it stayed at that level until the end of the month, the average end-year forecast of 4,909 implied a 2022 return of 8.2%. That is almost exactly the long-term average. It’s the classic “expected value” which nobody in fact expects.\nTwo hectic days of bullish trading later, the S&P stands just under 4,700 at the time of typing. That makes our forecasters far less bullish for 2022, with an average return prediction down to only 4.5%. The number of houses in Chachra’s list predicting an outright fall next year has risen from one (Morgan Stanley) to three (including Bank of America Corp. and Cornerstone Macro LLC.)\nThat in itself demonstrates the folly of looking at the market in calendar-year increments. It also explains why balanced portfolio investing continues, despite the well-established tendency for equities to outperform in the long run.\nBeyond that, it’s interesting that Wall Street is perceptibly less bullish than usual. It’s rare for institutions as big and influential as Morgan Stanley and BofA to be predicting an outright negative return, both because sell-side research departments have an interest in the market continuing to go up, and because the market does indeed usually go up. This year’s increase in inflation is a big deal, and it might require higher rates to cope with it. There will be much more to write about this between now and New Year’s Eve, but the clearest message from all the predictions is that inflation has clouded the picture. That might help a bigger return, or it might presage a major regime change. For now, the main point is that uncertainty is higher than usual.\nScattergraph of Hope\nIf one chart sums up the reason for resurgent animal spirits, it’s this one (produced by Deutsche Bank AG):\n\nWe all know the caveats by now. We’ve learned a lot about epidemiology in the last two years, and how little we or anyone else knows about epidemiology. But the basic point, at this early stage, is clear. In South Africa, there is a well-established relationship between the number of new Covid-19 cases that are reported, and the number of deaths that will occur from the disease 12 days later. Omicron has been identified for long enough that we can now look at how its lethality compares to pre-omicron lethality. And the two pale blue dots far below the cluster of dark blue dots above them suggest that something has changed, and that omicron is significantly less deadly than its predecessor variants.\nNot only is this good news in the sense that we needn’t worry too much about catching it. There’s even a chance, as omicron does indeed appear to be more transmissible than other variants, that it will crowd them out to become the dominant form of the virus. That would entail more people getting mildly ill and having some degree of natural immunity, leading to Covid-19 as a whole becoming a less dangerous disease. For a really optimistic parallel, consider the Spanish Flu of 1918, which died down because it had steadily morphed into a less dangerous but still highly contagious virus. As this Washington Post piece shows, the descendants of that dreadful pandemic are still around today.\nDoes this mean we can be sure the pandemic is about to end? Of course not. We all now understand the fallibility of medical science (making those of us who earn a living from economics, which everybody already knows is fallible, feel a bit better). For a reminder that even cancer research can be very ambiguous, and that researchers can lead themselves badly astray, I recommend this reportby the Reproducibility Project, a massive effort to replicate key experiments from more than 50 influential breakthrough papers. The bottom line to their findings, published this week, is that 46% of the effects that had previously been identified in the literature could be replicated successfully on more criteria than they failed. Or in other words, the results of more than half the experiments didn’t stand up when people tried to repeat them. So we shouldn’t assume that omicron is our savior just yet. But when it comes to daily trading in the stock market, the South African scattergraph is a good reason for prices to go up. And that’s why they did.\nLabor, Productivity and Inflation\nA key issue for 2021 involves the very heart of capitalism. Who is going to get the better in the battle between labor and capital? And if labor succeeds in extracting a better return, will capitalists respond by accepting lower profits, or by raising prices? The issue is important to the question of whether 2021’s resurgence of inflation turns into a secular increase in inflationary pressure.\nThe effect of the Global Financial Crisis was to crush workers’ negotiating power, particularly for the poorest paid. In the chart below (which I adapted from a chart in Pimco’s asset allocation outlook for next year), the proportion of small businesses finding it hard to fill jobs and the average wage increases for the lowest-paid 25% of workers are mapped on separate scales. The low-paid had a terrible time of it in the years after the GFC, but their power had been steadily recovering even ahead of the pandemic:\n\nThis is an unambiguous upward trend, and is in line with the experience of past pandemics, in which the power of labor tended to increase in the aftermath. Meanwhile, Tuesday also saw publication of new productivity data for the U.S. Unit labor costs rose much faster than had been expected in the third quarter.\nLooking to the longer term, unit labor costs have risen roughly in line with growth in gross domestic product for much of history, but this has contained big swings in the trend. In the following chart, unit labor costs for all non-financial corporates is shown as a share of constant-currency GDP, rebased to 1950:\n\nCompanies got a great deal in the 1950s and early 1960s as productivity steadily improved. Labor enjoyed the upper hand until the early 1980s, when a combination of Reaganomics and the determined anti-inflationary monetary policy of Paul Volcker at the Federal Reserve saw unit labor costs diminish sharply. Since the GFC, the relationship has been constant, with GDP and unit labor costs moving in line with each other (barring a very brief upward blip in productivity during the mass layoffs in spring last year).\nThis relationship has been flatlining at a level that is a great deal for companies and capital, and lousy for workers and labor. It’s also a level that has helped keep prices low. Are we seeing the first signs of a belated reversal?\nSurvival Tips\nOn the subject of vaccine hesitancy, vaccine inequality, vaccine nationalism and deep-seated distrust of science, I recently re-watched a movie that plays to the themes of today with startling relevance.The Constant Gardener, the film version of the John le Carre novel with Ralph Fiennes and Rachel Weisz in the leading roles, is a great thriller, shot through with all the classic le Carre themes of doubt, distrust and betrayal. Fiennes is brilliant, as are many of the others. Set mostly in Kenya, it’s also a sumptuously beautiful film to watch.\nThe particular reason to see it now is that the central plot concerns the attempt by Weisz’s character to get to the bottom of a dastardly plot by a big pharmaceutical company, aided and abetted by the British government, to test new drugs on poor Kenyans forced to be guinea pigs, and cover up evidence of the harmful side effects that result. There’s more to it than that, but like all great fiction it was written for one moment, and captures another perfectly — which is to say that its themes are eternal. I strongly recommend catching up with it.","news_type":1},"isVote":1,"tweetType":1,"viewCount":167,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606973334,"gmtCreate":1638830869882,"gmtModify":1638830870018,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/606973334","repostId":"1189410190","repostType":4,"repost":{"id":"1189410190","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638804387,"share":"https://www.laohu8.com/m/news/1189410190?lang=&edition=full","pubTime":"2021-12-06 23:26","market":"us","language":"en","title":"Stocks linked to the reopening of the economy gained on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1189410190","media":"Tiger Newspress","summary":"Stocks linked to the reopening of the economy gained on Monday.Airlines,Cruise lines and travel book","content":"<p>Stocks linked to the reopening of the economy gained on Monday.Airlines,Cruise lines&nbsp;and&nbsp;travel booking stocks&nbsp;jumped&nbsp;in morning trading.</p>\n<p><img src=\"https://static.tigerbbs.com/651aa4b1311ccf3c19aeb54b31cfa75d\" tg-width=\"410\" tg-height=\"485\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/f544513dbaea07f8bfb6ef95f4787209\" tg-width=\"416\" tg-height=\"188\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/f38b5565430c470461254d0b06da3752\" tg-width=\"405\" tg-height=\"178\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks linked to the reopening of the economy gained on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks linked to the reopening of the economy gained on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-06 23:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Stocks linked to the reopening of the economy gained on Monday.Airlines,Cruise lines&nbsp;and&nbsp;travel booking stocks&nbsp;jumped&nbsp;in morning trading.</p>\n<p><img src=\"https://static.tigerbbs.com/651aa4b1311ccf3c19aeb54b31cfa75d\" tg-width=\"410\" tg-height=\"485\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/f544513dbaea07f8bfb6ef95f4787209\" tg-width=\"416\" tg-height=\"188\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/f38b5565430c470461254d0b06da3752\" tg-width=\"405\" tg-height=\"178\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ABNB":"爱彼迎","ALK":"阿拉斯加航空集团有限公司","BA":"波音","DAL":"达美航空","BKNG":"Booking Holdings","SAVE":"Spirit Airlines","CCL":"嘉年华邮轮","UAL":"联合大陆航空","EXPE":"Expedia","LUV":"西南航空","AAL":"美国航空","NCLH":"挪威邮轮","JBLU":"捷蓝航空","RCL":"皇家加勒比邮轮"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189410190","content_text":"Stocks linked to the reopening of the economy gained on Monday.Airlines,Cruise lines and travel booking stocks jumped in morning trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":357,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608603500,"gmtCreate":1638697684792,"gmtModify":1638697684792,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Should I buy?","listText":"Should I buy?","text":"Should I buy?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/608603500","repostId":"2189557676","repostType":4,"isVote":1,"tweetType":1,"viewCount":406,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608321606,"gmtCreate":1638631302049,"gmtModify":1638631302132,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"comment and like","listText":"comment and like","text":"comment and like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608321606","repostId":"2188057871","repostType":4,"repost":{"id":"2188057871","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1638580800,"share":"https://www.laohu8.com/m/news/2188057871?lang=&edition=full","pubTime":"2021-12-04 09:20","market":"us","language":"en","title":"Adobe worth $26 billion less as DocuSign fears spark 'knee-jerk reaction' for stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2188057871","media":"Dow Jones","summary":"Adobe stock was the worst performer in S&P 500 Friday, after e-signature rival suggested pandemic bo","content":"<p>Adobe stock was the worst performer in S&amp;P 500 Friday, after e-signature rival suggested pandemic boom was slowing down</p>\n<p>Shares of Adobe Inc. sank to their worst performance in more than 20 months Friday, after DocuSign Inc. delivered what some saw as a the latest sign of a demand cool-down for work-from-home software.</p>\n<p>DocuSign <a href=\"https://laohu8.com/S/DOCU\">$(DOCU)$</a> Chief Executive Dan Springer acknowledged Thursday that while his electronic-signature company saw \"accelerated growth\" for six quarters amid the pandemic, customers have gone back to \"more normalized buying patterns.\" As a result, DocuSign delivered a downbeat bookings outlook, sending its shares cratering more than 40%.</p>\n<p>Some of that investor fear seemed to transfer over to Adobe <a href=\"https://laohu8.com/S/ADBE\">$(ADBE)$</a>, which also offers contract-management software and allows for the collection of e-signatures. Adobe's stock fell 8.2% Friday, its steepest single-day percentage drop since March 2020 and the worst performance on the day from an S&amp;P 500 stock. The move wiped away $26.3 billion in market capitalization, taking Adobe's valuation lower than $300 billion.</p>\n<p>The decline in Adobe shares struck Wedbush analyst Daniel Ives as a \"DOCU-related selloff,\" he told MarketWatch, as DocuSign's report served as a \"a barometer that the WFH tailwinds are now abating and could be a headwind for Adobe.\"</p>\n<p>\"The DOCU print was a shocker and this is a knee-jerk reaction,\" he said.</p>\n<p>Adobe is due to post its own quarterly results Dec. 16. The company highlighted its e-signature technology in its prior earnings report, as Chief Financial Officer John Murphy noted that \"third-quarter Document Cloud growth drivers included adoption of Sign in Acrobat driven by the increased need to collaborate in a hybrid work environment.\"</p>\n<p>While other at-home stocks took a hit on disappointing outlooks earlier in the course of the pandemic, DocuSign initially appeared more resilient. Its stock hit an all-time high in September and was up 165% since March 2020 as of Thursday's close. Now the company will need to \"show that it can generate, not just fulfill, demand on a regular basis,\" according to an Evercore analyst.</p>\n<p>Adobe has a more diversified business than DocuSign. While the company sells contract-related software, it has a variety of other offerings including subscriptions to creative programs like Photoshop. Adobe's Document Cloud accounted for about 13% of the company's overall revenue in its last-reported quarter.</p>\n<p>Shares of Adobe were up 86% since March 2020 as of Thursday's close.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Adobe worth $26 billion less as DocuSign fears spark 'knee-jerk reaction' for stock</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAdobe worth $26 billion less as DocuSign fears spark 'knee-jerk reaction' for stock\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-12-04 09:20</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Adobe stock was the worst performer in S&amp;P 500 Friday, after e-signature rival suggested pandemic boom was slowing down</p>\n<p>Shares of Adobe Inc. sank to their worst performance in more than 20 months Friday, after DocuSign Inc. delivered what some saw as a the latest sign of a demand cool-down for work-from-home software.</p>\n<p>DocuSign <a href=\"https://laohu8.com/S/DOCU\">$(DOCU)$</a> Chief Executive Dan Springer acknowledged Thursday that while his electronic-signature company saw \"accelerated growth\" for six quarters amid the pandemic, customers have gone back to \"more normalized buying patterns.\" As a result, DocuSign delivered a downbeat bookings outlook, sending its shares cratering more than 40%.</p>\n<p>Some of that investor fear seemed to transfer over to Adobe <a href=\"https://laohu8.com/S/ADBE\">$(ADBE)$</a>, which also offers contract-management software and allows for the collection of e-signatures. Adobe's stock fell 8.2% Friday, its steepest single-day percentage drop since March 2020 and the worst performance on the day from an S&amp;P 500 stock. The move wiped away $26.3 billion in market capitalization, taking Adobe's valuation lower than $300 billion.</p>\n<p>The decline in Adobe shares struck Wedbush analyst Daniel Ives as a \"DOCU-related selloff,\" he told MarketWatch, as DocuSign's report served as a \"a barometer that the WFH tailwinds are now abating and could be a headwind for Adobe.\"</p>\n<p>\"The DOCU print was a shocker and this is a knee-jerk reaction,\" he said.</p>\n<p>Adobe is due to post its own quarterly results Dec. 16. The company highlighted its e-signature technology in its prior earnings report, as Chief Financial Officer John Murphy noted that \"third-quarter Document Cloud growth drivers included adoption of Sign in Acrobat driven by the increased need to collaborate in a hybrid work environment.\"</p>\n<p>While other at-home stocks took a hit on disappointing outlooks earlier in the course of the pandemic, DocuSign initially appeared more resilient. Its stock hit an all-time high in September and was up 165% since March 2020 as of Thursday's close. Now the company will need to \"show that it can generate, not just fulfill, demand on a regular basis,\" according to an Evercore analyst.</p>\n<p>Adobe has a more diversified business than DocuSign. While the company sells contract-related software, it has a variety of other offerings including subscriptions to creative programs like Photoshop. Adobe's Document Cloud accounted for about 13% of the company's overall revenue in its last-reported quarter.</p>\n<p>Shares of Adobe were up 86% since March 2020 as of Thursday's close.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4023":"应用软件","BK4554":"元宇宙及AR概念","BK4566":"资本集团","BK4533":"AQR资本管理(全球第二大对冲基金)","DOCU":"Docusign","ADBE":"Adobe","BK4567":"ESG概念","BK4527":"明星科技股","BK4534":"瑞士信贷持仓","BK4528":"SaaS概念"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2188057871","content_text":"Adobe stock was the worst performer in S&P 500 Friday, after e-signature rival suggested pandemic boom was slowing down\nShares of Adobe Inc. sank to their worst performance in more than 20 months Friday, after DocuSign Inc. delivered what some saw as a the latest sign of a demand cool-down for work-from-home software.\nDocuSign $(DOCU)$ Chief Executive Dan Springer acknowledged Thursday that while his electronic-signature company saw \"accelerated growth\" for six quarters amid the pandemic, customers have gone back to \"more normalized buying patterns.\" As a result, DocuSign delivered a downbeat bookings outlook, sending its shares cratering more than 40%.\nSome of that investor fear seemed to transfer over to Adobe $(ADBE)$, which also offers contract-management software and allows for the collection of e-signatures. Adobe's stock fell 8.2% Friday, its steepest single-day percentage drop since March 2020 and the worst performance on the day from an S&P 500 stock. The move wiped away $26.3 billion in market capitalization, taking Adobe's valuation lower than $300 billion.\nThe decline in Adobe shares struck Wedbush analyst Daniel Ives as a \"DOCU-related selloff,\" he told MarketWatch, as DocuSign's report served as a \"a barometer that the WFH tailwinds are now abating and could be a headwind for Adobe.\"\n\"The DOCU print was a shocker and this is a knee-jerk reaction,\" he said.\nAdobe is due to post its own quarterly results Dec. 16. The company highlighted its e-signature technology in its prior earnings report, as Chief Financial Officer John Murphy noted that \"third-quarter Document Cloud growth drivers included adoption of Sign in Acrobat driven by the increased need to collaborate in a hybrid work environment.\"\nWhile other at-home stocks took a hit on disappointing outlooks earlier in the course of the pandemic, DocuSign initially appeared more resilient. Its stock hit an all-time high in September and was up 165% since March 2020 as of Thursday's close. Now the company will need to \"show that it can generate, not just fulfill, demand on a regular basis,\" according to an Evercore analyst.\nAdobe has a more diversified business than DocuSign. While the company sells contract-related software, it has a variety of other offerings including subscriptions to creative programs like Photoshop. Adobe's Document Cloud accounted for about 13% of the company's overall revenue in its last-reported quarter.\nShares of Adobe were up 86% since March 2020 as of Thursday's close.","news_type":1},"isVote":1,"tweetType":1,"viewCount":127,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865286656,"gmtCreate":1632987617711,"gmtModify":1632987618992,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"comment and like","listText":"comment and like","text":"comment and like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/865286656","repostId":"1132265874","repostType":4,"repost":{"id":"1132265874","pubTimestamp":1632987480,"share":"https://www.laohu8.com/m/news/1132265874?lang=&edition=full","pubTime":"2021-09-30 15:38","market":"us","language":"en","title":"Micron Stock: Buy the Dip or Bail After Post-Earnings Decline?","url":"https://stock-news.laohu8.com/highlight/detail?id=1132265874","media":"TheStreet","summary":"Micron stock is dipping lower on earnings, but it's not collapsing. Here's what the chart says now.\n","content":"<p>Micron stock is dipping lower on earnings, but it's not collapsing. Here's what the chart says now.</p>\n<p></p>\n<p></p>\n<p>Micron&nbsp;shares are down about 1.75% on Wednesday after reporting earnings.</p>\n<p>However, despite the post-earnings dip, shares are rallying off the lows. At one point, the stock was down around 4% on the day and that’s after yesterday’s 2.8% decline.</p>\n<p>The company beat on earnings and revenue expectations, which is likely helping it bounce from the lows.</p>\n<p>However, the “muted” outlook for next quarter is responsible for today’s dip.</p>\n<p>Last week, <i>TheStreet’s</i> Jim Cramer said he would be a buyer of Advanced Micro Devices&nbsp;and Nvidia&nbsp;if these two stock saw weakness as a result of Micron’s report.</p>\n<p>So far, they’re down slightly on the day.</p>\n<p>With the rally off Wednesday’s low, Micron is holding up above the prior September low. That said, the charts leave a lot to be desired.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/846c7a9e4223402236a0865b100849d9\" tg-width=\"1023\" tg-height=\"735\" width=\"100%\" height=\"auto\"><span>Daily chart of Micron stock.</span></p>\n<p>A look at the chart shows exactly what I mean by “a lot to be desired.” Even though Micron broke below the prior September low at $71.11, the silver lining is that the stock was able to reclaim this level and bounce higher.</p>\n<p>However, there are plenty of downsides. For example, Micron stock is still below the key $76.40 level. It’s also below all of its daily moving averages.</p>\n<p>In order to make a significant push higher, some of these levels will need to be reclaimed.</p>\n<p>Specifically, I want to see if Micron stock can rally back to and reclaim the 50-day moving average.</p>\n<p>This measure has been notable resistance for two months now and even though the stock looked like it was going to push through it earlier this week, the shares were eventually swatted lower.</p>\n<p>If Micron stock can clear the 50-day moving average, that puts the $76.40 level in play, followed by the 200-day moving average and downtrend resistance (purple line).</p>\n<p>Below Wednesday’s low puts the August low in play, at $68.81. A break of this mark could put the stock in a difficult position unless $68.81 is reclaimed.</p>\n<p></p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Micron Stock: Buy the Dip or Bail After Post-Earnings Decline?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMicron Stock: Buy the Dip or Bail After Post-Earnings Decline?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-30 15:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/buy-or-sell-micron-mu-stock-earnings-pullback><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Micron stock is dipping lower on earnings, but it's not collapsing. Here's what the chart says now.\n\n\nMicron shares are down about 1.75% on Wednesday after reporting earnings.\nHowever, despite the ...</p>\n\n<a href=\"https://www.thestreet.com/investing/buy-or-sell-micron-mu-stock-earnings-pullback\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MU":"美光科技"},"source_url":"https://www.thestreet.com/investing/buy-or-sell-micron-mu-stock-earnings-pullback","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1132265874","content_text":"Micron stock is dipping lower on earnings, but it's not collapsing. Here's what the chart says now.\n\n\nMicron shares are down about 1.75% on Wednesday after reporting earnings.\nHowever, despite the post-earnings dip, shares are rallying off the lows. At one point, the stock was down around 4% on the day and that’s after yesterday’s 2.8% decline.\nThe company beat on earnings and revenue expectations, which is likely helping it bounce from the lows.\nHowever, the “muted” outlook for next quarter is responsible for today’s dip.\nLast week, TheStreet’s Jim Cramer said he would be a buyer of Advanced Micro Devices and Nvidia if these two stock saw weakness as a result of Micron’s report.\nSo far, they’re down slightly on the day.\nWith the rally off Wednesday’s low, Micron is holding up above the prior September low. That said, the charts leave a lot to be desired.\nDaily chart of Micron stock.\nA look at the chart shows exactly what I mean by “a lot to be desired.” Even though Micron broke below the prior September low at $71.11, the silver lining is that the stock was able to reclaim this level and bounce higher.\nHowever, there are plenty of downsides. For example, Micron stock is still below the key $76.40 level. It’s also below all of its daily moving averages.\nIn order to make a significant push higher, some of these levels will need to be reclaimed.\nSpecifically, I want to see if Micron stock can rally back to and reclaim the 50-day moving average.\nThis measure has been notable resistance for two months now and even though the stock looked like it was going to push through it earlier this week, the shares were eventually swatted lower.\nIf Micron stock can clear the 50-day moving average, that puts the $76.40 level in play, followed by the 200-day moving average and downtrend resistance (purple line).\nBelow Wednesday’s low puts the August low in play, at $68.81. A break of this mark could put the stock in a difficult position unless $68.81 is reclaimed.","news_type":1},"isVote":1,"tweetType":1,"viewCount":160,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":698906072,"gmtCreate":1640271237633,"gmtModify":1640271237710,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Comment","listText":"Comment","text":"Comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/698906072","repostId":"1177863167","repostType":4,"repost":{"id":"1177863167","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640270946,"share":"https://www.laohu8.com/m/news/1177863167?lang=&edition=full","pubTime":"2021-12-23 22:49","market":"us","language":"en","title":"Tencent ADR rose more than 4% in early trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1177863167","media":"Tiger Newspress","summary":"Tencent ADR rose more than 4% in early trading.Tencent said on Thursday it will transfer HK$127.69 b","content":"<p>Tencent&nbsp;ADR&nbsp;rose&nbsp;more&nbsp;than&nbsp;4%&nbsp;in&nbsp;early&nbsp;trading.<img src=\"https://static.tigerbbs.com/5c64eef1168fcdac16b6cdfe487310c5\" tg-width=\"707\" tg-height=\"595\" width=\"100%\" height=\"auto\">Tencent said on Thursday it will transfer HK$127.69 billion ($16.37 billion) worth of its JD.com stake to shareholders, slashing its holding in China's second-biggest e-commerce company to 2.3% from around 17% now and losing its spot as JD.com's biggest shareholder to Walmart(WMT.N).</p>\n<p>The owner of WeChat, which first invested in JD.com in 2014, said it was the right time for the divestment, given the e-commerce firm had reached a stage where it can self-finance its growth.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tencent ADR rose more than 4% in early trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTencent ADR rose more than 4% in early trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-23 22:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Tencent&nbsp;ADR&nbsp;rose&nbsp;more&nbsp;than&nbsp;4%&nbsp;in&nbsp;early&nbsp;trading.<img src=\"https://static.tigerbbs.com/5c64eef1168fcdac16b6cdfe487310c5\" tg-width=\"707\" tg-height=\"595\" width=\"100%\" height=\"auto\">Tencent said on Thursday it will transfer HK$127.69 billion ($16.37 billion) worth of its JD.com stake to shareholders, slashing its holding in China's second-biggest e-commerce company to 2.3% from around 17% now and losing its spot as JD.com's biggest shareholder to Walmart(WMT.N).</p>\n<p>The owner of WeChat, which first invested in JD.com in 2014, said it was the right time for the divestment, given the e-commerce firm had reached a stage where it can self-finance its growth.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"00700":"腾讯控股","TCEHY":"腾讯控股ADR"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1177863167","content_text":"Tencent ADR rose more than 4% in early trading.Tencent said on Thursday it will transfer HK$127.69 billion ($16.37 billion) worth of its JD.com stake to shareholders, slashing its holding in China's second-biggest e-commerce company to 2.3% from around 17% now and losing its spot as JD.com's biggest shareholder to Walmart(WMT.N).\nThe owner of WeChat, which first invested in JD.com in 2014, said it was the right time for the divestment, given the e-commerce firm had reached a stage where it can self-finance its growth.","news_type":1},"isVote":1,"tweetType":1,"viewCount":452,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604341968,"gmtCreate":1639354721573,"gmtModify":1639354721699,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Comment","listText":"Comment","text":"Comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/604341968","repostId":"1155743884","repostType":4,"isVote":1,"tweetType":1,"viewCount":452,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":862443897,"gmtCreate":1632905933843,"gmtModify":1632905933990,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"like my article","listText":"like my article","text":"like my article","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/862443897","repostId":"1198528044","repostType":4,"repost":{"id":"1198528044","pubTimestamp":1632882697,"share":"https://www.laohu8.com/m/news/1198528044?lang=&edition=full","pubTime":"2021-09-29 10:31","market":"us","language":"en","title":"Technically Speaking: Is The Market \"Melting-Up?\"","url":"https://stock-news.laohu8.com/highlight/detail?id=1198528044","media":"seekingalpha","summary":"Summary\n\nGiven the Fed’s ongoing balance sheet operations, investors fully believe they have protect","content":"<p><b>Summary</b></p>\n<ul>\n <li>Given the Fed’s ongoing balance sheet operations, investors fully believe they have protection from a decline.</li>\n <li>As is always the case, the investing public believes future earnings will justify higher prices during a melt-up. It just never works out that way.</li>\n <li>While it is essential to take advantage of the melt-up while it lasts, just don’t become overly complacent “this time is different”.</li>\n</ul>\n<p>Is the<i>“market melting-up?”</i>Such was the question I received from my colleague at<i>Cut The Crap Investing.</i>It is an excellent question given the relentless increase in what investors believe is a<i>“no risk”</i>market.</p>\n<p>Of course, we need a definition of precisely what constitutes a melt-up.</p>\n<blockquote>\n <i>“A melt-up is a sustained and often unexpected improvement in the investment performance of an asset or asset class, driven partly</i>\n <i><b>by a stampede of investors who don’t want to miss out on its rise,</b></i>\n <i>rather than by fundamental improvements in the economy.“</i>–\n <i>Investopedia</i>\n</blockquote>\n<p>Currently, there is sufficient evidence to support the idea of an exuberant market.<b><i>As noted previously:</i></b></p>\n<blockquote>\n <i>“Near peaks of market cycles, investors become swept up by the underlying exuberance. That exuberance breeds the “rationalization” that “this time is different.” So how do you know the market is exuberant currently? Via Sentiment Trader:”</i>\n</blockquote>\n<blockquote>\n <i>‘This type of market activity is an indication that markets have returned their ‘enthusiasm’ stage. Such is characterized by:’</i>\n</blockquote>\n<ul>\n <li><b><i>High optimism</i></b></li>\n <li><b><i>Easy credit (too easy, with loose terms)</i></b></li>\n <li><b><i>A rush of initial and secondary offerings</i></b></li>\n <li><b><i>Risky stocks outperforming</i></b></li>\n <li><b><i>Stretched valuations</i></b></li>\n</ul>\n<p><img src=\"https://static.tigerbbs.com/ff8de3a84084162ca86b415584bbf793\" tg-width=\"731\" tg-height=\"468\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>However, while one would expect individuals to exhibit caution in such an environment, the opposite is true. Given the Fed’s ongoing balance sheet operations, investors fully believe they have protection from a decline.</p>\n<p><b>A Visualization Of A Market Melting-Up</b></p>\n<p>It is often easier to visualize something rather than explain it.<b>Since 1900, only two previous market periods qualify as a melt-up: 1920-1929 and 1995-2000.</b>The chart below shows both periods in terms of price.</p>\n<p><img src=\"https://static.tigerbbs.com/a218c7efe2ebd874d05c9ff7dd564436\" tg-width=\"797\" tg-height=\"437\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/9f193c9c32d55747bf7ff511c2f9fd53\" tg-width=\"793\" tg-height=\"439\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>However, the melt-up is also visually represented by the incredibly sharp rise in valuations. Such is essential because earnings are not rising at a fast enough clip to support higher prices.<b>As is always the case, the investing public believes future earnings will justify higher prices during a melt-up. It just never works out that way.</b></p>\n<p><img src=\"https://static.tigerbbs.com/c69e418d5a19d6fd03b305ab111e3be3\" tg-width=\"794\" tg-height=\"440\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/af03d3bbd071b8edfdf3a19e2c7b0bcd\" tg-width=\"796\" tg-height=\"437\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>We can compare those two previous periods with the current advance from the March 2020 lows. Again, we see a very similar sharp advance in price combined with a surge in valuations. As expected, investors are currently hoping that future earnings will rise sharply enough to justify current prices. However, the justification for paying high prices is the Federal Reserve’s ongoing balance sheet expansion.</p>\n<p><img src=\"https://static.tigerbbs.com/f3562aea27b24ad4921d0f5cd497e072\" tg-width=\"804\" tg-height=\"444\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>The following chart looks that the price advance and valuation measures a little differently. It shows the current deviation from the long-term exponential growth trend. Not surprisingly, during a market<i>“melt-up,”</i>there is a rapid deviation from the growth trend matching the acceleration in valuations.</p>\n<p><img src=\"https://static.tigerbbs.com/1419cf4b2afdcdc0f61e0cad862f498d\" tg-width=\"836\" tg-height=\"460\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>The problem with market<i>“melt-ups”</i>is not the melt-up itself but what always follows.</p>\n<p><b>Melting-Up Leads To Melting-Down</b></p>\n<p>A market melting-up is exciting while it lasts. During melt-ups, investors begin to rationalize why<i>“this time is different.”</i>They start taking on excess leverage to try and capitalize on the rapid advance in prices, and fundamentals take a back seat to price momentum.</p>\n<p>Market melt-ups are all about<i>“psychology.”</i><b>Historically, whatever has been the catalyst to spark the disregard of risk is readily witnessed in the corresponding surge in price and valuations.</b>The chart below shows the long-term deviations in relative strength, deviations, and valuations. The previous<i>‘melt-up”</i>periods should be easy to spot when compared with the advance currently.</p>\n<p><img src=\"https://static.tigerbbs.com/bc04cb25c0199dd17475a551a5dd7ec1\" tg-width=\"869\" tg-height=\"1024\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Given that current extensions match only a few rare periods in history, a couple of points should be readily apparent.</p>\n<ol>\n <li><b><i>Melt-ups can longer than logic would predict.</i></b></li>\n <li><b><i>The prevailing psychology is always “this time is different.”</i></b></li>\n <li><b><i>Valuations are dismissed in exchange for measures of momentum and forward expectations.</i></b></li>\n <li><b><i>Investors take on excess leverage and risk in order to participate in a seemingly “can’t lose” market.</i></b></li>\n <li><b><i>Lastly, and inevitably, “melt-ups” end and always in the worst possible outcomes.</i></b></li>\n</ol>\n<p>It is essential to recognize the markets are in a<i>“melt-up,</i>” and the duration of that event is unknowable. Therefore, investors need a strategy to participate in the advance and mitigate the damage from the eventual<i>“melting-down.”</i></p>\n<p><b>Surviving The Melt-Up</b></p>\n<p><b>As noted, none of this means the next</b><b><i>“bear market”</i></b><b>is lurking.</b>Given that a market melting-up is a function of psychology, they can last longer and go further than logic would predict. What is required to “<i>end”</i>a melt-up is an unanticipated exogenous event that changes psychology from bullish to bearish. Such is when the stampede for the exits occurs, and prices decline very quickly.</p>\n<p>As such, investors need a set of guidelines to participate in the market advance. But, of course, the hard part is keeping those gains when corrections inevitably occur.</p>\n<p>As portfolio managers for our clients, such is precisely the approach we must take. Accordingly, I have provided a general overview of the process that we employ.</p>\n<ol>\n <li><i><b>Tighten up stop-loss levels</b></i><i>to current support levels for each position.(Provides identifiable exit points when the market reverses.)</i></li>\n <li><i><b>Hedge portfolios</b></i><i>against major market declines.(Non-correlated assets, short-market positions, index put options)</i></li>\n <li><i><b>Take profits</b></i><i>in positions that have been big winners(Rebalancing overbought or extended positions to capture gains but continue to participate in the advance.)</i></li>\n <li><i><b>Sell laggards</b></i><i>and losers</i>.<i>(If something isn’t working in a market melt-up, it most likely won’t work during a broad decline. Better to eliminate the risk early.)</i></li>\n <li><i><b>Raise cash</b></i><i>and rebalance portfolios to target weightings.(Rebalancing risk on a regular basis keeps hidden risks somewhat mitigated.)</i></li>\n</ol>\n<p><b>Notice, nothing in there says,</b><b><i>“sell everything and go to cash.”</i></b></p>\n<p>There will be a time to raise significant levels of cash. A good portfolio management strategy will automatically ensure that<i>“stop-loss”</i>levels get triggered, exposure decreases, and cash levels rise when the selling begins.</p>\n<p>While it is essential to take advantage of the melt-up while it lasts, just don’t become overly complacent<i>“this time is different.”</i></p>\n<p>It likely isn’t.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Technically Speaking: Is The Market \"Melting-Up?\"</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTechnically Speaking: Is The Market \"Melting-Up?\"\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-29 10:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4457469-technically-speaking-is-the-market-melting-up><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nGiven the Fed’s ongoing balance sheet operations, investors fully believe they have protection from a decline.\nAs is always the case, the investing public believes future earnings will ...</p>\n\n<a href=\"https://seekingalpha.com/article/4457469-technically-speaking-is-the-market-melting-up\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite","SPY":"标普500ETF",".SPX":"S&P 500 Index"},"source_url":"https://seekingalpha.com/article/4457469-technically-speaking-is-the-market-melting-up","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1198528044","content_text":"Summary\n\nGiven the Fed’s ongoing balance sheet operations, investors fully believe they have protection from a decline.\nAs is always the case, the investing public believes future earnings will justify higher prices during a melt-up. It just never works out that way.\nWhile it is essential to take advantage of the melt-up while it lasts, just don’t become overly complacent “this time is different”.\n\nIs the“market melting-up?”Such was the question I received from my colleague atCut The Crap Investing.It is an excellent question given the relentless increase in what investors believe is a“no risk”market.\nOf course, we need a definition of precisely what constitutes a melt-up.\n\n“A melt-up is a sustained and often unexpected improvement in the investment performance of an asset or asset class, driven partly\nby a stampede of investors who don’t want to miss out on its rise,\nrather than by fundamental improvements in the economy.“–\n Investopedia\n\nCurrently, there is sufficient evidence to support the idea of an exuberant market.As noted previously:\n\n“Near peaks of market cycles, investors become swept up by the underlying exuberance. That exuberance breeds the “rationalization” that “this time is different.” So how do you know the market is exuberant currently? Via Sentiment Trader:”\n\n\n‘This type of market activity is an indication that markets have returned their ‘enthusiasm’ stage. Such is characterized by:’\n\n\nHigh optimism\nEasy credit (too easy, with loose terms)\nA rush of initial and secondary offerings\nRisky stocks outperforming\nStretched valuations\n\n\nHowever, while one would expect individuals to exhibit caution in such an environment, the opposite is true. Given the Fed’s ongoing balance sheet operations, investors fully believe they have protection from a decline.\nA Visualization Of A Market Melting-Up\nIt is often easier to visualize something rather than explain it.Since 1900, only two previous market periods qualify as a melt-up: 1920-1929 and 1995-2000.The chart below shows both periods in terms of price.\n\nHowever, the melt-up is also visually represented by the incredibly sharp rise in valuations. Such is essential because earnings are not rising at a fast enough clip to support higher prices.As is always the case, the investing public believes future earnings will justify higher prices during a melt-up. It just never works out that way.\n\nWe can compare those two previous periods with the current advance from the March 2020 lows. Again, we see a very similar sharp advance in price combined with a surge in valuations. As expected, investors are currently hoping that future earnings will rise sharply enough to justify current prices. However, the justification for paying high prices is the Federal Reserve’s ongoing balance sheet expansion.\n\nThe following chart looks that the price advance and valuation measures a little differently. It shows the current deviation from the long-term exponential growth trend. Not surprisingly, during a market“melt-up,”there is a rapid deviation from the growth trend matching the acceleration in valuations.\n\nThe problem with market“melt-ups”is not the melt-up itself but what always follows.\nMelting-Up Leads To Melting-Down\nA market melting-up is exciting while it lasts. During melt-ups, investors begin to rationalize why“this time is different.”They start taking on excess leverage to try and capitalize on the rapid advance in prices, and fundamentals take a back seat to price momentum.\nMarket melt-ups are all about“psychology.”Historically, whatever has been the catalyst to spark the disregard of risk is readily witnessed in the corresponding surge in price and valuations.The chart below shows the long-term deviations in relative strength, deviations, and valuations. The previous‘melt-up”periods should be easy to spot when compared with the advance currently.\n\nGiven that current extensions match only a few rare periods in history, a couple of points should be readily apparent.\n\nMelt-ups can longer than logic would predict.\nThe prevailing psychology is always “this time is different.”\nValuations are dismissed in exchange for measures of momentum and forward expectations.\nInvestors take on excess leverage and risk in order to participate in a seemingly “can’t lose” market.\nLastly, and inevitably, “melt-ups” end and always in the worst possible outcomes.\n\nIt is essential to recognize the markets are in a“melt-up,” and the duration of that event is unknowable. Therefore, investors need a strategy to participate in the advance and mitigate the damage from the eventual“melting-down.”\nSurviving The Melt-Up\nAs noted, none of this means the next“bear market”is lurking.Given that a market melting-up is a function of psychology, they can last longer and go further than logic would predict. What is required to “end”a melt-up is an unanticipated exogenous event that changes psychology from bullish to bearish. Such is when the stampede for the exits occurs, and prices decline very quickly.\nAs such, investors need a set of guidelines to participate in the market advance. But, of course, the hard part is keeping those gains when corrections inevitably occur.\nAs portfolio managers for our clients, such is precisely the approach we must take. Accordingly, I have provided a general overview of the process that we employ.\n\nTighten up stop-loss levelsto current support levels for each position.(Provides identifiable exit points when the market reverses.)\nHedge portfoliosagainst major market declines.(Non-correlated assets, short-market positions, index put options)\nTake profitsin positions that have been big winners(Rebalancing overbought or extended positions to capture gains but continue to participate in the advance.)\nSell laggardsand losers.(If something isn’t working in a market melt-up, it most likely won’t work during a broad decline. Better to eliminate the risk early.)\nRaise cashand rebalance portfolios to target weightings.(Rebalancing risk on a regular basis keeps hidden risks somewhat mitigated.)\n\nNotice, nothing in there says,“sell everything and go to cash.”\nThere will be a time to raise significant levels of cash. A good portfolio management strategy will automatically ensure that“stop-loss”levels get triggered, exposure decreases, and cash levels rise when the selling begins.\nWhile it is essential to take advantage of the melt-up while it lasts, just don’t become overly complacent“this time is different.”\nIt likely isn’t.","news_type":1},"isVote":1,"tweetType":1,"viewCount":22,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699741032,"gmtCreate":1639911447414,"gmtModify":1639911447498,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Test","listText":"Test","text":"Test","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/699741032","repostId":"2192035909","repostType":4,"repost":{"id":"2192035909","pubTimestamp":1639886839,"share":"https://www.laohu8.com/m/news/2192035909?lang=&edition=full","pubTime":"2021-12-19 12:07","market":"us","language":"en","title":"3 Stocks That Could Be Worth More Than Apple by 2035","url":"https://stock-news.laohu8.com/highlight/detail?id=2192035909","media":"Motley Fool","summary":"These companies could eclipse the iPhone maker's market cap in the long run.","content":"<p><a href=\"https://laohu8.com/S/AAPL\"><b>Apple</b></a> is currently the world's most valuable&nbsp;company with a market capitalization of $2.82 trillion. That isn't surprising as the tech titan is a dominant player in the smartphone market and has ancillary products and services to drive growth.</p>\n<p>The tech giant generated a whopping $365.8 billion in revenue in fiscal 2021, an increase of 33% over the prior year. The fact that Apple is growing at an eye-popping pace despite being a mega-cap company is impressive, but it's not surprising as its products and services are in great demand. More importantly, Apple isn't resting on its laurels and is looking to push the envelope by seizing emerging tech trends and moving into new markets.</p>\n<p>As such, Apple is pulling several strings to ensure that it remains the world's most valuable company for a long time to come. However, the likes of <a href=\"https://laohu8.com/S/NVDA\"><b>Nvidia</b> </a>, <a href=\"https://laohu8.com/S/ASML\"><b>ASML Holding</b> </a>, and <a href=\"https://laohu8.com/S/AMZN\"><b>Amazon</b> </a> could become more valuable than Apple by 2035, thanks to the fast-growing markets they operate in. Let's see why that may be the case.</p>\n<p>1. <a href=\"https://laohu8.com/S/NVDA\"><b>Nvidia</b> </a></p>\n<p>Nvidia has a market cap&nbsp;of $707 billion. It is worth noting that the graphics card specialist's market cap has grown at a much faster pace than that of Apple's in the past decade.</p>\n<p><img src=\"https://static.tigerbbs.com/014d345dc7df797b4ee5e9f0e2288910\" tg-width=\"720\" tg-height=\"387\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>NVDA data by YCharts</p>\n<p>Nvidia shares have stepped on the gas since 2016. They have gone supersonic in the past couple of years as it has become clear that its graphics cards play an important role in powering several applications ranging from gaming consoles to personal computers to data centers and autonomous vehicles. The massive demand for Nvidia's graphics cards is evident from the company's recent results.</p>\n<p>The company has generated&nbsp;$19.3 billion in revenue in the first nine months of fiscal 2022, a jump of 65% over the prior-year period. Its adjusted earnings have increased 81% in the first nine months of the year to $3.12 per share. This terrific growth has been driven by two key catalysts -- gaming and data centers.</p>\n<p>Nvidia absolutely dominates these two markets. The company has an 83% share&nbsp;of discrete graphics cards that power gaming PCs, while its share of the booming data center accelerator market reportedly stood at 80.6% a&nbsp;year ago. The good part is that both these markets are expected to add billions of dollars of revenue in the future. The GPU (graphics processing unit) market, for instance, is expected to clock a 33% annual growth rate through 2028 and hit $246 billion in value, according to a third-party estimate.</p>\n<p>The use of GPUs as data-center accelerators is increasing&nbsp;at 42% a year, a pace that's expected to continue through 2027. Throw in budding catalysts such as the omniverse and self-driving cars, and it is easy to see why Nvidia's earnings are expected to increase&nbsp;at an annual pace of close to 40% for the next five years. That's way higher than Apple's projected earnings growth rate&nbsp;of 15% over the same period, which further indicates why Nvidia could be a solid candidate to overtake Apple's market cap in the next 15 years.</p>\n<p>2. <a href=\"https://laohu8.com/S/ASML\"><b>ASML Holding</b> </a></p>\n<p>Apple was unable to make enough iPhones and iPads last quarter due to supply chain constraints arising out of the global chip shortage, and that cost&nbsp;the tech giant $6 billion in revenue. ASML is <a href=\"https://laohu8.com/S/AONE.U\">one</a> company that could help get more chips into the hands of Apple and others that are suffering from a lack of chips on account of the semiconductor shortage.</p>\n<p>This is probably one of the reasons why ASML stock has been a top performer in 2021 and has outpaced Apple's gains by a significant margin this year.</p>\n<p><img src=\"https://static.tigerbbs.com/6aab71d6833e529191334d42cac0289f\" tg-width=\"720\" tg-height=\"387\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>AAPL data by YCharts</p>\n<p>It won't be surprising to see this trend continue as the demand for ASML's machines that help foundries make chips has gone through the roof. Net bookings for ASML's machines increased&nbsp;to 6.2 billion euros in the third quarter of 2021, more than double as compared to net bookings of 2.87 billion euros in the year-ago period.</p>\n<p>The Dutch giant reported a 32% increase in revenue during the quarter to 5.24 billion euros. The fact that ASML's bookings increased at a faster pace than the actual revenue indicates that it can sustain its impressive top-line growth by fulfilling more of its orders and turning the backlog into actual sales. The company is on track to finish 2021 with 35% revenue growth, and Wall Street's estimates suggest that it can keep growing at such an impressive pace for a long time to come.</p>\n<p>Venture capital firm Air Street Capital estimates that ASML could hit $500 billion in market cap next year, which would be a huge jump over its current market cap of $311 billion. What's more, ASML's earnings are expected&nbsp;to grow at almost 30% a year for the next five years, which is double Apple's projected growth.</p>\n<p>ASML seems to be in a solid position to deliver on Wall Street's forecasts as the semiconductor market is expected to generate&nbsp;$1 trillion in revenue by 2030, a big jump from 2018 levels of $466 billion. Foundries would need to spend more money on equipment to cater to the huge demand, and this could supercharge ASML in the long run as it is the biggest player in the market for photolithography machines.</p>\n<p>3. <a href=\"https://laohu8.com/S/AMZN\"><b>Amazon</b> </a></p>\n<p>Amazon is yet another stock that has easily outpaced Apple's gains in the past decade.</p>\n<p><img src=\"https://static.tigerbbs.com/e823ea95df1ad4c8e9cc5d870dc478b7\" tg-width=\"720\" tg-height=\"387\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>AAPL data by YCharts</p>\n<p>Amazon's focus on diversifying itself from a vanilla e-commerce company into a leading provider of cloud computing services, video streaming, music streaming, and on dominating the markets it operates in has helped the company grow at an eye-popping pace and hit a market cap&nbsp;of $1.7 trillion. This tech stock is expected to keep up its tremendous growth in the coming years, with earnings expected&nbsp;to increase at a compound annual growth rate of 36%.</p>\n<p>Again, this is much higher than Apple's projected growth rate. That's because Amazon is on track to take advantage of several fast-growing end markets. For instance, the company's Amazon Web Services (AWS) cloud computing division holds&nbsp;a 32% share of the $150 billion cloud infrastructure market. Third-party estimates peg the size of the global cloud computing market&nbsp;at $927 billion by 2027, which should ensure a high pace of growth in the AWS segment.</p>\n<p>Amazon's AWS revenue had jumped&nbsp;39% year over year in the third quarter to $16 billion, outpacing the growth in the e-commerce segments. Meanwhile, Amazon holds 40% of the U.S. e-commerce market that's expected to hit $8 trillion in revenue by 2030. All this indicates that the company's top line could jump big time in the coming years compared to its trailing-12-month revenue&nbsp;of $458 billion.</p>\n<p>As such, Amazon stock could continue to be a better growth pick than Apple in the next decade and beyond. It may eventually eclipse the iPhone maker's market cap in the long run, considering its much faster pace of growth.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks That Could Be Worth More Than Apple by 2035</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks That Could Be Worth More Than Apple by 2035\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-19 12:07 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/18/stocks-that-could-be-worth-more-than-apple-2035/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Apple is currently the world's most valuable company with a market capitalization of $2.82 trillion. That isn't surprising as the tech titan is a dominant player in the smartphone market and has ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/18/stocks-that-could-be-worth-more-than-apple-2035/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4550":"红杉资本持仓","BK4554":"元宇宙及AR概念","BK4566":"资本集团","BK4532":"文艺复兴科技持仓","BK4515":"5G概念","BK4553":"喜马拉雅资本持仓","BK4170":"电脑硬件、储存设备及电脑周边","AAPL":"苹果","BK4559":"巴菲特持仓","BK4505":"高瓴资本持仓","BK4501":"段永平概念","BK4527":"明星科技股","BK4534":"瑞士信贷持仓","BK4507":"流媒体概念","BK4533":"AQR资本管理(全球第二大对冲基金)"},"source_url":"https://www.fool.com/investing/2021/12/18/stocks-that-could-be-worth-more-than-apple-2035/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192035909","content_text":"Apple is currently the world's most valuable company with a market capitalization of $2.82 trillion. That isn't surprising as the tech titan is a dominant player in the smartphone market and has ancillary products and services to drive growth.\nThe tech giant generated a whopping $365.8 billion in revenue in fiscal 2021, an increase of 33% over the prior year. The fact that Apple is growing at an eye-popping pace despite being a mega-cap company is impressive, but it's not surprising as its products and services are in great demand. More importantly, Apple isn't resting on its laurels and is looking to push the envelope by seizing emerging tech trends and moving into new markets.\nAs such, Apple is pulling several strings to ensure that it remains the world's most valuable company for a long time to come. However, the likes of Nvidia , ASML Holding , and Amazon  could become more valuable than Apple by 2035, thanks to the fast-growing markets they operate in. Let's see why that may be the case.\n1. Nvidia \nNvidia has a market cap of $707 billion. It is worth noting that the graphics card specialist's market cap has grown at a much faster pace than that of Apple's in the past decade.\n\nNVDA data by YCharts\nNvidia shares have stepped on the gas since 2016. They have gone supersonic in the past couple of years as it has become clear that its graphics cards play an important role in powering several applications ranging from gaming consoles to personal computers to data centers and autonomous vehicles. The massive demand for Nvidia's graphics cards is evident from the company's recent results.\nThe company has generated $19.3 billion in revenue in the first nine months of fiscal 2022, a jump of 65% over the prior-year period. Its adjusted earnings have increased 81% in the first nine months of the year to $3.12 per share. This terrific growth has been driven by two key catalysts -- gaming and data centers.\nNvidia absolutely dominates these two markets. The company has an 83% share of discrete graphics cards that power gaming PCs, while its share of the booming data center accelerator market reportedly stood at 80.6% a year ago. The good part is that both these markets are expected to add billions of dollars of revenue in the future. The GPU (graphics processing unit) market, for instance, is expected to clock a 33% annual growth rate through 2028 and hit $246 billion in value, according to a third-party estimate.\nThe use of GPUs as data-center accelerators is increasing at 42% a year, a pace that's expected to continue through 2027. Throw in budding catalysts such as the omniverse and self-driving cars, and it is easy to see why Nvidia's earnings are expected to increase at an annual pace of close to 40% for the next five years. That's way higher than Apple's projected earnings growth rate of 15% over the same period, which further indicates why Nvidia could be a solid candidate to overtake Apple's market cap in the next 15 years.\n2. ASML Holding \nApple was unable to make enough iPhones and iPads last quarter due to supply chain constraints arising out of the global chip shortage, and that cost the tech giant $6 billion in revenue. ASML is one company that could help get more chips into the hands of Apple and others that are suffering from a lack of chips on account of the semiconductor shortage.\nThis is probably one of the reasons why ASML stock has been a top performer in 2021 and has outpaced Apple's gains by a significant margin this year.\n\nAAPL data by YCharts\nIt won't be surprising to see this trend continue as the demand for ASML's machines that help foundries make chips has gone through the roof. Net bookings for ASML's machines increased to 6.2 billion euros in the third quarter of 2021, more than double as compared to net bookings of 2.87 billion euros in the year-ago period.\nThe Dutch giant reported a 32% increase in revenue during the quarter to 5.24 billion euros. The fact that ASML's bookings increased at a faster pace than the actual revenue indicates that it can sustain its impressive top-line growth by fulfilling more of its orders and turning the backlog into actual sales. The company is on track to finish 2021 with 35% revenue growth, and Wall Street's estimates suggest that it can keep growing at such an impressive pace for a long time to come.\nVenture capital firm Air Street Capital estimates that ASML could hit $500 billion in market cap next year, which would be a huge jump over its current market cap of $311 billion. What's more, ASML's earnings are expected to grow at almost 30% a year for the next five years, which is double Apple's projected growth.\nASML seems to be in a solid position to deliver on Wall Street's forecasts as the semiconductor market is expected to generate $1 trillion in revenue by 2030, a big jump from 2018 levels of $466 billion. Foundries would need to spend more money on equipment to cater to the huge demand, and this could supercharge ASML in the long run as it is the biggest player in the market for photolithography machines.\n3. Amazon \nAmazon is yet another stock that has easily outpaced Apple's gains in the past decade.\n\nAAPL data by YCharts\nAmazon's focus on diversifying itself from a vanilla e-commerce company into a leading provider of cloud computing services, video streaming, music streaming, and on dominating the markets it operates in has helped the company grow at an eye-popping pace and hit a market cap of $1.7 trillion. This tech stock is expected to keep up its tremendous growth in the coming years, with earnings expected to increase at a compound annual growth rate of 36%.\nAgain, this is much higher than Apple's projected growth rate. That's because Amazon is on track to take advantage of several fast-growing end markets. For instance, the company's Amazon Web Services (AWS) cloud computing division holds a 32% share of the $150 billion cloud infrastructure market. Third-party estimates peg the size of the global cloud computing market at $927 billion by 2027, which should ensure a high pace of growth in the AWS segment.\nAmazon's AWS revenue had jumped 39% year over year in the third quarter to $16 billion, outpacing the growth in the e-commerce segments. Meanwhile, Amazon holds 40% of the U.S. e-commerce market that's expected to hit $8 trillion in revenue by 2030. All this indicates that the company's top line could jump big time in the coming years compared to its trailing-12-month revenue of $458 billion.\nAs such, Amazon stock could continue to be a better growth pick than Apple in the next decade and beyond. It may eventually eclipse the iPhone maker's market cap in the long run, considering its much faster pace of growth.","news_type":1},"isVote":1,"tweetType":1,"viewCount":884,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696942268,"gmtCreate":1640610355358,"gmtModify":1640610355458,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/696942268","repostId":"1185167492","repostType":4,"repost":{"id":"1185167492","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640609888,"share":"https://www.laohu8.com/m/news/1185167492?lang=&edition=full","pubTime":"2021-12-27 20:58","market":"us","language":"en","title":"Toplines Before US Market Open on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1185167492","media":"Tiger Newspress","summary":"U.S. stock index futures inched higher on Monday, boosted by megacap companies, while hundreds of Om","content":"<p>U.S. stock index futures inched higher on Monday, boosted by megacap companies, while hundreds of Omicron-driven flight cancellations kept investors on edge at the start of this year's final trading week.</p>\n<p>Travel-related stocks, typically sensitive to news around the coronavirus, slid after U.S. airlines called off many flights for a third day on Sunday as surging COVID-19 cases forced Christmas weekend travelers to change plans.</p>\n<p>The S&amp;P 500 closed at a record high on Thursday, as upbeat news related to the Omicron coronavirus variant calmed investor nerves over the highly infection strain's economic impact after it upended markets earlier this month.</p>\n<p>Wall Street's three main indexes are eyeing a third straight yearly gain, with the benchmark S&amp;P 500 (.SPX) on track to close out the year 25.8% higher. The Dow is set to rise 17.5%, while the Nasdaq is looking at a 21.4% climb.</p>\n<p>At 8:00 a.m. ET, Dow e-minis were up 72 points, or 0.20% and S&amp;P 500 e-minis were up 15.50 points, or 0.33%.</p>\n<p>Nasdaq 100 e-minis were up 70.00 points, or 0.43% as megacap companies Tesla Inc (TSLA.O) and Microsoft Corp (MSFT.O) and Meta Platform (FB.O) firmed between 0.5% and 1%.Airline stocks – The major carriers saw their shares fall in the premarket after a surge in weekend cancellations due to staffing issues. United Airlines (UAL) slid 1.8%, American Airlines (AAL) fell 1.4%, Delta Air Lines (DAL) was down 1% and Southwest (LUV) declined 1.5%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/09541de8c4bcd965c62dbe3f6b7f6bc5\" tg-width=\"649\" tg-height=\"205\" width=\"100%\" height=\"auto\"><span>*Source From Tiger Trade, EST 08:00</span></p>\n<p><b>Stocks making the biggest moves premarket</b></p>\n<p>Cruise line stocks – Stocks of major cruise lines declined in premarket trading following three Covid-19 outbreaks in the past week on ships operated by Carnival (CCL) and Royal Caribbean (RCL). Carnival slid 2.2% in the premarket, while Royal Caribbean lost 1.9% and Norwegian Cruise Line Holdings (NCLH) slid 1.6%.</p>\n<p>Grab（GRAB）–&nbsp;Grab stock climbed more than 7% in premarket trading&nbsp;as&nbsp;Wall Street saw massive upside for Asian tech giant Grab, after disappointing debut.</p>\n<p>GoDaddy (GDDY) – GoDaddy jumped 3.9% in premarket action after the Wall Street Journal reported that activist investor Starboard Value had taken a 6.5% stake in the internet domain name registration company.</p>\n<p></p>\n<p>Apple (AAPL) – Apple was cited by the top competition regulator in the Netherlands, which said the company broke competition laws, and ordered changes to Apple’s App Store payment policies. Apple said it would appeal the ruling.</p>\n<p></p>\n<p>Cigna (CI) – The insurer will reaffirm its 2021 and 2022 earnings guidance at its upcoming investor meetings, according to an SEC filing. Cigna expected 2021 adjusted earnings of at least $20.35 per share and sees projected growth of at least 10% for 2022.</p>\n<p></p>\n<p>Moderna (MRNA) – The drugmaker is fighting a shareholder proposal that the company open up its vaccine technology to poorer countries, according to a report in the Financial Times. The proposal calls on Moderna to explain why its prices are so high in light of the amount of government financial support it has received. Moderna fell 2% in the premarket.</p>\n<p></p>\n<p>Avis Budget (CAR) – The car rental firm’s shares jumped 2.6% in premarket trading, following a 3.2% gain Thursday. Average daily rental rates are at $81 per day, according to travel firm Kayak. That’s up 31% from a year ago.</p>\n<p></p>\n<p>Didi Global (DIDI) – Didi fell 1.3% in the premarket after the Financial Times reported that the China-based ride-hailing company is blocking employees from selling the shares for an indefinite period. That follows the company’s move to delist in the United States.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-27 20:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. stock index futures inched higher on Monday, boosted by megacap companies, while hundreds of Omicron-driven flight cancellations kept investors on edge at the start of this year's final trading week.</p>\n<p>Travel-related stocks, typically sensitive to news around the coronavirus, slid after U.S. airlines called off many flights for a third day on Sunday as surging COVID-19 cases forced Christmas weekend travelers to change plans.</p>\n<p>The S&amp;P 500 closed at a record high on Thursday, as upbeat news related to the Omicron coronavirus variant calmed investor nerves over the highly infection strain's economic impact after it upended markets earlier this month.</p>\n<p>Wall Street's three main indexes are eyeing a third straight yearly gain, with the benchmark S&amp;P 500 (.SPX) on track to close out the year 25.8% higher. The Dow is set to rise 17.5%, while the Nasdaq is looking at a 21.4% climb.</p>\n<p>At 8:00 a.m. ET, Dow e-minis were up 72 points, or 0.20% and S&amp;P 500 e-minis were up 15.50 points, or 0.33%.</p>\n<p>Nasdaq 100 e-minis were up 70.00 points, or 0.43% as megacap companies Tesla Inc (TSLA.O) and Microsoft Corp (MSFT.O) and Meta Platform (FB.O) firmed between 0.5% and 1%.Airline stocks – The major carriers saw their shares fall in the premarket after a surge in weekend cancellations due to staffing issues. United Airlines (UAL) slid 1.8%, American Airlines (AAL) fell 1.4%, Delta Air Lines (DAL) was down 1% and Southwest (LUV) declined 1.5%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/09541de8c4bcd965c62dbe3f6b7f6bc5\" tg-width=\"649\" tg-height=\"205\" width=\"100%\" height=\"auto\"><span>*Source From Tiger Trade, EST 08:00</span></p>\n<p><b>Stocks making the biggest moves premarket</b></p>\n<p>Cruise line stocks – Stocks of major cruise lines declined in premarket trading following three Covid-19 outbreaks in the past week on ships operated by Carnival (CCL) and Royal Caribbean (RCL). Carnival slid 2.2% in the premarket, while Royal Caribbean lost 1.9% and Norwegian Cruise Line Holdings (NCLH) slid 1.6%.</p>\n<p>Grab（GRAB）–&nbsp;Grab stock climbed more than 7% in premarket trading&nbsp;as&nbsp;Wall Street saw massive upside for Asian tech giant Grab, after disappointing debut.</p>\n<p>GoDaddy (GDDY) – GoDaddy jumped 3.9% in premarket action after the Wall Street Journal reported that activist investor Starboard Value had taken a 6.5% stake in the internet domain name registration company.</p>\n<p></p>\n<p>Apple (AAPL) – Apple was cited by the top competition regulator in the Netherlands, which said the company broke competition laws, and ordered changes to Apple’s App Store payment policies. Apple said it would appeal the ruling.</p>\n<p></p>\n<p>Cigna (CI) – The insurer will reaffirm its 2021 and 2022 earnings guidance at its upcoming investor meetings, according to an SEC filing. Cigna expected 2021 adjusted earnings of at least $20.35 per share and sees projected growth of at least 10% for 2022.</p>\n<p></p>\n<p>Moderna (MRNA) – The drugmaker is fighting a shareholder proposal that the company open up its vaccine technology to poorer countries, according to a report in the Financial Times. The proposal calls on Moderna to explain why its prices are so high in light of the amount of government financial support it has received. Moderna fell 2% in the premarket.</p>\n<p></p>\n<p>Avis Budget (CAR) – The car rental firm’s shares jumped 2.6% in premarket trading, following a 3.2% gain Thursday. Average daily rental rates are at $81 per day, according to travel firm Kayak. That’s up 31% from a year ago.</p>\n<p></p>\n<p>Didi Global (DIDI) – Didi fell 1.3% in the premarket after the Financial Times reported that the China-based ride-hailing company is blocking employees from selling the shares for an indefinite period. That follows the company’s move to delist in the United States.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1185167492","content_text":"U.S. stock index futures inched higher on Monday, boosted by megacap companies, while hundreds of Omicron-driven flight cancellations kept investors on edge at the start of this year's final trading week.\nTravel-related stocks, typically sensitive to news around the coronavirus, slid after U.S. airlines called off many flights for a third day on Sunday as surging COVID-19 cases forced Christmas weekend travelers to change plans.\nThe S&P 500 closed at a record high on Thursday, as upbeat news related to the Omicron coronavirus variant calmed investor nerves over the highly infection strain's economic impact after it upended markets earlier this month.\nWall Street's three main indexes are eyeing a third straight yearly gain, with the benchmark S&P 500 (.SPX) on track to close out the year 25.8% higher. The Dow is set to rise 17.5%, while the Nasdaq is looking at a 21.4% climb.\nAt 8:00 a.m. ET, Dow e-minis were up 72 points, or 0.20% and S&P 500 e-minis were up 15.50 points, or 0.33%.\nNasdaq 100 e-minis were up 70.00 points, or 0.43% as megacap companies Tesla Inc (TSLA.O) and Microsoft Corp (MSFT.O) and Meta Platform (FB.O) firmed between 0.5% and 1%.Airline stocks – The major carriers saw their shares fall in the premarket after a surge in weekend cancellations due to staffing issues. United Airlines (UAL) slid 1.8%, American Airlines (AAL) fell 1.4%, Delta Air Lines (DAL) was down 1% and Southwest (LUV) declined 1.5%.\n*Source From Tiger Trade, EST 08:00\nStocks making the biggest moves premarket\nCruise line stocks – Stocks of major cruise lines declined in premarket trading following three Covid-19 outbreaks in the past week on ships operated by Carnival (CCL) and Royal Caribbean (RCL). Carnival slid 2.2% in the premarket, while Royal Caribbean lost 1.9% and Norwegian Cruise Line Holdings (NCLH) slid 1.6%.\nGrab（GRAB）– Grab stock climbed more than 7% in premarket trading as Wall Street saw massive upside for Asian tech giant Grab, after disappointing debut.\nGoDaddy (GDDY) – GoDaddy jumped 3.9% in premarket action after the Wall Street Journal reported that activist investor Starboard Value had taken a 6.5% stake in the internet domain name registration company.\n\nApple (AAPL) – Apple was cited by the top competition regulator in the Netherlands, which said the company broke competition laws, and ordered changes to Apple’s App Store payment policies. Apple said it would appeal the ruling.\n\nCigna (CI) – The insurer will reaffirm its 2021 and 2022 earnings guidance at its upcoming investor meetings, according to an SEC filing. Cigna expected 2021 adjusted earnings of at least $20.35 per share and sees projected growth of at least 10% for 2022.\n\nModerna (MRNA) – The drugmaker is fighting a shareholder proposal that the company open up its vaccine technology to poorer countries, according to a report in the Financial Times. The proposal calls on Moderna to explain why its prices are so high in light of the amount of government financial support it has received. Moderna fell 2% in the premarket.\n\nAvis Budget (CAR) – The car rental firm’s shares jumped 2.6% in premarket trading, following a 3.2% gain Thursday. Average daily rental rates are at $81 per day, according to travel firm Kayak. That’s up 31% from a year ago.\n\nDidi Global (DIDI) – Didi fell 1.3% in the premarket after the Financial Times reported that the China-based ride-hailing company is blocking employees from selling the shares for an indefinite period. That follows the company’s move to delist in the United States.","news_type":1},"isVote":1,"tweetType":1,"viewCount":725,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605532748,"gmtCreate":1639188876484,"gmtModify":1639188876558,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Comment and like","listText":"Comment and like","text":"Comment and like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/605532748","repostId":"2190673267","repostType":4,"repost":{"id":"2190673267","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639176815,"share":"https://www.laohu8.com/m/news/2190673267?lang=&edition=full","pubTime":"2021-12-11 06:53","market":"us","language":"en","title":"Wall St Week Ahead-Investors await faster taper, inflation view at Fed meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2190673267","media":"Reuters","summary":"NEW YORK, Dec 10 (Reuters) - Investors are bracing for the last Federal Reserve meeting of the year,","content":"<p>NEW YORK, Dec 10 (Reuters) - Investors are bracing for the last Federal Reserve meeting of the year, with market participants hungry to learn how quickly the central bank plans to finish unwinding its bond-buying program and pick up signs of when it may start to raise rates in 2022.</p>\n<p>Stocks are back at record highs following last week’s selloff – a market spasm brought on by worries over the Omicron variant of the coronavirus&nbsp;and comments from Fed Chairman Jerome Powell, who said the central bank may discuss speeding up the reduction of its $120 billion per month bond buying program at next week's meeting.</p>\n<p>There is potential for renewed volatility, however, if the Fed takes a more hawkish than expected view on rolling back the easy money policies that have helped stocks more than double from their March 2020 lows, including a rapid reduction in bond buying that clears the way for the central bank to raise rates sooner.</p>\n<p>Markets could also be roiled if the Fed signals greater worry about inflation, which Powell said can no longer be described as \"transitory.\" Data on Friday showed consumer prices last month notched their largest annual gain in nearly four decades, bolstering the case for higher rates.</p>\n<p>“The biggest factor in the equity market remains and will remain to be interest rates,\" said Jack Ablin, chief investment officer at Cresset Capital Management.</p>\n<p>Higher yields - which can rise on expectations of tighter monetary policy - can dim the allure of stocks by creating a greater discount for companies' future cash flows, potentially pressuring valuations that are already elevated by historical standards.</p>\n<p>The S&amp;P 500 , which has climbed 25% this year, is trading at 20.5 times forward 12-month earnings estimates, compared with its historic valuation average of 15.5 times, according to Refinitiv Datastream.</p>\n<p>The yield on the benchmark 10-year Treasury note has climbed about 15 basis points from the start of the month to 1.49%, but is below the 1.776% it reached in March.</p>\n<p>Some stocks have already been hit by higher rate worries this year, including technology and growth companies that thrived during 2020's lockdowns.</p>\n<p>The broader market, however, has generally tolerated tightening monetary policy, analysts at BofA Global Research said in a recent report, noting that stocks mostly climbed as the Fed normalized policy in the last decade.</p>\n<p>The Fed last month began \"tapering\" its purchases of Treasuries and mortgage-backed securities at a pace that would have put it on track to complete the wind-down by mid-2022. Following Powell's comments, investors now believe the Fed could quicken the pace of reductions that will end the bond-buying by March, which could allow the central bank to potentially start raising rates sooner.</p>\n<p>Bets on earlier rate increases have also grown. Traders late on Friday saw a more than 50% chance of a rate hike by May 2022, up from a roughly 30% chance a month ago, according to the CME Group's FedWatch program.</p>\n<p>Investors are also keen to learn the central bank's view on the Omicron variant's potential impact on economic growth or inflation.</p>\n<p>One possible scenario outlined by UBS Global Wealth Management in a report sees the virus complicating supply-chain issues that have helped stoke inflation in recent months, bringing concerns the Fed may need to tighten monetary policy faster. The bank’s base case scenario, however, assumes the Omicron variant will not derail the recovery.</p>\n<p>Mona Mahajan, senior investment strategist at Edward Jones, said the Fed meeting could bring more clarity to investors after an upsurge of volatility in recent weeks.</p>\n<p>“It feels like the market has climbed two walls of worry already: Omicron and the path of the Fed,\" she said. \"I do think over the next couple of weeks we will get a little bit more certainty on both fronts.”</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St Week Ahead-Investors await faster taper, inflation view at Fed meeting</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St Week Ahead-Investors await faster taper, inflation view at Fed meeting\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-11 06:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>NEW YORK, Dec 10 (Reuters) - Investors are bracing for the last Federal Reserve meeting of the year, with market participants hungry to learn how quickly the central bank plans to finish unwinding its bond-buying program and pick up signs of when it may start to raise rates in 2022.</p>\n<p>Stocks are back at record highs following last week’s selloff – a market spasm brought on by worries over the Omicron variant of the coronavirus&nbsp;and comments from Fed Chairman Jerome Powell, who said the central bank may discuss speeding up the reduction of its $120 billion per month bond buying program at next week's meeting.</p>\n<p>There is potential for renewed volatility, however, if the Fed takes a more hawkish than expected view on rolling back the easy money policies that have helped stocks more than double from their March 2020 lows, including a rapid reduction in bond buying that clears the way for the central bank to raise rates sooner.</p>\n<p>Markets could also be roiled if the Fed signals greater worry about inflation, which Powell said can no longer be described as \"transitory.\" Data on Friday showed consumer prices last month notched their largest annual gain in nearly four decades, bolstering the case for higher rates.</p>\n<p>“The biggest factor in the equity market remains and will remain to be interest rates,\" said Jack Ablin, chief investment officer at Cresset Capital Management.</p>\n<p>Higher yields - which can rise on expectations of tighter monetary policy - can dim the allure of stocks by creating a greater discount for companies' future cash flows, potentially pressuring valuations that are already elevated by historical standards.</p>\n<p>The S&amp;P 500 , which has climbed 25% this year, is trading at 20.5 times forward 12-month earnings estimates, compared with its historic valuation average of 15.5 times, according to Refinitiv Datastream.</p>\n<p>The yield on the benchmark 10-year Treasury note has climbed about 15 basis points from the start of the month to 1.49%, but is below the 1.776% it reached in March.</p>\n<p>Some stocks have already been hit by higher rate worries this year, including technology and growth companies that thrived during 2020's lockdowns.</p>\n<p>The broader market, however, has generally tolerated tightening monetary policy, analysts at BofA Global Research said in a recent report, noting that stocks mostly climbed as the Fed normalized policy in the last decade.</p>\n<p>The Fed last month began \"tapering\" its purchases of Treasuries and mortgage-backed securities at a pace that would have put it on track to complete the wind-down by mid-2022. Following Powell's comments, investors now believe the Fed could quicken the pace of reductions that will end the bond-buying by March, which could allow the central bank to potentially start raising rates sooner.</p>\n<p>Bets on earlier rate increases have also grown. Traders late on Friday saw a more than 50% chance of a rate hike by May 2022, up from a roughly 30% chance a month ago, according to the CME Group's FedWatch program.</p>\n<p>Investors are also keen to learn the central bank's view on the Omicron variant's potential impact on economic growth or inflation.</p>\n<p>One possible scenario outlined by UBS Global Wealth Management in a report sees the virus complicating supply-chain issues that have helped stoke inflation in recent months, bringing concerns the Fed may need to tighten monetary policy faster. The bank’s base case scenario, however, assumes the Omicron variant will not derail the recovery.</p>\n<p>Mona Mahajan, senior investment strategist at Edward Jones, said the Fed meeting could bring more clarity to investors after an upsurge of volatility in recent weeks.</p>\n<p>“It feels like the market has climbed two walls of worry already: Omicron and the path of the Fed,\" she said. \"I do think over the next couple of weeks we will get a little bit more certainty on both fronts.”</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190673267","content_text":"NEW YORK, Dec 10 (Reuters) - Investors are bracing for the last Federal Reserve meeting of the year, with market participants hungry to learn how quickly the central bank plans to finish unwinding its bond-buying program and pick up signs of when it may start to raise rates in 2022.\nStocks are back at record highs following last week’s selloff – a market spasm brought on by worries over the Omicron variant of the coronavirus and comments from Fed Chairman Jerome Powell, who said the central bank may discuss speeding up the reduction of its $120 billion per month bond buying program at next week's meeting.\nThere is potential for renewed volatility, however, if the Fed takes a more hawkish than expected view on rolling back the easy money policies that have helped stocks more than double from their March 2020 lows, including a rapid reduction in bond buying that clears the way for the central bank to raise rates sooner.\nMarkets could also be roiled if the Fed signals greater worry about inflation, which Powell said can no longer be described as \"transitory.\" Data on Friday showed consumer prices last month notched their largest annual gain in nearly four decades, bolstering the case for higher rates.\n“The biggest factor in the equity market remains and will remain to be interest rates,\" said Jack Ablin, chief investment officer at Cresset Capital Management.\nHigher yields - which can rise on expectations of tighter monetary policy - can dim the allure of stocks by creating a greater discount for companies' future cash flows, potentially pressuring valuations that are already elevated by historical standards.\nThe S&P 500 , which has climbed 25% this year, is trading at 20.5 times forward 12-month earnings estimates, compared with its historic valuation average of 15.5 times, according to Refinitiv Datastream.\nThe yield on the benchmark 10-year Treasury note has climbed about 15 basis points from the start of the month to 1.49%, but is below the 1.776% it reached in March.\nSome stocks have already been hit by higher rate worries this year, including technology and growth companies that thrived during 2020's lockdowns.\nThe broader market, however, has generally tolerated tightening monetary policy, analysts at BofA Global Research said in a recent report, noting that stocks mostly climbed as the Fed normalized policy in the last decade.\nThe Fed last month began \"tapering\" its purchases of Treasuries and mortgage-backed securities at a pace that would have put it on track to complete the wind-down by mid-2022. Following Powell's comments, investors now believe the Fed could quicken the pace of reductions that will end the bond-buying by March, which could allow the central bank to potentially start raising rates sooner.\nBets on earlier rate increases have also grown. Traders late on Friday saw a more than 50% chance of a rate hike by May 2022, up from a roughly 30% chance a month ago, according to the CME Group's FedWatch program.\nInvestors are also keen to learn the central bank's view on the Omicron variant's potential impact on economic growth or inflation.\nOne possible scenario outlined by UBS Global Wealth Management in a report sees the virus complicating supply-chain issues that have helped stoke inflation in recent months, bringing concerns the Fed may need to tighten monetary policy faster. The bank’s base case scenario, however, assumes the Omicron variant will not derail the recovery.\nMona Mahajan, senior investment strategist at Edward Jones, said the Fed meeting could bring more clarity to investors after an upsurge of volatility in recent weeks.\n“It feels like the market has climbed two walls of worry already: Omicron and the path of the Fed,\" she said. \"I do think over the next couple of weeks we will get a little bit more certainty on both fronts.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":131,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696573176,"gmtCreate":1640741411722,"gmtModify":1640741411807,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Comment","listText":"Comment","text":"Comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/696573176","repostId":"1157924593","repostType":4,"isVote":1,"tweetType":1,"viewCount":446,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607805191,"gmtCreate":1639521531337,"gmtModify":1639521531424,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/607805191","repostId":"2191937155","repostType":4,"repost":{"id":"2191937155","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639521474,"share":"https://www.laohu8.com/m/news/2191937155?lang=&edition=full","pubTime":"2021-12-15 06:37","market":"us","language":"en","title":"Pfizer says COVID-19 pill near 90% protective against hospitalization, death","url":"https://stock-news.laohu8.com/highlight/detail?id=2191937155","media":"Reuters","summary":"NEW YORK, Dec 14 (Reuters) - Pfizer Inc on Tuesday said its antiviral COVID-19 pill showed near 90% ","content":"<p>NEW YORK, Dec 14 (Reuters) - Pfizer Inc&nbsp;on Tuesday said its antiviral COVID-19 pill showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent lab data suggests the drug retains its effectiveness against the fast spreading Omicron variant of the coronavirus.</p>\n<p>The U.S. drugmaker last month said the oral medicine was around 89% effective in preventing hospitalizations or deaths when compared to placebo, based on interim results in around 1,200 people. Data from its final analysis of the trial disclosed on Tuesday includes an additional 1,000 people.</p>\n<p>Nobody in the trial who received the Pfizer treatment died, compared with 12 deaths among placebo recipients.</p>\n<p>The Pfizer pills are taken with the older antiviral ritonavir every 12 hours for five days beginning shortly after onset of symptoms. If authorized, the treatment will be sold as Paxlovid.</p>\n<p>\"It's a stunning outcome,\" Pfizer Chief Scientific Officer Mikael Dolsten said in an interview.</p>\n<p>\"We're talking about a staggering number of lives saved and hospitalizations prevented. And of course, if you deploy this quickly after infection, we are likely to reduce transmission dramatically,\" Dolsten said.</p>\n<p>Pfizer also released early data from a second study suggesting that the treatment reduced hospitalizations by around 70% in a smaller trial of standard-risk adults, including some higher-risk vaccinated people.</p>\n<p>Pfizer said those results showed a positive trend, but were not statistically significant. They are following the results and plan to release data from the final 20% of participants in the 1,100-patient trial. The trial did not show that the drug alleviated symptoms of COVID-19 in that population.</p>\n<p>Dolsten said he expects authorization for use in high-risk individuals from the U.S. Food and Drug Administration and other regulatory agencies soon. He does not believe an FDA advisory panel meeting will be needed.</p>\n<p>\"We're in very advanced regulatory dialogues with both Europe and the UK, and we have dialogues with most of the major regulatory agencies globally,\" Dolsten said.</p>\n<p><b>'VERY EXCITING RESULTS'</b></p>\n<p>Pfizer submitted data to the FDA last month, asking for emergency use authorization (EUA) of the drug.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/04e1175e6a0c8ba936538fabc8038071\" tg-width=\"960\" tg-height=\"640\" width=\"100%\" height=\"auto\"><span>Paxlovid, a Pfizer's coronavirus disease (COVID-19) pill, is seen manufactured in Ascoli, Italy, in this undated handout photo obtained by Reuters on November 16, 2021. Pfizer/Handout via REUTERS</span></p>\n<p>\"These are very exciting results,\" said Dr. Paul Sax, a professor at Harvard Medical School.</p>\n<p>Sax said the FDA should try to accelerate the authorization process as much as possible, noting there are very limited treatment options for high-risk people outside of the hospital.</p>\n<p>There are currently no oral antiviral treatments for COVID-9 authorized in the United States.</p>\n<p>Analysts on average forecast 2022 revenue of more than $24 billion from the pill, which would more than make up for any decline in vaccine sales after 2021.</p>\n<p>Rival Merck &amp; Co&nbsp;has asked for an EUA for its antiviral pill molnupiravir. But that drug only reduced hospitalizations and deaths in its clinical trial of high-risk patients by around 30%.</p>\n<p>Some scientists have also raised safety concerns about the potential for birth defects from the Merck drug, as well as worries that it could cause the virus to mutate.</p>\n<p>Pfizer's treatment works differently. It is part of a class of drugs called protease inhibitors currently used to treat HIV, hepatitis C and other viruses.</p>\n<p>Recent laboratory testing showed that activity against the protease of the Omicron variant is as \"good as basically any SARS-COV-2 variant of concern,\" Dolsten said.</p>\n<p>The company has said it can have 180,000 treatment courses ready to ship this year and plans to produce at least 80 million more in 2022.</p>\n<p>Dolsten said Pfizer is looking to expand that output further as new variants, like the newly-discovered Omicron, could push the need for antivirals substantially higher. Current vaccines appear to be less effective at preventing infection with Omicron.</p>\n<p>Pfizer, which makes one of the leading COVID-19 vaccines with German partner BioNTech , has agreed to allow generic manufacturers to supply versions of the drug to 95 low- and middle-income countries through a licensing agreement with international public health group Medicines Patent Pool (MPP). However, Dolsten said that for next year he expects the drug will be mainly produced by Pfizer.</p>\n<p>The MPP told Reuters in a statement, that it will be \"well into next year\" before pills produced by generic manufacturers under its licenses will be ready for use.</p>\n<p>The U.S. government has already secured 10 million courses of the Pfizer treatment for $5.29 billion.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer says COVID-19 pill near 90% protective against hospitalization, death</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer says COVID-19 pill near 90% protective against hospitalization, death\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-15 06:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>NEW YORK, Dec 14 (Reuters) - Pfizer Inc&nbsp;on Tuesday said its antiviral COVID-19 pill showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent lab data suggests the drug retains its effectiveness against the fast spreading Omicron variant of the coronavirus.</p>\n<p>The U.S. drugmaker last month said the oral medicine was around 89% effective in preventing hospitalizations or deaths when compared to placebo, based on interim results in around 1,200 people. Data from its final analysis of the trial disclosed on Tuesday includes an additional 1,000 people.</p>\n<p>Nobody in the trial who received the Pfizer treatment died, compared with 12 deaths among placebo recipients.</p>\n<p>The Pfizer pills are taken with the older antiviral ritonavir every 12 hours for five days beginning shortly after onset of symptoms. If authorized, the treatment will be sold as Paxlovid.</p>\n<p>\"It's a stunning outcome,\" Pfizer Chief Scientific Officer Mikael Dolsten said in an interview.</p>\n<p>\"We're talking about a staggering number of lives saved and hospitalizations prevented. And of course, if you deploy this quickly after infection, we are likely to reduce transmission dramatically,\" Dolsten said.</p>\n<p>Pfizer also released early data from a second study suggesting that the treatment reduced hospitalizations by around 70% in a smaller trial of standard-risk adults, including some higher-risk vaccinated people.</p>\n<p>Pfizer said those results showed a positive trend, but were not statistically significant. They are following the results and plan to release data from the final 20% of participants in the 1,100-patient trial. The trial did not show that the drug alleviated symptoms of COVID-19 in that population.</p>\n<p>Dolsten said he expects authorization for use in high-risk individuals from the U.S. Food and Drug Administration and other regulatory agencies soon. He does not believe an FDA advisory panel meeting will be needed.</p>\n<p>\"We're in very advanced regulatory dialogues with both Europe and the UK, and we have dialogues with most of the major regulatory agencies globally,\" Dolsten said.</p>\n<p><b>'VERY EXCITING RESULTS'</b></p>\n<p>Pfizer submitted data to the FDA last month, asking for emergency use authorization (EUA) of the drug.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/04e1175e6a0c8ba936538fabc8038071\" tg-width=\"960\" tg-height=\"640\" width=\"100%\" height=\"auto\"><span>Paxlovid, a Pfizer's coronavirus disease (COVID-19) pill, is seen manufactured in Ascoli, Italy, in this undated handout photo obtained by Reuters on November 16, 2021. Pfizer/Handout via REUTERS</span></p>\n<p>\"These are very exciting results,\" said Dr. Paul Sax, a professor at Harvard Medical School.</p>\n<p>Sax said the FDA should try to accelerate the authorization process as much as possible, noting there are very limited treatment options for high-risk people outside of the hospital.</p>\n<p>There are currently no oral antiviral treatments for COVID-9 authorized in the United States.</p>\n<p>Analysts on average forecast 2022 revenue of more than $24 billion from the pill, which would more than make up for any decline in vaccine sales after 2021.</p>\n<p>Rival Merck &amp; Co&nbsp;has asked for an EUA for its antiviral pill molnupiravir. But that drug only reduced hospitalizations and deaths in its clinical trial of high-risk patients by around 30%.</p>\n<p>Some scientists have also raised safety concerns about the potential for birth defects from the Merck drug, as well as worries that it could cause the virus to mutate.</p>\n<p>Pfizer's treatment works differently. It is part of a class of drugs called protease inhibitors currently used to treat HIV, hepatitis C and other viruses.</p>\n<p>Recent laboratory testing showed that activity against the protease of the Omicron variant is as \"good as basically any SARS-COV-2 variant of concern,\" Dolsten said.</p>\n<p>The company has said it can have 180,000 treatment courses ready to ship this year and plans to produce at least 80 million more in 2022.</p>\n<p>Dolsten said Pfizer is looking to expand that output further as new variants, like the newly-discovered Omicron, could push the need for antivirals substantially higher. Current vaccines appear to be less effective at preventing infection with Omicron.</p>\n<p>Pfizer, which makes one of the leading COVID-19 vaccines with German partner BioNTech , has agreed to allow generic manufacturers to supply versions of the drug to 95 low- and middle-income countries through a licensing agreement with international public health group Medicines Patent Pool (MPP). However, Dolsten said that for next year he expects the drug will be mainly produced by Pfizer.</p>\n<p>The MPP told Reuters in a statement, that it will be \"well into next year\" before pills produced by generic manufacturers under its licenses will be ready for use.</p>\n<p>The U.S. government has already secured 10 million courses of the Pfizer treatment for $5.29 billion.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4007":"制药","BK4550":"红杉资本持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4534":"瑞士信贷持仓","BK4568":"美国抗疫概念","PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191937155","content_text":"NEW YORK, Dec 14 (Reuters) - Pfizer Inc on Tuesday said its antiviral COVID-19 pill showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent lab data suggests the drug retains its effectiveness against the fast spreading Omicron variant of the coronavirus.\nThe U.S. drugmaker last month said the oral medicine was around 89% effective in preventing hospitalizations or deaths when compared to placebo, based on interim results in around 1,200 people. Data from its final analysis of the trial disclosed on Tuesday includes an additional 1,000 people.\nNobody in the trial who received the Pfizer treatment died, compared with 12 deaths among placebo recipients.\nThe Pfizer pills are taken with the older antiviral ritonavir every 12 hours for five days beginning shortly after onset of symptoms. If authorized, the treatment will be sold as Paxlovid.\n\"It's a stunning outcome,\" Pfizer Chief Scientific Officer Mikael Dolsten said in an interview.\n\"We're talking about a staggering number of lives saved and hospitalizations prevented. And of course, if you deploy this quickly after infection, we are likely to reduce transmission dramatically,\" Dolsten said.\nPfizer also released early data from a second study suggesting that the treatment reduced hospitalizations by around 70% in a smaller trial of standard-risk adults, including some higher-risk vaccinated people.\nPfizer said those results showed a positive trend, but were not statistically significant. They are following the results and plan to release data from the final 20% of participants in the 1,100-patient trial. The trial did not show that the drug alleviated symptoms of COVID-19 in that population.\nDolsten said he expects authorization for use in high-risk individuals from the U.S. Food and Drug Administration and other regulatory agencies soon. He does not believe an FDA advisory panel meeting will be needed.\n\"We're in very advanced regulatory dialogues with both Europe and the UK, and we have dialogues with most of the major regulatory agencies globally,\" Dolsten said.\n'VERY EXCITING RESULTS'\nPfizer submitted data to the FDA last month, asking for emergency use authorization (EUA) of the drug.\nPaxlovid, a Pfizer's coronavirus disease (COVID-19) pill, is seen manufactured in Ascoli, Italy, in this undated handout photo obtained by Reuters on November 16, 2021. Pfizer/Handout via REUTERS\n\"These are very exciting results,\" said Dr. Paul Sax, a professor at Harvard Medical School.\nSax said the FDA should try to accelerate the authorization process as much as possible, noting there are very limited treatment options for high-risk people outside of the hospital.\nThere are currently no oral antiviral treatments for COVID-9 authorized in the United States.\nAnalysts on average forecast 2022 revenue of more than $24 billion from the pill, which would more than make up for any decline in vaccine sales after 2021.\nRival Merck & Co has asked for an EUA for its antiviral pill molnupiravir. But that drug only reduced hospitalizations and deaths in its clinical trial of high-risk patients by around 30%.\nSome scientists have also raised safety concerns about the potential for birth defects from the Merck drug, as well as worries that it could cause the virus to mutate.\nPfizer's treatment works differently. It is part of a class of drugs called protease inhibitors currently used to treat HIV, hepatitis C and other viruses.\nRecent laboratory testing showed that activity against the protease of the Omicron variant is as \"good as basically any SARS-COV-2 variant of concern,\" Dolsten said.\nThe company has said it can have 180,000 treatment courses ready to ship this year and plans to produce at least 80 million more in 2022.\nDolsten said Pfizer is looking to expand that output further as new variants, like the newly-discovered Omicron, could push the need for antivirals substantially higher. Current vaccines appear to be less effective at preventing infection with Omicron.\nPfizer, which makes one of the leading COVID-19 vaccines with German partner BioNTech , has agreed to allow generic manufacturers to supply versions of the drug to 95 low- and middle-income countries through a licensing agreement with international public health group Medicines Patent Pool (MPP). However, Dolsten said that for next year he expects the drug will be mainly produced by Pfizer.\nThe MPP told Reuters in a statement, that it will be \"well into next year\" before pills produced by generic manufacturers under its licenses will be ready for use.\nThe U.S. government has already secured 10 million courses of the Pfizer treatment for $5.29 billion.","news_type":1},"isVote":1,"tweetType":1,"viewCount":512,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602987487,"gmtCreate":1638957914980,"gmtModify":1638957915210,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/602987487","repostId":"1149172224","repostType":4,"isVote":1,"tweetType":1,"viewCount":167,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606973334,"gmtCreate":1638830869882,"gmtModify":1638830870018,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Like and comment","listText":"Like and comment","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/606973334","repostId":"1189410190","repostType":4,"repost":{"id":"1189410190","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638804387,"share":"https://www.laohu8.com/m/news/1189410190?lang=&edition=full","pubTime":"2021-12-06 23:26","market":"us","language":"en","title":"Stocks linked to the reopening of the economy gained on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1189410190","media":"Tiger Newspress","summary":"Stocks linked to the reopening of the economy gained on Monday.Airlines,Cruise lines and travel book","content":"<p>Stocks linked to the reopening of the economy gained on Monday.Airlines,Cruise lines&nbsp;and&nbsp;travel booking stocks&nbsp;jumped&nbsp;in morning trading.</p>\n<p><img src=\"https://static.tigerbbs.com/651aa4b1311ccf3c19aeb54b31cfa75d\" tg-width=\"410\" tg-height=\"485\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/f544513dbaea07f8bfb6ef95f4787209\" tg-width=\"416\" tg-height=\"188\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/f38b5565430c470461254d0b06da3752\" tg-width=\"405\" tg-height=\"178\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks linked to the reopening of the economy gained on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks linked to the reopening of the economy gained on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-06 23:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Stocks linked to the reopening of the economy gained on Monday.Airlines,Cruise lines&nbsp;and&nbsp;travel booking stocks&nbsp;jumped&nbsp;in morning trading.</p>\n<p><img src=\"https://static.tigerbbs.com/651aa4b1311ccf3c19aeb54b31cfa75d\" tg-width=\"410\" tg-height=\"485\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/f544513dbaea07f8bfb6ef95f4787209\" tg-width=\"416\" tg-height=\"188\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/f38b5565430c470461254d0b06da3752\" tg-width=\"405\" tg-height=\"178\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ABNB":"爱彼迎","ALK":"阿拉斯加航空集团有限公司","BA":"波音","DAL":"达美航空","BKNG":"Booking Holdings","SAVE":"Spirit Airlines","CCL":"嘉年华邮轮","UAL":"联合大陆航空","EXPE":"Expedia","LUV":"西南航空","AAL":"美国航空","NCLH":"挪威邮轮","JBLU":"捷蓝航空","RCL":"皇家加勒比邮轮"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189410190","content_text":"Stocks linked to the reopening of the economy gained on Monday.Airlines,Cruise lines and travel booking stocks jumped in morning trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":357,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690177008,"gmtCreate":1639650842823,"gmtModify":1639650842951,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/690177008","repostId":"1184616731","repostType":4,"isVote":1,"tweetType":1,"viewCount":589,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604928017,"gmtCreate":1639314938678,"gmtModify":1639314938787,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Sure anot??","listText":"Sure anot??","text":"Sure anot??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/604928017","repostId":"2190679207","repostType":4,"repost":{"id":"2190679207","pubTimestamp":1639281804,"share":"https://www.laohu8.com/m/news/2190679207?lang=&edition=full","pubTime":"2021-12-12 12:03","market":"us","language":"en","title":"Want $1 Million in Retirement? Invest $100,000 in These 2 Stocks and Hold Until 2035","url":"https://stock-news.laohu8.com/highlight/detail?id=2190679207","media":"Motley Fool","summary":"These two stocks could change your retirement.","content":"<p>Over the past 15 years, the <b>S&amp;P 500</b> has risen in price 232%, which results in a 9.8% compound annual growth rate without inflation. If this continued for the next 15 years, you would have over $300,000 in savings to retire on if you invested $100,000, which is bigger than the average 60-year-old American's 401(k) balance.</p>\n<p>While this strategy could produce solid returns, there are two stocks that could crush that average by 2035. Here's why I think <b>Latch</b> (NASDAQ:LTCH) and <b>Lemonade</b> (NYSE:LMND) have the potential to provide high-quality returns so that you can retire right.</p>\n<h2>1. Latch: Smart security</h2>\n<p>This smart lock manufacturer is taking the industry by storm with its software. With LatchOS, apartment managers can get a birds-eye view of all their apartments on <a href=\"https://laohu8.com/S/AONE.U\">one</a> platform, making sure all of their tenants are safe and secure. Moreover, managers can let in workers or delivery people from that platform. Latch is the only company that can offer a combination of smart, keyless locks and innovative software, so it's no wonder it is rapidly being adopted by apartment buildings across America.</p>\n<p>Nearly a third of new apartment buildings are being built today with Latch installed in them, and once Latch's locks are in, it can be incredibly hard to replace them with a competitor. Additionally, when customers agree to use Latch, they sign six- to 10-year contracts to use LatchOS. These two factors provide amazingly high switching costs, so once Latch is installed, it's likely that its users will stay Latch users for a long time. Latch has experienced zero turnovers since it started operations in 2017, and that will probably continue to be the case.</p>\n<p>Latch's market is massive, and the high switching costs and first-mover advantage will likely allow the company to capitalize on it. Latch sees a market opportunity of $54 billion in the U.S. alone, and if the company is able to expand internationally in a few years, that adds another $90 billion.</p>\n<p>Latch's partnerships will be another integral part of the company's success. Since Latch customers sign agreements with Latch to use its products before the apartments are even built, it is crucial that Latch is in talks with apartment managers before the construction team breaks ground. That is why Latch has partnered with some of the largest apartment builders in the U.S., like <b>Brookfield</b> (NYSE:BAM) and <b>Avalon Bay</b> (NYSE:AVB).</p>\n<p>This company has only been operational since 2017, so there are plenty of risks with this business. The primary risk is that it is losing lots of cash.</p>\n<table border=\"1\">\n <tbody>\n  <tr>\n   <th>Metric</th>\n   <th>Q3 2020</th>\n   <th>Q3 2021</th>\n   <th>Change</th>\n  </tr>\n  <tr>\n   <td>Net loss</td>\n   <td>$15.9 million</td>\n   <td>$34.2 million</td>\n   <td>115%</td>\n  </tr>\n  <tr>\n   <td>Net loss as a percentage of revenue</td>\n   <td>311.5%</td>\n   <td>305.7%</td>\n   <td>N/A</td>\n  </tr>\n </tbody>\n</table>\n<p>The company is making most of its money today on its locks, which it sells at a loss. These losses are bad today, but Latch's profitability can improve. Latch has noted that the timeframe it takes from construction to a builder beginning their subscription services is 24 months. The contracts the company has seen could finally turn into reportable revenue within the next couple of years. Analysts see the potential as well with growth forecasts of nearly 50% for the next five years.</p>\n<p>Also, as its customers stay with the company longer and pay more in its subscription fees for the software -- which has gross margins of 90% -- the company's losses will likely improve to provide a pathway to profitability. This could be a multi-year effort, but if it can use its differentiated product and strong partnerships to attract customers and its high switching costs to retain them, Latch could give investors immense returns by 2035.</p>\n<h2>2. Lemonade: An insurance provider anyone can love</h2>\n<p>Lemonade is making insurance enjoyable. Whether applying for insurance or getting a claim, Lemonade's process is easy and hassle-free with its artificial intelligence (AI)-based bots that can approve applicants and claims in seconds. The company is also aligning its interest with its consumers: Lemonade charges a flat fee, and any money from leftover claims that went unpaid goes to charities that Lemonade customers choose. So far in 2021, Lemonade has donated over $2.2 million in unpaid claims on behalf of its customers.</p>\n<p>Lemonade's incentive alignment structure can hurt its bottom line, but it has resulted in amazing customer attraction. Lemonade has over 1.3 million customers, and it has been one of the fastest-growing insurance stocks ever.</p>\n<p>The company started in renters insurance, targeting young renters. However, just as its customers have moved on in life, Lemonade has expanded. Now it offers homeowners, pet, life, and even car insurance. Lemonade hopes to attract young customers with small offerings like renters and car insurance, then integrate them deeper into the ecosystem with its fast and delightful service.</p>\n<table border=\"1\">\n <tbody>\n  <tr>\n   <th>Metric</th>\n   <th>First Nine Months of 2020</th>\n   <th>First Nine Months of 2021</th>\n   <th>Change</th>\n  </tr>\n  <tr>\n   <td>Net loss</td>\n   <td>$88.4 million</td>\n   <td>$171.0 million</td>\n   <td>93.4%</td>\n  </tr>\n  <tr>\n   <td>Net loss as a percentage of revenue</td>\n   <td>119.6%</td>\n   <td>195.6%</td>\n   <td><p>N/A</p></td>\n  </tr>\n </tbody>\n</table>\n<p>This major uptick in net losses has primarily been because of the company's loss ratio. Lemonade's net loss ratio -- which represents the amount of premium paid out on claims -- was 77% in the third quarter. A ratio of 75% or below is the long-term goal that management is targeting, but it has been consistently higher in 2021 because of the new products that Lemonade has launched this year and in 2020.</p>\n<p>Lemonade's AI can often take time to learn and collect data about its new markets, resulting in poor short-term performance but long-term opportunities. As its AI obtains more data, it should become more accurate, lowering its loss ratio and its net loss. With the lowered loss ratio, investors could expect the company to generate a profit, which would provide optimism beyond its environmental, social, and governance (ESG) efforts.</p>\n<p>Both of these companies are incredibly young and are quite risky today, which is clearly noted in the stock decreases of more than 25% for each year-to-date. But in a balanced portfolio, these stocks could define someone's future investing success. If both companies can use their competitive edges to rapidly grow their business over the next 15 years and become profitable, they could reward investors by 2035.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want $1 Million in Retirement? Invest $100,000 in These 2 Stocks and Hold Until 2035</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant $1 Million in Retirement? Invest $100,000 in These 2 Stocks and Hold Until 2035\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-12 12:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/11/want-1-million-in-retirement-invest-100000-in-thes/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Over the past 15 years, the S&P 500 has risen in price 232%, which results in a 9.8% compound annual growth rate without inflation. If this continued for the next 15 years, you would have over $300,...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/11/want-1-million-in-retirement-invest-100000-in-thes/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AVB":"阿湾物产","BK4528":"SaaS概念","BK4023":"应用软件","BK4107":"财产与意外伤害保险","BK4551":"寇图资本持仓","LTCH":"Latch, Inc.","ESG":"FlexShares STOXX US ESG Select Index Fund","BK4535":"淡马锡持仓","BK4543":"AI","BK4549":"软银资本持仓","BK4135":"资产管理与托管银行","AI":"C3.ai, Inc.","BK4548":"巴美列捷福持仓","BAM":"布鲁克菲尔德资产管理","BK4215":"住宅房地产投资信托","LMND":"Lemonade, Inc."},"source_url":"https://www.fool.com/investing/2021/12/11/want-1-million-in-retirement-invest-100000-in-thes/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190679207","content_text":"Over the past 15 years, the S&P 500 has risen in price 232%, which results in a 9.8% compound annual growth rate without inflation. If this continued for the next 15 years, you would have over $300,000 in savings to retire on if you invested $100,000, which is bigger than the average 60-year-old American's 401(k) balance.\nWhile this strategy could produce solid returns, there are two stocks that could crush that average by 2035. Here's why I think Latch (NASDAQ:LTCH) and Lemonade (NYSE:LMND) have the potential to provide high-quality returns so that you can retire right.\n1. Latch: Smart security\nThis smart lock manufacturer is taking the industry by storm with its software. With LatchOS, apartment managers can get a birds-eye view of all their apartments on one platform, making sure all of their tenants are safe and secure. Moreover, managers can let in workers or delivery people from that platform. Latch is the only company that can offer a combination of smart, keyless locks and innovative software, so it's no wonder it is rapidly being adopted by apartment buildings across America.\nNearly a third of new apartment buildings are being built today with Latch installed in them, and once Latch's locks are in, it can be incredibly hard to replace them with a competitor. Additionally, when customers agree to use Latch, they sign six- to 10-year contracts to use LatchOS. These two factors provide amazingly high switching costs, so once Latch is installed, it's likely that its users will stay Latch users for a long time. Latch has experienced zero turnovers since it started operations in 2017, and that will probably continue to be the case.\nLatch's market is massive, and the high switching costs and first-mover advantage will likely allow the company to capitalize on it. Latch sees a market opportunity of $54 billion in the U.S. alone, and if the company is able to expand internationally in a few years, that adds another $90 billion.\nLatch's partnerships will be another integral part of the company's success. Since Latch customers sign agreements with Latch to use its products before the apartments are even built, it is crucial that Latch is in talks with apartment managers before the construction team breaks ground. That is why Latch has partnered with some of the largest apartment builders in the U.S., like Brookfield (NYSE:BAM) and Avalon Bay (NYSE:AVB).\nThis company has only been operational since 2017, so there are plenty of risks with this business. The primary risk is that it is losing lots of cash.\n\n\n\nMetric\nQ3 2020\nQ3 2021\nChange\n\n\nNet loss\n$15.9 million\n$34.2 million\n115%\n\n\nNet loss as a percentage of revenue\n311.5%\n305.7%\nN/A\n\n\n\nThe company is making most of its money today on its locks, which it sells at a loss. These losses are bad today, but Latch's profitability can improve. Latch has noted that the timeframe it takes from construction to a builder beginning their subscription services is 24 months. The contracts the company has seen could finally turn into reportable revenue within the next couple of years. Analysts see the potential as well with growth forecasts of nearly 50% for the next five years.\nAlso, as its customers stay with the company longer and pay more in its subscription fees for the software -- which has gross margins of 90% -- the company's losses will likely improve to provide a pathway to profitability. This could be a multi-year effort, but if it can use its differentiated product and strong partnerships to attract customers and its high switching costs to retain them, Latch could give investors immense returns by 2035.\n2. Lemonade: An insurance provider anyone can love\nLemonade is making insurance enjoyable. Whether applying for insurance or getting a claim, Lemonade's process is easy and hassle-free with its artificial intelligence (AI)-based bots that can approve applicants and claims in seconds. The company is also aligning its interest with its consumers: Lemonade charges a flat fee, and any money from leftover claims that went unpaid goes to charities that Lemonade customers choose. So far in 2021, Lemonade has donated over $2.2 million in unpaid claims on behalf of its customers.\nLemonade's incentive alignment structure can hurt its bottom line, but it has resulted in amazing customer attraction. Lemonade has over 1.3 million customers, and it has been one of the fastest-growing insurance stocks ever.\nThe company started in renters insurance, targeting young renters. However, just as its customers have moved on in life, Lemonade has expanded. Now it offers homeowners, pet, life, and even car insurance. Lemonade hopes to attract young customers with small offerings like renters and car insurance, then integrate them deeper into the ecosystem with its fast and delightful service.\n\n\n\nMetric\nFirst Nine Months of 2020\nFirst Nine Months of 2021\nChange\n\n\nNet loss\n$88.4 million\n$171.0 million\n93.4%\n\n\nNet loss as a percentage of revenue\n119.6%\n195.6%\nN/A\n\n\n\nThis major uptick in net losses has primarily been because of the company's loss ratio. Lemonade's net loss ratio -- which represents the amount of premium paid out on claims -- was 77% in the third quarter. A ratio of 75% or below is the long-term goal that management is targeting, but it has been consistently higher in 2021 because of the new products that Lemonade has launched this year and in 2020.\nLemonade's AI can often take time to learn and collect data about its new markets, resulting in poor short-term performance but long-term opportunities. As its AI obtains more data, it should become more accurate, lowering its loss ratio and its net loss. With the lowered loss ratio, investors could expect the company to generate a profit, which would provide optimism beyond its environmental, social, and governance (ESG) efforts.\nBoth of these companies are incredibly young and are quite risky today, which is clearly noted in the stock decreases of more than 25% for each year-to-date. But in a balanced portfolio, these stocks could define someone's future investing success. If both companies can use their competitive edges to rapidly grow their business over the next 15 years and become profitable, they could reward investors by 2035.","news_type":1},"isVote":1,"tweetType":1,"viewCount":283,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608603500,"gmtCreate":1638697684792,"gmtModify":1638697684792,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Should I buy?","listText":"Should I buy?","text":"Should I buy?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/608603500","repostId":"2189557676","repostType":4,"isVote":1,"tweetType":1,"viewCount":406,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608321606,"gmtCreate":1638631302049,"gmtModify":1638631302132,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"comment and like","listText":"comment and like","text":"comment and like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608321606","repostId":"2188057871","repostType":4,"repost":{"id":"2188057871","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1638580800,"share":"https://www.laohu8.com/m/news/2188057871?lang=&edition=full","pubTime":"2021-12-04 09:20","market":"us","language":"en","title":"Adobe worth $26 billion less as DocuSign fears spark 'knee-jerk reaction' for stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2188057871","media":"Dow Jones","summary":"Adobe stock was the worst performer in S&P 500 Friday, after e-signature rival suggested pandemic bo","content":"<p>Adobe stock was the worst performer in S&amp;P 500 Friday, after e-signature rival suggested pandemic boom was slowing down</p>\n<p>Shares of Adobe Inc. sank to their worst performance in more than 20 months Friday, after DocuSign Inc. delivered what some saw as a the latest sign of a demand cool-down for work-from-home software.</p>\n<p>DocuSign <a href=\"https://laohu8.com/S/DOCU\">$(DOCU)$</a> Chief Executive Dan Springer acknowledged Thursday that while his electronic-signature company saw \"accelerated growth\" for six quarters amid the pandemic, customers have gone back to \"more normalized buying patterns.\" As a result, DocuSign delivered a downbeat bookings outlook, sending its shares cratering more than 40%.</p>\n<p>Some of that investor fear seemed to transfer over to Adobe <a href=\"https://laohu8.com/S/ADBE\">$(ADBE)$</a>, which also offers contract-management software and allows for the collection of e-signatures. Adobe's stock fell 8.2% Friday, its steepest single-day percentage drop since March 2020 and the worst performance on the day from an S&amp;P 500 stock. The move wiped away $26.3 billion in market capitalization, taking Adobe's valuation lower than $300 billion.</p>\n<p>The decline in Adobe shares struck Wedbush analyst Daniel Ives as a \"DOCU-related selloff,\" he told MarketWatch, as DocuSign's report served as a \"a barometer that the WFH tailwinds are now abating and could be a headwind for Adobe.\"</p>\n<p>\"The DOCU print was a shocker and this is a knee-jerk reaction,\" he said.</p>\n<p>Adobe is due to post its own quarterly results Dec. 16. The company highlighted its e-signature technology in its prior earnings report, as Chief Financial Officer John Murphy noted that \"third-quarter Document Cloud growth drivers included adoption of Sign in Acrobat driven by the increased need to collaborate in a hybrid work environment.\"</p>\n<p>While other at-home stocks took a hit on disappointing outlooks earlier in the course of the pandemic, DocuSign initially appeared more resilient. Its stock hit an all-time high in September and was up 165% since March 2020 as of Thursday's close. Now the company will need to \"show that it can generate, not just fulfill, demand on a regular basis,\" according to an Evercore analyst.</p>\n<p>Adobe has a more diversified business than DocuSign. While the company sells contract-related software, it has a variety of other offerings including subscriptions to creative programs like Photoshop. Adobe's Document Cloud accounted for about 13% of the company's overall revenue in its last-reported quarter.</p>\n<p>Shares of Adobe were up 86% since March 2020 as of Thursday's close.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Adobe worth $26 billion less as DocuSign fears spark 'knee-jerk reaction' for stock</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAdobe worth $26 billion less as DocuSign fears spark 'knee-jerk reaction' for stock\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-12-04 09:20</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Adobe stock was the worst performer in S&amp;P 500 Friday, after e-signature rival suggested pandemic boom was slowing down</p>\n<p>Shares of Adobe Inc. sank to their worst performance in more than 20 months Friday, after DocuSign Inc. delivered what some saw as a the latest sign of a demand cool-down for work-from-home software.</p>\n<p>DocuSign <a href=\"https://laohu8.com/S/DOCU\">$(DOCU)$</a> Chief Executive Dan Springer acknowledged Thursday that while his electronic-signature company saw \"accelerated growth\" for six quarters amid the pandemic, customers have gone back to \"more normalized buying patterns.\" As a result, DocuSign delivered a downbeat bookings outlook, sending its shares cratering more than 40%.</p>\n<p>Some of that investor fear seemed to transfer over to Adobe <a href=\"https://laohu8.com/S/ADBE\">$(ADBE)$</a>, which also offers contract-management software and allows for the collection of e-signatures. Adobe's stock fell 8.2% Friday, its steepest single-day percentage drop since March 2020 and the worst performance on the day from an S&amp;P 500 stock. The move wiped away $26.3 billion in market capitalization, taking Adobe's valuation lower than $300 billion.</p>\n<p>The decline in Adobe shares struck Wedbush analyst Daniel Ives as a \"DOCU-related selloff,\" he told MarketWatch, as DocuSign's report served as a \"a barometer that the WFH tailwinds are now abating and could be a headwind for Adobe.\"</p>\n<p>\"The DOCU print was a shocker and this is a knee-jerk reaction,\" he said.</p>\n<p>Adobe is due to post its own quarterly results Dec. 16. The company highlighted its e-signature technology in its prior earnings report, as Chief Financial Officer John Murphy noted that \"third-quarter Document Cloud growth drivers included adoption of Sign in Acrobat driven by the increased need to collaborate in a hybrid work environment.\"</p>\n<p>While other at-home stocks took a hit on disappointing outlooks earlier in the course of the pandemic, DocuSign initially appeared more resilient. Its stock hit an all-time high in September and was up 165% since March 2020 as of Thursday's close. Now the company will need to \"show that it can generate, not just fulfill, demand on a regular basis,\" according to an Evercore analyst.</p>\n<p>Adobe has a more diversified business than DocuSign. While the company sells contract-related software, it has a variety of other offerings including subscriptions to creative programs like Photoshop. Adobe's Document Cloud accounted for about 13% of the company's overall revenue in its last-reported quarter.</p>\n<p>Shares of Adobe were up 86% since March 2020 as of Thursday's close.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4023":"应用软件","BK4554":"元宇宙及AR概念","BK4566":"资本集团","BK4533":"AQR资本管理(全球第二大对冲基金)","DOCU":"Docusign","ADBE":"Adobe","BK4567":"ESG概念","BK4527":"明星科技股","BK4534":"瑞士信贷持仓","BK4528":"SaaS概念"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2188057871","content_text":"Adobe stock was the worst performer in S&P 500 Friday, after e-signature rival suggested pandemic boom was slowing down\nShares of Adobe Inc. sank to their worst performance in more than 20 months Friday, after DocuSign Inc. delivered what some saw as a the latest sign of a demand cool-down for work-from-home software.\nDocuSign $(DOCU)$ Chief Executive Dan Springer acknowledged Thursday that while his electronic-signature company saw \"accelerated growth\" for six quarters amid the pandemic, customers have gone back to \"more normalized buying patterns.\" As a result, DocuSign delivered a downbeat bookings outlook, sending its shares cratering more than 40%.\nSome of that investor fear seemed to transfer over to Adobe $(ADBE)$, which also offers contract-management software and allows for the collection of e-signatures. Adobe's stock fell 8.2% Friday, its steepest single-day percentage drop since March 2020 and the worst performance on the day from an S&P 500 stock. The move wiped away $26.3 billion in market capitalization, taking Adobe's valuation lower than $300 billion.\nThe decline in Adobe shares struck Wedbush analyst Daniel Ives as a \"DOCU-related selloff,\" he told MarketWatch, as DocuSign's report served as a \"a barometer that the WFH tailwinds are now abating and could be a headwind for Adobe.\"\n\"The DOCU print was a shocker and this is a knee-jerk reaction,\" he said.\nAdobe is due to post its own quarterly results Dec. 16. The company highlighted its e-signature technology in its prior earnings report, as Chief Financial Officer John Murphy noted that \"third-quarter Document Cloud growth drivers included adoption of Sign in Acrobat driven by the increased need to collaborate in a hybrid work environment.\"\nWhile other at-home stocks took a hit on disappointing outlooks earlier in the course of the pandemic, DocuSign initially appeared more resilient. Its stock hit an all-time high in September and was up 165% since March 2020 as of Thursday's close. Now the company will need to \"show that it can generate, not just fulfill, demand on a regular basis,\" according to an Evercore analyst.\nAdobe has a more diversified business than DocuSign. While the company sells contract-related software, it has a variety of other offerings including subscriptions to creative programs like Photoshop. Adobe's Document Cloud accounted for about 13% of the company's overall revenue in its last-reported quarter.\nShares of Adobe were up 86% since March 2020 as of Thursday's close.","news_type":1},"isVote":1,"tweetType":1,"viewCount":127,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696656798,"gmtCreate":1640689318434,"gmtModify":1640689363451,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696656798","repostId":"2194610717","repostType":4,"isVote":1,"tweetType":1,"viewCount":754,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602543556,"gmtCreate":1639047177157,"gmtModify":1639047177229,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Comm","listText":"Comm","text":"Comm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602543556","repostId":"1128116582","repostType":4,"isVote":1,"tweetType":1,"viewCount":269,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604928940,"gmtCreate":1639314954285,"gmtModify":1639318695866,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Zzz","listText":"Zzz","text":"Zzz","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604928940","repostId":"2190679207","repostType":4,"repost":{"id":"2190679207","pubTimestamp":1639281804,"share":"https://www.laohu8.com/m/news/2190679207?lang=&edition=full","pubTime":"2021-12-12 12:03","market":"us","language":"en","title":"Want $1 Million in Retirement? Invest $100,000 in These 2 Stocks and Hold Until 2035","url":"https://stock-news.laohu8.com/highlight/detail?id=2190679207","media":"Motley Fool","summary":"These two stocks could change your retirement.","content":"<p>Over the past 15 years, the <b>S&amp;P 500</b> has risen in price 232%, which results in a 9.8% compound annual growth rate without inflation. If this continued for the next 15 years, you would have over $300,000 in savings to retire on if you invested $100,000, which is bigger than the average 60-year-old American's 401(k) balance.</p>\n<p>While this strategy could produce solid returns, there are two stocks that could crush that average by 2035. Here's why I think <b>Latch</b> (NASDAQ:LTCH) and <b>Lemonade</b> (NYSE:LMND) have the potential to provide high-quality returns so that you can retire right.</p>\n<h2>1. Latch: Smart security</h2>\n<p>This smart lock manufacturer is taking the industry by storm with its software. With LatchOS, apartment managers can get a birds-eye view of all their apartments on <a href=\"https://laohu8.com/S/AONE.U\">one</a> platform, making sure all of their tenants are safe and secure. Moreover, managers can let in workers or delivery people from that platform. Latch is the only company that can offer a combination of smart, keyless locks and innovative software, so it's no wonder it is rapidly being adopted by apartment buildings across America.</p>\n<p>Nearly a third of new apartment buildings are being built today with Latch installed in them, and once Latch's locks are in, it can be incredibly hard to replace them with a competitor. Additionally, when customers agree to use Latch, they sign six- to 10-year contracts to use LatchOS. These two factors provide amazingly high switching costs, so once Latch is installed, it's likely that its users will stay Latch users for a long time. Latch has experienced zero turnovers since it started operations in 2017, and that will probably continue to be the case.</p>\n<p>Latch's market is massive, and the high switching costs and first-mover advantage will likely allow the company to capitalize on it. Latch sees a market opportunity of $54 billion in the U.S. alone, and if the company is able to expand internationally in a few years, that adds another $90 billion.</p>\n<p>Latch's partnerships will be another integral part of the company's success. Since Latch customers sign agreements with Latch to use its products before the apartments are even built, it is crucial that Latch is in talks with apartment managers before the construction team breaks ground. That is why Latch has partnered with some of the largest apartment builders in the U.S., like <b>Brookfield</b> (NYSE:BAM) and <b>Avalon Bay</b> (NYSE:AVB).</p>\n<p>This company has only been operational since 2017, so there are plenty of risks with this business. The primary risk is that it is losing lots of cash.</p>\n<table border=\"1\">\n <tbody>\n  <tr>\n   <th>Metric</th>\n   <th>Q3 2020</th>\n   <th>Q3 2021</th>\n   <th>Change</th>\n  </tr>\n  <tr>\n   <td>Net loss</td>\n   <td>$15.9 million</td>\n   <td>$34.2 million</td>\n   <td>115%</td>\n  </tr>\n  <tr>\n   <td>Net loss as a percentage of revenue</td>\n   <td>311.5%</td>\n   <td>305.7%</td>\n   <td>N/A</td>\n  </tr>\n </tbody>\n</table>\n<p>The company is making most of its money today on its locks, which it sells at a loss. These losses are bad today, but Latch's profitability can improve. Latch has noted that the timeframe it takes from construction to a builder beginning their subscription services is 24 months. The contracts the company has seen could finally turn into reportable revenue within the next couple of years. Analysts see the potential as well with growth forecasts of nearly 50% for the next five years.</p>\n<p>Also, as its customers stay with the company longer and pay more in its subscription fees for the software -- which has gross margins of 90% -- the company's losses will likely improve to provide a pathway to profitability. This could be a multi-year effort, but if it can use its differentiated product and strong partnerships to attract customers and its high switching costs to retain them, Latch could give investors immense returns by 2035.</p>\n<h2>2. Lemonade: An insurance provider anyone can love</h2>\n<p>Lemonade is making insurance enjoyable. Whether applying for insurance or getting a claim, Lemonade's process is easy and hassle-free with its artificial intelligence (AI)-based bots that can approve applicants and claims in seconds. The company is also aligning its interest with its consumers: Lemonade charges a flat fee, and any money from leftover claims that went unpaid goes to charities that Lemonade customers choose. So far in 2021, Lemonade has donated over $2.2 million in unpaid claims on behalf of its customers.</p>\n<p>Lemonade's incentive alignment structure can hurt its bottom line, but it has resulted in amazing customer attraction. Lemonade has over 1.3 million customers, and it has been one of the fastest-growing insurance stocks ever.</p>\n<p>The company started in renters insurance, targeting young renters. However, just as its customers have moved on in life, Lemonade has expanded. Now it offers homeowners, pet, life, and even car insurance. Lemonade hopes to attract young customers with small offerings like renters and car insurance, then integrate them deeper into the ecosystem with its fast and delightful service.</p>\n<table border=\"1\">\n <tbody>\n  <tr>\n   <th>Metric</th>\n   <th>First Nine Months of 2020</th>\n   <th>First Nine Months of 2021</th>\n   <th>Change</th>\n  </tr>\n  <tr>\n   <td>Net loss</td>\n   <td>$88.4 million</td>\n   <td>$171.0 million</td>\n   <td>93.4%</td>\n  </tr>\n  <tr>\n   <td>Net loss as a percentage of revenue</td>\n   <td>119.6%</td>\n   <td>195.6%</td>\n   <td><p>N/A</p></td>\n  </tr>\n </tbody>\n</table>\n<p>This major uptick in net losses has primarily been because of the company's loss ratio. Lemonade's net loss ratio -- which represents the amount of premium paid out on claims -- was 77% in the third quarter. A ratio of 75% or below is the long-term goal that management is targeting, but it has been consistently higher in 2021 because of the new products that Lemonade has launched this year and in 2020.</p>\n<p>Lemonade's AI can often take time to learn and collect data about its new markets, resulting in poor short-term performance but long-term opportunities. As its AI obtains more data, it should become more accurate, lowering its loss ratio and its net loss. With the lowered loss ratio, investors could expect the company to generate a profit, which would provide optimism beyond its environmental, social, and governance (ESG) efforts.</p>\n<p>Both of these companies are incredibly young and are quite risky today, which is clearly noted in the stock decreases of more than 25% for each year-to-date. But in a balanced portfolio, these stocks could define someone's future investing success. If both companies can use their competitive edges to rapidly grow their business over the next 15 years and become profitable, they could reward investors by 2035.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want $1 Million in Retirement? Invest $100,000 in These 2 Stocks and Hold Until 2035</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant $1 Million in Retirement? Invest $100,000 in These 2 Stocks and Hold Until 2035\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-12 12:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/11/want-1-million-in-retirement-invest-100000-in-thes/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Over the past 15 years, the S&P 500 has risen in price 232%, which results in a 9.8% compound annual growth rate without inflation. If this continued for the next 15 years, you would have over $300,...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/11/want-1-million-in-retirement-invest-100000-in-thes/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AVB":"阿湾物产","BK4528":"SaaS概念","BK4023":"应用软件","BK4107":"财产与意外伤害保险","BK4551":"寇图资本持仓","LTCH":"Latch, Inc.","ESG":"FlexShares STOXX US ESG Select Index Fund","BK4535":"淡马锡持仓","BK4543":"AI","BK4549":"软银资本持仓","BK4135":"资产管理与托管银行","AI":"C3.ai, Inc.","BK4548":"巴美列捷福持仓","BAM":"布鲁克菲尔德资产管理","BK4215":"住宅房地产投资信托","LMND":"Lemonade, Inc."},"source_url":"https://www.fool.com/investing/2021/12/11/want-1-million-in-retirement-invest-100000-in-thes/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190679207","content_text":"Over the past 15 years, the S&P 500 has risen in price 232%, which results in a 9.8% compound annual growth rate without inflation. If this continued for the next 15 years, you would have over $300,000 in savings to retire on if you invested $100,000, which is bigger than the average 60-year-old American's 401(k) balance.\nWhile this strategy could produce solid returns, there are two stocks that could crush that average by 2035. Here's why I think Latch (NASDAQ:LTCH) and Lemonade (NYSE:LMND) have the potential to provide high-quality returns so that you can retire right.\n1. Latch: Smart security\nThis smart lock manufacturer is taking the industry by storm with its software. With LatchOS, apartment managers can get a birds-eye view of all their apartments on one platform, making sure all of their tenants are safe and secure. Moreover, managers can let in workers or delivery people from that platform. Latch is the only company that can offer a combination of smart, keyless locks and innovative software, so it's no wonder it is rapidly being adopted by apartment buildings across America.\nNearly a third of new apartment buildings are being built today with Latch installed in them, and once Latch's locks are in, it can be incredibly hard to replace them with a competitor. Additionally, when customers agree to use Latch, they sign six- to 10-year contracts to use LatchOS. These two factors provide amazingly high switching costs, so once Latch is installed, it's likely that its users will stay Latch users for a long time. Latch has experienced zero turnovers since it started operations in 2017, and that will probably continue to be the case.\nLatch's market is massive, and the high switching costs and first-mover advantage will likely allow the company to capitalize on it. Latch sees a market opportunity of $54 billion in the U.S. alone, and if the company is able to expand internationally in a few years, that adds another $90 billion.\nLatch's partnerships will be another integral part of the company's success. Since Latch customers sign agreements with Latch to use its products before the apartments are even built, it is crucial that Latch is in talks with apartment managers before the construction team breaks ground. That is why Latch has partnered with some of the largest apartment builders in the U.S., like Brookfield (NYSE:BAM) and Avalon Bay (NYSE:AVB).\nThis company has only been operational since 2017, so there are plenty of risks with this business. The primary risk is that it is losing lots of cash.\n\n\n\nMetric\nQ3 2020\nQ3 2021\nChange\n\n\nNet loss\n$15.9 million\n$34.2 million\n115%\n\n\nNet loss as a percentage of revenue\n311.5%\n305.7%\nN/A\n\n\n\nThe company is making most of its money today on its locks, which it sells at a loss. These losses are bad today, but Latch's profitability can improve. Latch has noted that the timeframe it takes from construction to a builder beginning their subscription services is 24 months. The contracts the company has seen could finally turn into reportable revenue within the next couple of years. Analysts see the potential as well with growth forecasts of nearly 50% for the next five years.\nAlso, as its customers stay with the company longer and pay more in its subscription fees for the software -- which has gross margins of 90% -- the company's losses will likely improve to provide a pathway to profitability. This could be a multi-year effort, but if it can use its differentiated product and strong partnerships to attract customers and its high switching costs to retain them, Latch could give investors immense returns by 2035.\n2. Lemonade: An insurance provider anyone can love\nLemonade is making insurance enjoyable. Whether applying for insurance or getting a claim, Lemonade's process is easy and hassle-free with its artificial intelligence (AI)-based bots that can approve applicants and claims in seconds. The company is also aligning its interest with its consumers: Lemonade charges a flat fee, and any money from leftover claims that went unpaid goes to charities that Lemonade customers choose. So far in 2021, Lemonade has donated over $2.2 million in unpaid claims on behalf of its customers.\nLemonade's incentive alignment structure can hurt its bottom line, but it has resulted in amazing customer attraction. Lemonade has over 1.3 million customers, and it has been one of the fastest-growing insurance stocks ever.\nThe company started in renters insurance, targeting young renters. However, just as its customers have moved on in life, Lemonade has expanded. Now it offers homeowners, pet, life, and even car insurance. Lemonade hopes to attract young customers with small offerings like renters and car insurance, then integrate them deeper into the ecosystem with its fast and delightful service.\n\n\n\nMetric\nFirst Nine Months of 2020\nFirst Nine Months of 2021\nChange\n\n\nNet loss\n$88.4 million\n$171.0 million\n93.4%\n\n\nNet loss as a percentage of revenue\n119.6%\n195.6%\nN/A\n\n\n\nThis major uptick in net losses has primarily been because of the company's loss ratio. Lemonade's net loss ratio -- which represents the amount of premium paid out on claims -- was 77% in the third quarter. A ratio of 75% or below is the long-term goal that management is targeting, but it has been consistently higher in 2021 because of the new products that Lemonade has launched this year and in 2020.\nLemonade's AI can often take time to learn and collect data about its new markets, resulting in poor short-term performance but long-term opportunities. As its AI obtains more data, it should become more accurate, lowering its loss ratio and its net loss. With the lowered loss ratio, investors could expect the company to generate a profit, which would provide optimism beyond its environmental, social, and governance (ESG) efforts.\nBoth of these companies are incredibly young and are quite risky today, which is clearly noted in the stock decreases of more than 25% for each year-to-date. But in a balanced portfolio, these stocks could define someone's future investing success. If both companies can use their competitive edges to rapidly grow their business over the next 15 years and become profitable, they could reward investors by 2035.","news_type":1},"isVote":1,"tweetType":1,"viewCount":131,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691985311,"gmtCreate":1640125986981,"gmtModify":1640126022488,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Comment","listText":"Comment","text":"Comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691985311","repostId":"1198919837","repostType":4,"repost":{"id":"1198919837","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1640098127,"share":"https://www.laohu8.com/m/news/1198919837?lang=&edition=full","pubTime":"2021-12-21 22:48","market":"us","language":"en","title":"Amgen's Otezla Wins FDA Approval For Psoriasis, Regardless Of Severity Level","url":"https://stock-news.laohu8.com/highlight/detail?id=1198919837","media":"Benzinga","summary":"The FDA has approved Amgen Inc's Otezla (apremilast) to treat adult patients with plaque psoriasis w","content":"<p>The&nbsp;FDA has approved&nbsp;<b>Amgen Inc's</b>&nbsp;Otezla (apremilast) to treat adult patients with plaque psoriasis who are candidates for phototherapy or systemic therapy.</p>\n<ul>\n <li>With this expanded indication, Otezla is now the first and only oral treatment approved in adult patients with plaque psoriasis across all severities, including mild, moderate, and severe.</li>\n <li>The FDA approval is based on Phase 3 ADVANCE trial data. Five times as many adults receiving oral Otezla 30 achieved the primary endpoint of Static Physician's Global Assessment response at week 16 compared to placebo (21.6% versus 4.1%).</li>\n <li>Otezla is approved for three indications in the U.S.</li>\n <li><b>Price Action:</b>&nbsp;AMGN shares closed at $219.99 on Monday.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Amgen's Otezla Wins FDA Approval For Psoriasis, Regardless Of Severity Level</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmgen's Otezla Wins FDA Approval For Psoriasis, Regardless Of Severity Level\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-12-21 22:48</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>The&nbsp;FDA has approved&nbsp;<b>Amgen Inc's</b>&nbsp;Otezla (apremilast) to treat adult patients with plaque psoriasis who are candidates for phototherapy or systemic therapy.</p>\n<ul>\n <li>With this expanded indication, Otezla is now the first and only oral treatment approved in adult patients with plaque psoriasis across all severities, including mild, moderate, and severe.</li>\n <li>The FDA approval is based on Phase 3 ADVANCE trial data. Five times as many adults receiving oral Otezla 30 achieved the primary endpoint of Static Physician's Global Assessment response at week 16 compared to placebo (21.6% versus 4.1%).</li>\n <li>Otezla is approved for three indications in the U.S.</li>\n <li><b>Price Action:</b>&nbsp;AMGN shares closed at $219.99 on Monday.</li>\n</ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMGN":"安进"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1198919837","content_text":"The FDA has approved Amgen Inc's Otezla (apremilast) to treat adult patients with plaque psoriasis who are candidates for phototherapy or systemic therapy.\n\nWith this expanded indication, Otezla is now the first and only oral treatment approved in adult patients with plaque psoriasis across all severities, including mild, moderate, and severe.\nThe FDA approval is based on Phase 3 ADVANCE trial data. Five times as many adults receiving oral Otezla 30 achieved the primary endpoint of Static Physician's Global Assessment response at week 16 compared to placebo (21.6% versus 4.1%).\nOtezla is approved for three indications in the U.S.\nPrice Action: AMGN shares closed at $219.99 on Monday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":425,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699341695,"gmtCreate":1639752339922,"gmtModify":1639752629684,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Buy","listText":"Buy","text":"Buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699341695","repostId":"2192997802","repostType":4,"isVote":1,"tweetType":1,"viewCount":691,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865286656,"gmtCreate":1632987617711,"gmtModify":1632987618992,"author":{"id":"3578003727844992","authorId":"3578003727844992","name":"olddirtbag","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"comment and like","listText":"comment and like","text":"comment and like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/865286656","repostId":"1132265874","repostType":4,"isVote":1,"tweetType":1,"viewCount":160,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}